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ABSTRACT  
 
In Liberia, the most common neglected tropical diseases (NTDs) are: lymphatic 
filariasis (LF); schistosomiasis (SCH); soil-transmitted helminthiasis (STH); and 
onchocerciasis (Oncho). My research sought to explore an integrated approach for the 
control of these NTDs to assist the Ministry of Health (MoH) in establishing a better 
co-ordinated, economical and cost-effective intervention. As a result of my research, 
the MoH, in collaboration with the Centre for Neglected Tropical Diseases (CNTD) at 
the Liverpool School of Tropical Medicine, progressively unified the disease-specific 
vertical programmes into a single umbrella, entitled: ‘The Integrated NTDs 
Programme’. Previously, Oncho control was the only tropical disease programme 
established within the MoH and acted as a stand-alone. Steps towards integration were 
first tailored upon the existing vertical delivery mechanisms for Oncho i.e., 
Community-Directed Treatment with Ivermectin (CDTI) through existing drug 
distribution networks and school-based programmes.   
The aim of my study was to develop and implement an integrated strategy for 
LF, SCH and STH first using the CDTI Oncho networks to obtain data on the prevalence 
and risk factors for these diseases simultaneously. During my study period, certain 
activities within the MoH were suspended due to the emergency response to the Ebola 
epidemic. This eventually led my thesis to be structured into two parts, pre- and post-
epidemic. Pre-epidemic – LF: The first national baseline disease mapping by 
immunochromatographic test (ICT) cards and baseline microfilaria pre-Mass Drug 
Administration (MDA) in Liberia. This provided epidemiological data for the entire 
country, which was used by the MoH to identify implementation units for MDA. The 
overall ICT prevalence was 24.0% with the highest percentage prevalence observed in 
the coastal region. The study also revealed that LF was endemic in 13 out of the 15 
counties in Liberia. The baseline microfilaria result reported, in the study, a 6.0% 
prevalence rate. A total of 1,498 men were examined for the clinical manifestation of 
the disease, of which, 12.0% hydrocele and 6.0% lymphoedema cases were observed. 
A population-based knowledge and compliance study on LF was carried out in Bong 
County. Analysis of the results showed that more than 60.0% of the participants were 
aware of the disease, but only 43.0% of the participants admitted to taking both 
Albendazole and Ivermectin, demonstrating low treatment coverage, even though 
50.0% of the participants knew the mode of LF transmission. Post-epidemic – STH 
iv  
and SCH: Parastiological surveillance studies were undertaken in Bong County as a 
representative epidemiological indicator for the national control programme to provide 
up-to-date information on SCH and STH. An epidemiological update on urogenital and 
intestinal SCH was undertaken amongst schoolchildren in Bong County, northern 
Liberia alongside observations on STH. A cross-sectional study examined 1,003 
school-aged children from 10 schools representing eight health districts in the country 
where MDA campaigns were ongoing. In total, 12.0% of the children were infected 
with Schistosoma mansoni and 11.0% infected with Schistosoma haematobium, while 
general prevalence of STH was much lower with hookworm having the highest 
prevalence of 3.0%. For the first time, a knowledge attitude and practices survey for 
SCH, LF and STH was assessed amongst school-aged children in Bong County, 
northern Liberia, which highlighted the need for better health education and improved 
sanitation. For example, analysis of data demonstrated that from the 1,003 participants 
92.0% had not heard of LF, 86.0% had not heard of STH, and 90.0% had not heard of 
SCH. Only 9.0% of participants had access to pipe water. To investigate the morbidity 
associated with SCH, a cross-sectional assessment using portable ultrasound was 
undertaken, which was the first ever field-based investigation in Liberia. Of the 272 
school-aged children examined, morbidity was low (<1.0%) demonstrating little 
clinical moribidity in this school-based setting.My research was activated and first 
guided by recommendations from the World Health Organization (Global Plan to 
Combat NTDs, 2008–2015) to examine ways in which interventions against NTDs 
could be better co-ordinated and streamlined. The concept of integrated NTD control is 
attractive in resource poor settings such as Liberia as it can rationalize costs associated 
with logistics, staffing, and also better delivery of medicines. My research suggests that, 
the integrated approach to controlling NTDs is possible, cost-effective, and less time 
consuming. The recommendations made are that, the integrated NTDs programme at 
the MoH should collaborate with other health service programmes at the MoH, the 
Ministry of Education, the Liberia water and sewer company, the National Drug 
Service, and other relevant stakeholders in order to achieve its goal and produce more 
maintainable impact. The conclusions are that, an integrated disease programme should 
strengthen and not threaten or compromise the current efforts to efficiently co-ordinate, 
reduce, eliminate, and ultimately eradicate specific diseases within the NTDs.  
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CHAPTER 1: BACKGROUND  
 
1.1 Introduction  
Neglected tropical diseases (NTDs) are a varied group of parasitic, fungal, viral and 
bacterial envenomicing diseases that prevail in tropical and subtropical conditions. 
NTDs are found in approximately 149 countries globally and affect an estimated 1.4 
billion of the world’s poorest people. It is referred to as the ‘accent afflictions’. NTDs 
are often associated with significant physical debilitation that results in lower economic 
productivity and social ostracism (Hotez, Ottesen, Fenwick, & Molyneux, 2006; Hotez, 
Fenwick, Savioli, & Molyneux, 2009). In recent years, a number of NTDs have been 
targeted for control or elimination, with some as early as 2020 (WHO, 2012a).  
With the help of international partners, some endemic countries are now 
demonstrating strong ownership and leadership, in variable financial, political and 
environmental circumstances, to ensure their NTD programmes are successful in 
meeting 2020 targets, which is inspired by the World Health Organization (WHO) 2011 
roadmap on NTDs (WHO, 2011a). Some countries are achieving elimination goals, 
more people are being reached, and the drug donation programme for NTDs, which is 
the largest public health drug donation programme in the world, continues to grow 
(Molyneux, 2004).  
In most countries that had started Mass Drug Administration (MDA), efforts to 
prevent and treat NTDs was through disease-specific programmes that were funded 
through myriad sources at international level. Strategies for the different NTD 
programmes were not co-ordinated well to best harmonise activities and resources, and 
the international donor funding similarly lacked a macro strategy.  
To address these shortcomings, the global NTDs community in May 2013, at 
the sixty-sixth World Health Assembly adopted Resolution WHA66.12 on NTDs to call 
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on Member States to intensify and integrate measures and plan investment to improve 
the health and social well-being of affected populations (WHO, 2013a). This approach 
would be unlike the traditional vertical approach, which targeted specific diseases.  
An integrated approach for the NTDs takes into consideration that all of these 
diseases in a particular country can be incorporated into a single programme, this could 
potentially make implementation easier and could facilitate an increase in the 
efficiencies of the delivery of drugs in a co-ordinated fashion and would lead to better 
costeffectiveness in an already resource-stretched country. It is very important to 
integrate these diseases because they demonstrate geographical overlap. In addition, 
drugs used as preventive chemotherapy also treat other diseases, different than those 
they were targeted against (Molyneux, Hotez, & Fenwick, 2005). It cannot also be over-
emphasised that integration reduces cost for the country (Conteh, Engels, & Molyneux, 
2010).  
  
Figure 1.1: Overlapping of four of the most common NTDs in Liberia  
  
Source: MoHSW (2017a).  
  
Table 1.1: Four of the most common NTDs co-endemicity in Liberia, by counties  
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         NTDs Counties (+) = present in county (–) = absent in county  
  LF  Oncho  STH  SCH  
Bomi  –  +  +  –  
Bong  +  +  +  +  
Grand Bassa  +  +  +  –  
Grand Cape Mount  +  +  +  –  
Grand Gedeh  +  +  +  –  
Grand Kru  +  +  +  –  
Lofa  +  +  +  +  
Margibi  +  +  +  +  
Maryland  +  +  +  –  
Montserrado  +  +  +  –  
Nimba  +  +  +  +  
Rivercess  +  +  +  –  
Sinoe  +  +  +  –  
River Gee  +  +  +  –  
Gbarbolu  –  +  +  –  
Source: MoHSW (2017a).  
  
The present integrated strategy promoted by WHO to control NTDs including 
schistosomiasis (SCH), onchocerciasis (Oncho), lymphatic filariasis (LF) and 
soiltransmitted helminthiasis (STH) that are amenable to MDA was adopted by the 
Ministry of Health (MoH) Liberia in 2011, at the inception of the integrated NTD 
programme at the MoH. However, baseline data from mapping of NTDs in Liberia 
indicated that there is a high prevalence and overlap of the four most common NTDs in 
the country: Oncho,  
LF, SCH and STH see Figure 1 and Table 1.1  
According to the WHO tenth meeting of the Strategic and Technical Advisory Group 
for NTDs held in 2017, there are 20 NTDs in the world (WHO, 2017a):   
1. Buruli ulcer   
2. Chagas disease (American trypansomiasis)   
3. Cutaneous leishmaniasis and cisceral leishmaniasis   
4. Dengue/Chikungumya  
5. Echinococcus   
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6. Foodborne trematode infections  
7. Guinea worm (Dracunculiasis)  
8. Human African trypanosomiasis   
9. Leprosy (Hansen disease)  
10. LF (elephantiasis)  
11. Mycetoma, chromoblastomycosis and other deep mycoses  
12. Oncho (river blindness)  
13. Rabies  
14. Scabies and other ectoparasites   
15. SCH (Bilharzia)  
16. Snakebite envenoming   
17. STH  
18. Taeniasis and cysticercosis  
19. Trachoma (preventable blindness)   
20. Yaws (Endemic treponematoses)  
  
While some of the NTDs can be controllable by MDA, others require individual 
treatment. The NTDs that can be controlled by MDA is as follows: STH; SCH; LF 
(elephantiasis); Oncho (river blindness); and trachoma (preventable blindness). Guinea 
worm can be controlled by clean drinking water. NTDs that can be treated on an 
individual basis are as follows: leprosy; Buruli ulcer; Chagas disease; human African 
trypanosomiasis; Cutaneous Leishmaniasis; Visceral Leishmaniasis; and Dengue. The 
zoonotic parasitic diseases are Neurocysticercosis, and Echinococcus. Animals that 
serve as a reservoir for NTDs are: Brucellosis and rabies (Keenan, et al., 2013). The 
greatest burden of the disease can be found in sub-Saharan Africa (see Table 1.2)  
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Table 1.2: Prevalent cases of NTDs in 2013 and percent change from 1990 to 2013 
according to Global Burden of Disease Study (GBD) 2013  
Disease  
Prevalent  cases  
millions) in 2013  
(in  Percent 
since 1990  
change  
Ascariasis  804.4    -25.5%   
Trichuriasis  477.4    -11.6%   
Hookworm  471.8    -5.1%   
Schistosomiasis  290.6    30.9%   
Foodborne trematodiases  80.2    51.1%   
Dengue*+  58.4    610.9%   
Lymphatic filariasis  43.9    -32.1%   
Onchocerciasis  17    -31.2%   
Chagas disease  9.4    22.4%   
Cutaneous/mucocutaneous 
leishamaniasis  3.9  
  
174.2%  
 
Trachoma+  2.4    -39.2%   
Cysticercosis+  1    -26.3%   
Cystic echinococcosis+  0.8    -15.4%   
Leprosy  0.7    61.3%   
Visceral leishmaniasis  0.7    35.1%   
Rabies*+  0.02    -40.4%   
African trypanossomiasis  0.02    -71.1%   
Other NTDs  59.7    -5.0%   
Total Cases  2322    NA   
Additional NTDs  
Prevalent 
millions) in 
2013 
cases  
  
(in  
Percentage change 
since 1990  
Trichomoniasis  67.1   45.6%  
Scabies  66.1   24.8%  
Typhoid fever*  11   -19.9%  
Paratyphiod fever*  6.4   -27.9%  
6  
Venomous animal contact*  5.5   -2.7%  
Cholera*  2.3   6.1%  
Cryptosporidiosis*  1.4   -19.4%  
Amoebiasis*  0.4   17.0%  
Total  cases  of  additional  
neglected diseases  160.2  
 
NA  
*  Incident cases in 2013 rather than prevalent cases.  
+  Symptomatic cases only.  
NOTE: For information on percent change calculations, see GBD 2013 capstone paper 
on incidence, prevalence, and years lived with disability (YLDs) [3]. All data presented 
in this table (except for rabies, cholera, cryptosporidiosis, and ameoebiasis) are also 
available from the instutite for Health Metrics and Evaluation (IHME) website and were 
previously published [3]. Abbreviations: NA, non-applicable. 
https://doi.org/10.1371/journal.pntd.0005424.t001  
  
At the time when this thesis started in 2010, there was no NTD programme in 
Liberia, the only vertical NTD programme that was being implemented in the country 
was for Oncho, where there was community-directed efforts for control of Oncho using 
Ivermectin. This PhD thesis served as an eye opener to the MoH on the NTDs to initiate 
and fast track an integrated NTD programme. Table 1.3 gives the disease burden and 
disability-adjusted life years (DALYs) in sub-Saharan Africa resulting from NTDs.  
  
Table 1.3: Disease burden (DALYs) in sub-Saharan Africa resulting from the NTDs 
(global burden of disease study)  
NTD  
DALYs  (in  
millions) in 2013  
Percent 
change 
 for 
DALYs  
2005-2013  
YLDs (in 
millions) in 
2013  
YLLS (in 
millions) in 
2013  
Visceral leishmaniasis  4.24   8.7%   0.008   4.23   
Foodborne trematodiases  3.63   14.6%   3.63   0   
Schistosomiasis  3.06   -13.9%   2.86   0.2   
Hookworm  2.18   -0.5%   2.18   0   
Lymphatic filariasis  2.02   -14.3%   2.02   0   
Ascariasis  1.27   -29.0%   0.93   0.34   
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Rabies  1.24  
 
-14.6%  
 
0.0001  
 
1.24  
 
Onchocerciasis  1.18   -19.4%   1.18   0   
Dengue  1.14  
 
17.0%  
 
0.56  
 
0.58  
 
Trichuriasis  0.58   -12.3%   0.58   0   
African trypanossomiasis  0.39   -54.3%   0.005   0.38   
Chagas disease  0.34   4.6%   0.1   0.24   
Cysticercosis  0.34  
 
-16.4%  
 
0.31  
 
0.03  
 
Cystic echinococcosis  0.18  
 
-14.1%  
 
0.08  
 
0.1  
 
Trachoma  0.17   -18.1%   0.17   0   
Cutaneous  and  mucocutaneous  
leishamaniasis  0.04  
 
35.9%  
 
0.04  
 
0  
 
Leprosy  0.04   8.6%   0.04   0   
Other NTDs  3.13   -11.8%   2.26   0.87   
Total NTDs  25.17   NA   16.95   8.21   
Additional neglected diseases  
DALYs  
millions) in 
2013 
(in  
  
Percent 
change 
DALYs  
2005-
2013 
for  
  
YLDs (in 
millions) in 
2013  
YLLs (in 
millions) in 
2013  
Typhoid fever  11.13  -13.7%  0.16  10.97  
Cholera  5.17  20.1  0.04  5.13  
Parathphoid fever  3.82  -8.0%  0.04  3.78  
Cryptosporidiosis  3.46  -29.6  0.19  3.27  
Venomous animal contact  3  -3.4%  0.15  2.85  
Scabies  1.71  4.8%  1.71  0  
Amoebiasis  0.38  -23.8%  0.04  0.34  
Trichomoniasis  0.11  8.2%  0.11  0  
Total  deaths  from  additional  
neglected diseases  28.78  NA  2.44  26.34  
NOTE: For information on percent change calculations, see Global Burden on Disease (GBD 2013) capstone paper DALY [2]. 
The estimates presented in this tables are all are also available from the Instutite for Health Metrics and Evaluation (IHME) website 
and were previously published in [2-4]. Information on DALYs and YLDs for cholera, Cryptosporidiosis, and Amoebiasis is not 
available from IHME website or capestone papers. Abbreviations: NA, non-applicable.  
https://doi.org/10.1371/journal.pntd.0005424.t003  
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1.2 Objectives  
To optimise the current strategies to an integrated approach for the control of NTDs in 
a post-conflict country and develop a platform for monitoring and evaluation of these 
diseases in a cost-effective manner.  
  
1.2.1 Specific objectives  
• To assess the geographical distribution and prevalence of LF in Liberia.  
• To develop an integrated map of LF, SCH and STH.   
• To determine the morbidity due to SCH in school-aged children in Bong County by the use of 
ultrasound.  
1.3 General methods  
The methodology used for the review of historical data on the distribution and 
epidemiology of Wuchereria bancrofti was based on a systematic review of the 
literature in four electronic databases and 17 articles were selected to be included in the 
study. For the study on the baseline mapping of LF the methodology used was that as 
described in the WHO guidelines for preparing and implementing a national plan to 
eliminate LF (WHO, 2000a) and WHO operational guidelines for rapid mapping of 
Bancroftian filariasis in Africa (WHO, 2000b).  
For the epidemiology, update started with studies on urogenital and intestinal  
SCH with observations on STH with a cross-sectional study of 10 schools in Bong 
County, northern Liberia, were investigated using the Kato-Katz method. A 
semistructured questionnaire was used to access the knowledge, attitude and practice 
(KAP) towards STH, SCH and LF amongst school-aged children in Bong County, 
northern Liberia. For the ultrasound study a Mindary diagnostic system ultrasound 
Model MS  
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MR-17003578 with a convex transducer was used to access morbidity due to SCH. The  
Niamey protocol was used to score lesions within a graded system.   
  
1.4 Justification of the study  
At the genesis of this study, Liberia did not have an established NTD programme and 
had not started MDA for the control of LF and SCH. There was an unco-ordinated 
distribution of the drug Mebendazole to schoolchildren in an attempt to decrease the 
burden of worm infestation in the country. The epidemiology and burden of these 
diseases were not adequately known. Therefore, an integrated approach provided a 
unique opportunity to properly co-ordinate the NTD activities in the country. The MoH 
has now developed an integreated approach to NTDs as suggested by this study.  
This research project was carried out in collaboration with the national NTD 
programme at the Ministry of Health and Social Welfare. It looked at the impact of 
MDA after two rounds of treatment, which could determine when to stop MDA, and 
the impact of MDA on morbidity control.  
  
  
1.5 Study area  
Liberia is a post-conflict country with 14 years of civil war, which ended in 2003. The deadly 
Ebola virus disease (EVD) hit the country in 2013 where hundreds lost their lives.  
Liberia is located at latitude 60:30 North of the equator and longitude 90:30 West of  
Greenwich meridian, with a landscape of 111,370 square kilometres. It is bordered by 
the Atlantic Ocean to the South, Côte d’Ivoire to the East, Sierra Leone to the North-
West, and Guinea to the North-East (see Figure 2). Administratively, it is divided into 
15 counties with a total population of 3,476,608 in 2008 (see Table 1.4).  
  
10  
Table 1.4: Liberia at a glance, April 2011  
Topic  Status  
Geographic size  111,369 square kilometres  
Annual rainfall  4,000 mm (one of the highest in the world)  
Natural resources  Iron ore, rubber, timber, diamonds, and gold  
Founded  July 26, 1847  
Executive  President: Ellen Johnson-Sirleaf (2006)  
Legislature  Bicameral (Senate and House of Representatives)  
Per capita gross domestic product (GDP)  US$247 (2010 estimate)  
GDP growth rate  1.8% (2001–2010 estimates), 5.9% (2010 estimate)  
Population living on less than US$1 per day  76.2%  
Population   3,476,608 (32% in Monrovia; 2008 Census)  
Population growth rate  2.1% (2008 Census)  
Life expectancy  59.1 years (UNDP, 2010)  
Under-5 mortality rate  114/1000 live births (DHS, 2007)  
Maternal mortality rate  994/100,000 live birth (DHS, 2007)  
Access to improved drinking water  75.0% (93.0% urban, 58.0% rural) (LMIS, 2009)  
Access to adequate sanitation  44.0% (63.0% urban, 27.0% rural) (LMIS, 2009)  
Human immunodeficiency virus (HIV) 
seroprevalence  
1.5% (1.8% female, 1.2% male) (DHS, 2007)  
Supervised childbirth  46.0% (DHS, 2007)  
Institutional deliveries  37.0% (DHS, 2007)  
Vaccination coverage (full)  51.0% (2010)  
Net enrolment primary school  74.0% male, 58.0% female (2000–2006 average)  
Net enrolment secondary school  37.0% male, 27.0% female (2000–2006 average)  
Source: Adapted from MoHSW (2011a).  
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Figure 1.2 Political Map of Liberia  
  
Source: MoHSW (2011a).  
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CHAPTER 2: LITERATURE REVIEW  
2.1 LF  
2.1.1 A brief history of LF  
LF also known as elephantiasis is one of the ancient diseases and furthermost 
disfiguring of all the NTDs. There are 73 countries across the globe that are endemic 
for the disease and an estimated 1.39 billion population live in areas where filariasis is 
endemic and therefore are at risk of infection and transmission (WHO, 2012a). In the 
context of control some countries have reached elimination for LF while others have 
started preventive chemotherapy.   
In 1993, LF was recognised as a potentially eradicable disease by the 
International Task Force for Disease Eradication (Ichimori & Graves, 2017). In 1997, 
the World Health Assembly recognised LF as a public health problem and targeted it 
for elimination by 2020; it then approved Resolution WHA50.29 calling on Member 
States to begin programmes for the elimination of the disease. In 2000, WHO launched 
the Global Programme to Eliminate Lymphatic Filariasis (GPELF), with the aim to stop 
the spread of LF infection (interrupting transmission) and alleviate the suffering of 
affected persons (controlling morbidity) (WHO, 2010a).  
The antiquity of LF dates as far back as 600 BC when some Indian and Persian 
physicians described clear signs and symptoms of LF. In the Temple of Hatshepsut in 
Egypt (1501–1480) there are drawings on the tomb, which depicts the presence of LF 
as early as 1500 BC; also at the Tokyo National Museum in Japan, both males and 
females with LF dating as far back as AD 1100–1200 was found in the ‘Disease Picture  
Scroll’ (Otsuji, 2011) (see also Figure 2.1).   
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Figure 2.1: In Japan, picture of a Japenese woman (d) with elephantiasis-like of the 
lower limb  
  
Source: History and control of LF (Otsuji, 2011).  
  
In the year 1863, a French surgeon Jean Nicolas Demarquay (1814–1875) was 
the first to discover microfilaria in the fluid collected from a Cuban with hydrocele. 
This was followed by the discovery of adult worms in 1876 by Joseph Bancrofti, which 
is now known as Wuchereria bancrofti. Patrick Manson in 1877 was the first to describe 
the lifecycle of LF. Manson was able to determine that the vector of the disease was 
mosquitoes. George Carmichael-Low was the first to identify LF transmission 
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mechanism, where he noted that individuals were infected from the bite of infected 
mosquitoes (Despommier, Gwadz, & Hotez, 1995).  
 
2.1.2 The global burden of LF  
LF is caused by infection with the parasitic filarial nematodes (roundworms) its species 
are as follows: W. bancrofti; Brugia malayi; and Brugia timori. The filarial infection is 
transmitted by mosquitoes and humans are definitive hosts. Once an individual gets 
infected the infection inhabits the lymphatics and subcutaneous tissues, which 
eventually leads to damage of the lymphatic vessels, resulting in clinical disease 
manifested as hydrocele, lymphoedema and elephantiasis. LF is the second leading 
cause of disability globally with an estimate of about 120 million people infected with 
the nematodes and approximately 40 million people are suffering from its 
complications. It is a major cause of disfigurement and disability in endemic areas, 
leading to significant economic and psychosocial impact (WHO, 2017b).  
According to the GPELF 2011 report, nearly 40 million people are suffering 
from the stigma and incapacitating clinical expressions of the disease, of which 15 
million have lymphoedema and 25 million men have urogenital swelling, which is 
mainly scrotal hydrocele (WHO, 2019).  
W. bancrofti is found in sub-Saharan Africa, South East Asia, the Indian subcontinent, parts 
of the Pacific Islands, parts of Latin America, and the Caribbean.  
Brugia malayi occurs mainly in India, Malaysia, the Philippines, Indonesia, and various 
Pacific Islands where it may co-exist with W. bancrofti. Brugia timori occurs on the 
Timor island of Indonesia. Approximately two-thirds of individuals infected with LF 
are in Asia (see Figure 2.2).  
  
15  
Figure 2.2 Countries where LF is endemic and the status of MDA in those  
 
countries, in 2014  
Source: GPELF programme, progress report (2014).  
  
The epidemiology of LF has changed due to the MDA initiated by GPELF to 
cut the disease transmission. This has led to the reclassification of some countries (e.g., 
Trinidad and Tobago and Costa Rica) as non-endemic, while others such as Cambodia, 
China, the Cook Islands, Egypt, Maldives, the Marshall Islands, Niue, Palau, Republic 
of Korea, Thailand, Togo, Tonga Vanuatu, Vietnam, and Wallis and Futuna have 
eliminated transmission completely (GPELF progress report 2016; WHO, 2019).  
The disease was observed to occur intermittently in children. However, in recent 
years, sensitive diagnostic tests (e.g., ultrasound examination, antigen detection) have 
now revealed that LF can be acquired in early childhood. About one-third of children 
infected with LF before the age of 5 remain subclinical for years or present with 
nonspecific presentations of swollen lymph nodes or glands, but after puberty the 
clinical manifestation of the disease is seen (Witt & Ottesen, 2001).   
A study of 159 Kenyan pregnant women with active W. bancrofti infection, their 
neonates cord blood was tested at birth and was shown not to have the filarialspecific T cell 
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responses, had a 13-fold increased risk of developing childhood LF infection compared to 
the uninfected controls (Ondigo et. al., 2018).  
In endemic areas, it has been observed that the prevalence of the microfilaremia 
increases with age and by the third or fourth decade of life most people in endemic areas 
have been exposed. The adult worm does not replicate within the human host, therefore, 
if an individual leaves an endemic area, the adult worm burden cannot increase, since 
exposure to infective larvae has ceased (Witt & Ottesen, 2001).  
  
2.1.3 The vector  
In 1877, Sir Patrick Manson proved that mosquitoes were the vectors for filariasis, 
which also indicated an attach point for control. In some sub-Saharan African countries 
where malaria is endemic, the use of mosquito nets to control LF has been encouraged 
by some NTD programmes at the MoH in collaboration with the National Malaria  
Control Programme. Mosquito vectors for W. bancrofti include Aedes, Culex, 
Coquillettidia, Mansonia and Anopheles. Vectors for Brugia are Aedes and Mansonia. 
In Africa, the Anopheles gambiae complex is the dominant vector for LF. There are 
reports of urban and rural transmissions of the disease, which is mostly due to 
travelling, but the transmission is low, and this could be attributed to the use of bednets, 
mosquito repellents and MDA. Humans are the only host for Bancroftian filariasis in 
comparison to Brugian filariasis, which infects humans and domestic and wild animals  
(Mwakitalu, Malecela, Pedersen, Mosha, & Simonsen, 2013).   
  
2.1.4 In sub-Saharan Africa  
According to the ranking of NTDs in sub-Saharan Africa by prevalence it is reported that 
approximately 40.0% of the world's 120 million cases of LF occur in sub-Saharan  
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Africa, with approximately 46 million to 51 million LF cases. A review of the prevalence and 
distribution of NTDs reported that and an estimated 6.0% to 9.0% of the sub-Saharan African 
population is infected with LF with an estimated 382 million to 394 million people are at risk of 
infection in sub-Saharan Africa, of which this figure includes 176 million children (Hotez, et al., 2006). 
In sub-Saharan Africa, 39 Member  
States are endemic of LF. The highest number of people at risk of LF are from Nigeria, Democratic 
Republic of Congo, Tanzania, Ethiopia and Kenya (WHO, 2008).   
NTDs are associated with poverty as it occurs in countries with low economic 
power and where there is poor sanitation, poor hygiene and a poor health system. NTDs 
are common amongst the rural communities and in some slum communities in Africa  
(Hotez, et al., 2007) (see Table 2.1).  
 
Table 2.1: Poverty in sub-Saharan Africa compared to the world  
 
Percentage of population living on less than US$1.25 per day   51.0%  
Total population living on less than US$1.25 per day  390.60 million  
Percentage of world’s population living on less than US$1.25 per day   
28.0%  
Total population living on less than US$2 per day  556.7million  
Percentage of world’s population living on less than US$2 per day  22.0%  
 
Source: Hotez, et al., (2007).  
2.1.5 In West Africa  
In West Africa, the vectors of malaria, the female A. gambiae mosquitoes, are the main 
vectors of LF. Current practices in the management of LF in West Africa have been 
influenced by the push for integrated control of NTDs amenable to MDA and vector 
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control is now being encouraged for the prevention, control, elimination and eradication 
of NTDs (de Souza, et al., 2012).  
2.1.6 In Liberia  
Historical review conducted for LF in Liberia indicates that the disease dates as far back 
as the 1900s. Data on LF in Liberia shows the infection is caused by W. bancrofti and 
the parasite is transmitted by A. gambiae and Anopheles funestus mosquitoes (see  
Chapter 3).   
 
Figure 2.3 Prevalence and distribution of LF in Liberia Source: 
MoHSW (2011a).  
 
  
  
A nationwide LF mapping exercise was conducted in 2010 by the Liberian MoH 
and partners with technical and financial assistance from WHO, and the Centre for 
Neglected Tropical Diseases/Liverpool School of Tropical Medicine (CNTD/LSTM). 
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From the results, 13 of the 15 counties were endemic for LF. Clinical evidence of LF 
has been seen in many parts of rural Liberia, especially along the coastal regions (see  
Figure 2.3).  
  
2.1.7 The parasite and its life cycle  
The Centers for Disease Control and Prevention (CDC) (see Figure 6) provide a vivid 
description of the life cycle of W. bancrofti, the explanation is as follows: The life cycle 
of filariasis commences after a blood meal when the filarial larvae is injected into 
human skin by a mosquito. The larvae then travel through the biting site and enter the 
lymphatic vessels where they reside. After 9 months, the larvae develop into adult 
worms. The female and male adult worms mate and produce microfilariae. The 
microfilaria then goes into the lymph and blood vessels of the infected person, who if 
gets bitten by the mosquito, the microfilaria then develops into third stage larvae and 
can infect another person if they also get bitten by the infected mosquito.  
In some parts of the world, the microfilaria can be visible in the bloodstream 
during the evening hours, mostly between 22:00 p.m. and 02:00 a.m., where this is 
called ‘nocturnal periodicity’. In the South Pacific, the microfilaria can be found any 
time in the bloodstream, and this is called ‘subperiodic’, but they are found in high 
levels during midday. It takes about 12 months from the bite of a mosquito to the 
detection of microfilariae in the bloodstream of an infected person. The adult worm 
lives for about 5 years, but in some few cases can live up to 12 to 15 years (CDC,  
2019a).  
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 Figure 2.4 Life cycle of LF  
   
Source: Reproduced from CDC (2019a).  
  
2.1.8 Clinical presentation of LF  
The symptoms and signs of LF when contracted in childhood does not manifest itself 
until adolesence or adulthood. However, there are reports that state that children in 
endemic regions have suffered lymphoedema of the limbs and acute 
dermatolymphangio-adenitis (ADLA) signs and symptoms. Approximately 70.0% of 
people infected with LF may have asymptomatic microfilaremia, while some may 
progress to the clinical manifestations of the disease and develop lymphatic dysfunction 
causing lymphoedema, hydrocele, scrotal and elephantiasis. It has also been reported 
that people who have newly arrived to disease endemic areas may develop afebrile 
episodes of lymphadenitis and lymphangitis. The common acute clinical presentation 
of LF is ADLA, which manifests as nocturnal coughing, wheezing, fever, chills, pain 
in the affected area, vomiting and eosinophilia. Lymphoedema of the lower limb is the 
most frequent chronic clinical presentation of LF and is graded as:  
Grade I: Pitting oedema, reversible on elevation of the affected limb.  
Grade II:  Pitting or non-pitting oedema, which does not reverse on elevation of 
the affected limb and there are no skin changes.  
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Grade III: Non-pitting oedema that is not reversible, with thickening of the skin.  
Grade IV: Non-pitting oedema that is not reversible, with thickening of the skin 
along with nodular or warty excrescences – the stage of elephantiasis.  
The other lymphoedema of the upper limb, breast and male genitalia, are less commom   
  
as compared to the lower limb (Kumaraswami, 2000).  
  
2.1.9 Diagnosis of LF  
To make a diagnosis of LF, a complete history taken from patients is necessary. A high 
suspicion of LF should be suspected in anyone with an exposure history who presents 
with pathognomonic signs and symptoms or unexplained eosinophilia and who have 
travelled to or live in endemic areas. Definitive diagnosis can be made by various 
methods, which range from detection of circulating filarial antigen (for W. bancrofti 
infection only), demonstration of microfilariae or filarial deoxyribonucleic acid (DNA) 
in the blood, to detection of the adult worms located in the lymphatics (Pani, et al.,  
1995).  
2.1.10 Treatment and prevention of LF  
The treatment of LF varies from country to country depending on the co-endmicity of 
some NTDs. Diethylcarbamazine (DEC) is the best treatment for people with LF, but 
the drawback is that the drug is contra-indicated in patients with Oncho due to the 
possibility of the Mazzotti reaction and as a result this should be used in caution with 
patients with Loaiasis (see also Table 2.2).  
Table 2.2: Current treatment guidelines for LF, STH and SCH  
Disease  Drugs and dosages  Threshold for implementation  Frequency 
intervention  
of  
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LF  Albendazole 400 mg for 
children aged >2 years plus 
DEC 6mg/Kg in countries 
where Oncho is not 
coendemic  
Prevalence of >1.0%  Annual:  
Treatment must be 
combined with limb 
care of patients with 
elephantiasis or 
hydrocele surgery  
Or Ivermectin 150μ/Kg in 
countries where Oncho is 
endemic  
STH  (i.e.,  
Ascaris,  
hookworms, 
and  
Trichuris 
trichiura)  
Albendazole  400 mg  for  
children above 2 years, or 
Mebendazole 500 mg  
Prevalence >50.0%: treat school-aged children, and 
adults at high risk, twice yearly   
  
Annual or twice 
yearly (depending 
on prevalence):  
Water  and  
sanitation strategies 
must be 
implemented  
Prevalence >20.0% to <50.0%: treat school-aged 
children once per year.  
Prevalence <20.0%: individualised treatment. 
Preschoolchildren and women of child-bearing age 
should also be treated (as part of maternal and child 
health programmes)  
SCH  Praziquantel 40 mg/Kg 
(using dose pole) for children 
over 4 years (or  
94 cms)  
Prevalence >50.0%: treat all school-aged children.  
Adults at high risk may also be treated  
  
Annual treatment: 
Treatment holidays 
can be given  if 
prevalence drops.  
Water  and  
sanitation strategies 
must be 
implemented  
Prevalence >10.0% to <50.0%: treat children once 
every 2 years   
Prevalence <10.0%: individualised treatment  
Source: WHO (2006a).  
  
Ivermectin is effective in reducing the microfilaremia, but this has no effect on 
the adult worm. Albendazole has no direct effect on microfilariae, but this leads to a 
slow decline in microfilaremia due to its macrofilaricidal activity against the adult 
worms. However, side effects due to rapid killing of microfilariae have not been seen 
when Albendazole is used with Ivermectin during MDA (Partono, Maizels, & Purnomo, 
1989). MDA has been the concentration of control of the disease. Vector control with 
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insecticide-treated nets (ITNs) is also useful for W. bancrofti elimination, in 
communities where Anopheles mosquitoes transmit the parasite. Unfortunately, there is 
no vaccine available for LF.  
  
2.2 SCH  
2.2.1 A brief history of SCH  
SCH is one of the ancient parasitic infections affecting humans. Symptoms of the 
disease such as haematuria were first recognised as far back as 1900 BC by Egyptian 
physicians. They called the disease ‘menstruating males of Egypt’. In the year 1851, a 
German Physician, Theodor Maximilian Bilharz, (1825–1862) was the first to discover 
the disease by finding long white helminths in the portal vein. The discovery was made 
while he worked at the Egyptian department of hygiene, he then described long white 
helminthes in the portal vein of men who died of haematuria in series of autopsies he 
carried out. He noted that these changes were consistent across the cadavers on which 
he performed the autopsies. He also noted helminthes eggs in the stools of the cadavers. 
The disease is also called ‘Bilharziasis’ named after Bilharz for his contributions to the 
disease Brazilian Parasitologist, Manuel Augusto. Pirajá da Silva (1873–1961) also 
made a contribution to the discovery of the life cycle of intestinal SCH ,(Tan & Ahana,  
2007).  
2.2.2 The global burden of SCH  
SCH is a disease caused by infection with parasitic blood flukes. Although it is 
controlled in some countries, it still remains a major public health problem. There are 
an estimated 207 million cases of SCH worldwide of which 93.0% occur in sub-Saharan  
Africa (Steinmann, Keiser, Bos, Tanner, & Utzinger, 2006). The parasites that cause 
SCH live in certain types of freshwater snail in subtropical and tropical regions. People 
living around swamp lands, dams and reservoirs are particularly at risk for the disease.  
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The disease occurs when the skin comes into contact with contaminated water and is penetrated by the 
schistosome parasite (Brooker, 2007). This is graphically shown in Figure 2.5  
  
Figure 2.5: Life cycle of SCH  
  
Source: Reproduced from CDC (2019b).  
  
Increasing population and movement have contributed to increased spread and 
transfer of SCH to new areas. Most endemic countries are amongst the developing 
countries in the world with poor health systems. Constraints to disease control in these 
developing countries vary from lack of political commitment to limited or poor 
infrastructure for public health interventions (Chitsulo, Engels, Montresor, & Savioli,  
2000).    
Figure 2. 6 Distribution of SCH worldwide in 2009  
       
 
 
 
 
 
 
 
 
 
 
Source: http://gamapserver.who.int/maplibrary/files/maps/global_schistosomiasis_2009  
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2.2.3 Epidemiology  
It has been reported that there are approximately 207 million people infected with SCH, 
amongst which 120 million are symptomatic, 20 million have severe disease, about 600 
million people are at risk of infection and around 200,000 deaths may occur every year 
(Ultroska, et al., 1989). This is indeed a public health emergency and should claim the 
attention of every national government in the world.Figure 2.6 shows the distribution 
of SCH in 2009.  
Table 2.3: Geographical distribution of SCH  
  Species  Geographical distribution  
 Schistosoma mansoni  Africa, the Middle East, the Caribbean,  
Brazil, Venezuela, and Suriname  
Intestinal  Schistosoma japonicum  China, Indonesia, the Philippines  
SCH  
 Schistosoma mekongi  Several districts of Cambodia and the  
Lao People’s Democratic Republic  
 
 
Schistosoma guineensis Rainforest areas of Central Africa and 
related S. intercalatum  
Urogenital  Schistosoma haematobium Africa, the Middle East, Corsica  
SCH  (France)  
 
Source: Nicolls, et al., (2008).  
  
Table 2.4: Human schistosome species and snail  
Human schistosome  Snail (mollusc) species  
S. mansoni  Biomphalaria  
S. haematobium  
Bulinus  
S. intercalatum  
S. japonicum  Oncomelania  
S. mekongi  Tricula  
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Every human schistosome species has a special snail as its intermediate host. In 
addition, the environment plays a significant role in the locality of the fresh water snails 
(Clements, Moyeed, & Brooker, 2006). Table 8 outlines the human schistosome species 
and the genus or snail associated with transmission.  
  
2.2.4 In Africa  
SCH is widely distributed in Africa. Of the global 207 million estimated cases of SCH, 
93.0% are from sub-Saharan Africa. The following sub-Saharan African countries 
account for the highest prevalence of SCH and are listed in order of highest prevalence, 
respectively: Nigeria; Tanzania; Ghana; and the Democratic Republic of Congo 
(Adenowoa, Oyinloyea, Ogunyinkaa, & Kappo, 2015). Due to MDA using Praziquantel 
and other successful control projects in a number of countries, the distribution of SCH 
has altered over the past years. However, despite all the interventions, the number of 
people infected or at risk of infection remains the same (Steinmann, et al., 2006).  
  
2.2.5 In Liberia  
Studies on the epidemiology of SCH were carried out at the Liberian Institute for 
Biomedical Research (LIBR) from the 1970s to 1989. Many water bodies (streams and 
ponds) in Lofa, Bong, and Nimba Counties were considered to be the sources of 
infection. These unpublished reports were lost during the Liberian civil crisis. However, 
a study was conducted by Dennis et al. in 1983, on the prevalence and intensity of 
schistosomial infections in Bong County and the bionomics of the snail intermediate 
hosts, which found some fresh water bodies to be harbouring the snails (Biomphalaria 
and Bulinus) species. The study also revealed a higher overall prevalence of S. mansoni 
(25.0%) as compared to S. haematobium (23.0%). This result correlated with the 2011 
integrated mapping survey for STH and SCH using the Kato-Katz method. The results 
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indicated that SCH was prevalent in Bong County at 63.0% for S. mansoni and 56.0% 
for S. haematobium. Figures 9 and 10 show the prevalence and distribution in Liberia 
for S. mansoni and S. haematobium.  
  
Figure 2.7: S. mansoni prevalence and distribution in Liberia  
  
Source: MoHSW (2011a).  
  
  
  
Figure 2.8: S. haematobium prevalence and distribution in Liberia  
  
Source: MoHSW (2011a).  
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Figure 2.9: SCH endemicity in Liberia  
  
Source: MoHSW (2011a).  
  
  
2.2.6 Pathogenesis of SCH  
Only few people who become infected with the disease develop symptoms. The natural 
course depends on the following three factors: i) age of initial exposure; ii) intensity of 
exposure; and iii) immunity and genetic susceptibility (Gryseels, Polman, Clerinx, & 
Kestens, 2006). It has been reported in 1998 by Butterworth that, the intensity of the 
infection increases during the first two decades of life and decreases in adulthood.  
  
2.2.7 Clinical manifestation of SCH  
The clinical disease is due to the infected person’s response to the migrating eggs, which 
could sometimes lead to entrapment, inflammation and subsequent fibrosis (Gryseels, 
1996). Many times, when the cercariae enter the host, it is associated with fever, 
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diarrhoea or respiratory symptoms. For the intestinal SCH the disease may progress and 
lead to hepatomegaly or splenomegaly. Heavy infection may lead to periportal fibrosis. 
Infection with the urogenital SCH, which is S. haematobium, the disease may remain 
in the urinary tract causing dysuria or haematuria. In late stages of the disease, bladder 
calcifications may be observed, which could lead to an increased risk of bladder cancer 
(Pollack, 1981).  
  
2.2.8 Diagnosis of SCH  
There are many screening tools available for the diagnosis of SCH such as serology, 
urinalysis and microscopy of urine and/or stools. Some studies have reported that 
antibodies detection is more sensitive than egg detection for the demonstration of the 
infection (Stelma, Talla, Verle, Niang, & Gryseels, 1994; Clerinx, Bottieau, Wichmann, 
Tannich, & Van Esbroeck, 2011).  
  
2.2.9 Treatment and prevention of SCH  
There are three important purposes on the treatment of SCH.  
  
1. Preventing complications from the diease.  
2. Reduction of egg production.  
3. Reversing the chronic or acute disease.   
  
The drug used for the treatment of SCH is Praziquantel, as well as good sanitation 
and safe drinking water. SCH control strategies include health education, MDA, and 
improvement of water and sanitation.   
2.3 STH  
2.3.1 A brief history and global burden of STH  
In 1943, Dr Norman R. Stoll (1952 to 1973) an American parasitologist conducted a 
survey amongst some elementary schoolchildren in Princeton, USA, where he noted 
that the schoolchildren harboured worm infections. In 1946, de Silva and colleagues 
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also reported that there was a high burden of STH amongst North Americans (de Silva 
et al. 2003).  
STH is the most prevalent NTD in the world. There are four main nematode 
species of human STH infections, also known as geohelminths: Ascaris lumbricoides, 
Trichuris trichiura (whipworm), and the hookworms Ancylostoma duodenale and 
Necator americanus. These infections occur mostly in developing countries especially 
in tropical and subtropical regions. Their prevalence in these regions can be attributed 
to: limited clean drinking water; poor health care; and poor sanitation systems (Haque, 
2007). WHO in its progress report 2001–2010 and its strategic plan 2011–2020 reported 
that children aged 1 to 4 years in STH endemic areas are also at high risk for STH 
infection. The diseases related to infections of STH can be chronic or asymptomatic 
and include: malnutrition; cognitive development; growth disorders (short stature); and 
malabsorption of nutrients. This could lead to poor performance in school. According 
to the WHO estimates, approximately 836 million children around the world are in need 
of medication for STH. In 2016, WHO in its report on the global health observatory 
data reported that at least 75.0% of school-aged children had received medication for  
STH (Shi, et al., 2015).  
  
2.3.2 Epidemiology and transmission of STH  
Global estimates of the disease report that around 2 billion people are infected with 
STH where the highest numbers are in Asia followed by sub-Saharan Africa. According 
to the CDC, globally 807 million to 1,121 million of the STH infections are estimated 
to be due to Ascaris, 604 million to 795 million are due to whipworm, while 576 million 
to 740 million are due to hookworms. Transmission of STH is associated with poor 
sanitation practices, infected persons whose faecal contaminates soil, food or water and 
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who have been barefooted (de Silva, et al., 2003). Figures 2.10, 2.11 and 2.12 illustrate 
the lifecycle of STH (hookworm, T. trichiura and Ascaris).  
 Figure 2.10: The hookworm life cycle  
  
Source: Reproduced from CDC (2019c).   
  
Figure 2.11: The T. trichiura life cycle  
          
Source: Reproduced from CDC (2017).   
Figure 2.12: A. lumbricoides life cycle  
  
Source: Reproduced from CDC (2019d).  
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2.3.3 In Liberia  
STH namely, A. lumbricoides, T. trichiura and hookworms are widely distributed in Liberia; 
and are prevalent in all 15 counties. A nationwide study conducted in 2011 on  
3,144 schoolchildren in 59 schools, showed that the highest prevalence at 50.0% to  
100.0% was found in the south-eastern counties (Maryland, Grand Kru, Sinoe and 
Rivercess). Maryland, Grand Kru, Rivercess and Sinoe Counties in the central part of 
Liberia showed moderate prevalence at 20.0% to 50.0%. The lowest prevalence at 0.1% 
to 20.0% was found in the northern counties including: Lofa; Bong; Gbarpolu; Bomi;  
Montserrado; and Nimba.  
  
Figure 2.13 STH prevalence and distribution in Liberia  
  
Source: MoHSW (2011a).  
  
Results showed that prevalence of Ascaris was 20.0%, hookworm was 9.0% and T. 
trichiura was 3.0%, (MoHSW, 2011a). Table 9 shows the results of the STH prevalence 
survey conducted in 2010 using the Kato-Katz method.  
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Table 2.5: Prevalence of STH, by county in Liberia  
County  Location/site (GPS co-ordinates)  N  
A.  
lumbricoides  
Hookwor 
m  
T. trichiura  
Bomi  
Klay  (6.75566”N-10.85056”W)  100  17(17%)  2(20%)  3(3%)  
Senjeh  (6.86498”N -10.8194”W)  100  9(9%)  5(5%)  2(2%)  
Sub-total   200  26(13%)  7(4%)  5(3%)  
Bong  
Gbarnga  (7.11379”N -9.46214”W)  100  21(21%)  1(1%)  0(0%)  
Suakoko (6.95005”N -9.45022”W)  99  4(4%)  4(4%)  1(1%)  
Sub-total   199  25(13%)  5(3%)  1(1%)  
Grand Cape Mount  
Garwula (7.06343”N -10.87632”W)  100  32(32%)  6(6%)  1(1%)  
Tewor (7.06275”N -10.04662”W)  100  17(17%)  3(3%)  0(0%)  
Sub-total   200  49  9  1(1%)  
Grand Bassa  Buchanan (6.00743”N -9.9009”W)  100  13(13%)  11(11%)  2(2%)  
 
 District #3 (5.88508”N)  100  16(16%)  6(6%)  1(1%)  
Sub-total   200  29  17(9%)  3(2%)  
Grand Gedeh  
Tchien (6.96887”N -11.31224”W)  100  16(16%)  0(0%)  1(1%)  
Gbarzon (6.71755”N -11.06412”W)  100  22(22%)  5(5%)  6(6%)  
Sub-total   200  38(19%)  5(3%)  7(7%)  
Grand Kru  
Barclayville  (6.0652”N  - 
8.13602”W)  
100  53(53%)  5(5%)  3(3%)  
Buah (5.19103”N -7.96096”W)  100  50(50%)  10(10%)  3(3%)  
Sub-total   200  103(52%)  15(8%)  6(3%)  
Gbarpolu  
Bopolu (4.94518”N -8.16542”W)  99  9(9%)  6(6%)  2(2%)  
Gbama (4.67583”N -8.22685”W)  100  6(6%)  13(13%)  3(3%)  
Sub-total   199  15(8%)  19(10%)  5(3%)  
Montserrado  
Careysburg(8.41415”N  - 
9.72119”W)  
197  13(7%)  10(5%)  1(1%)  
 Left  Bank  (8.38408”N- 
10.20299”W)  
199  6(3%)  7(4%)  5(3%)  
Sub-total   396  19(5%)  17(4%)  6(2%)  
Maryland  
Happer (6.67074”N -10.22611”W)  100  56(56%)  8(8%)  33(33%)  
Pleebo (6.71456”N -10.21816”W)  100  53(53%)  17(17%)  11(11%)  
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Sub-total   200  109(55%)  25(13%)  44(22%)  
Margibi  
Gibi (4.3765”N -7.71116”W)  100  16(16%)  6(6%)  1(1%)  
Kakata (4.38449”N -7.69465”W)  100  11(11%)  10(10%)  0(0%)  
Sub-total   200  27(14%)  16(8%)  1(1%)  
Nimba  
Sanniquellie(6.43304”N- 
1.49024”W)  
100  4(4%)  7(7%)  0(0%)  
Saclepea (6.34755”N -7.72861”W)  100  4(4%)  6(6%)  0(0%)  
Sub-total   200  8(4%)  13(7%)  0(0%)  
Lofa  
Foya (7.28003”N -8.82301”W)  100  9(9%)  10(10%)  3(3%)  
Voinjama (7.10562”N -8.90699”W)  100  10(10%)  1(1%)  1(1%)  
Sub-total   200  19(10%)  11(6%)  4(2%)  
Sinoe  
Greenville (5.52205”N -9.61881”W)  100  22(22%)  44(44%)  5(5%)  
LowerKanyan(5.68675”N -9.50088”W)  100  20(20%)  25(25%)  4(4%)  
Sub-total   200  42(21%)  69(35%)  9(5%)  
Rivercess  
Central C (5.2204”N -8.00809”W)  100  40(40%)  25(25%)  8(8%)  
Timbo (5.19608”N -7.38255”W)  50  26(52%)  25(50%)  5(10%)  
Sub-total   150  66(44%)  50(33%)  13(9%)  
River Gee  
Gbeapo (5.01103”N -9.03833”W)  100  34(34%)  2(2%)  2(2%)  
Potupo (4.9893”N -8.96154”W)  100  20(20%)  0(0%)  0(0%)  
Sub-total   
 
54(27%)  2(1%)  2(1%)  
Grand Total   
44  
629(20%)  280(9%)  107(3%)  
Source MoHSW (2017a). GPS = global positioning system.  
  
2.3.4 Clinical presentation, diagnosis and treatment of STH  
Infected persons initially may at times present with respiratory manifestations. They 
may also present with vomiting or coughing during the migration of the adult worm 
(Proffitt & Walton, 1962). Complications of STH vary from iron deficiency anaemia, 
stunted growth, malnutrition, intestinal obstruction, learning impairment to pancreatitis 
and hepatobillary involvement.   
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The diagnosis of STH can be established by good history taking and physical 
examination. Laboratory diagnosis on stool examinations to detect worm eggs is 
commonly practised in developed countries. The Kato-Katz method is the most widely 
used method for the diagnosis of STH. However, there are still no reliable serologic 
tests available to diagnose STH (Lamberton & Jourdan, 2015). Anthelminthic treatment 
of STH infection is prescribed as follows: Albendazole (400 mg once) or Mebendazole  
100 mg twice daily for 3 consecutive days. (See table 2.2)  
2.3.5 Prevention of STH  
Preventive measures of STH entails good hygiene, access to safe drinking water, proper 
washing and cooking of food, frequent handwashing and protection of the feet for those 
in endemic areas. Deworming programmes in schools administering anthelminthic 
drugs (Albendazole 400 mg for children above 2 years, or Mebendazole 500 mg, see 
Table 6) and preventive chemotherapy targeting at-risk populations are measures to 
maintain low individual worm burdens (Albonico, Montresor, Crompton, & Savioli, 
2006).    
2.4 Prevalence and distribution of onchocerciasis in Liberia  
The African program for Onchocerciasis, conducted a rapid epidemiological mapping 
of Onchocerciasis (REMO) for Liberia in 1999 and reported that the disease is prevalent 
in all 15 counties. With an estimated 1,113,213 of Liberia’s 4 million population at risk. 
Onchocerciasis in Liberia was first diagnosed by the Harvard expedition to Africa in 
1926 – 1927 and was found to be more prevalent in the rainforest region of the country 
as compared to the coastal regions. Simulium yahense has been identified as the  
Simulium species that transmits the disease in Liberia. Since the REMO mapping. The  
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Ministry of Health and Social Welfare in collaboration with its partners has conducted 
Mass Drug Administration for onchocerciasis  in the country and has achived a 
therapeutic coverage of 83%. (Ministry of Helath NTD master Plan 2016-2020.)  
Figure 2.14 REMO mapping of Liberia  1999  
  
Source: https://www.who.int/apoc/cdti/remo/en/  
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CHAPTER 3: A CRITICAL ANALYSIS OF HISTORICAL DATA ON THE 
EPIDEMIOLOGY AND DISTRIBUTION OF W. BANCROFTI IN VECTOR 
AND HUMAN POPULATIONS IN LIBERIA   
3.1 Abstract  
3.1.1 Background  
The filarial infection is transmitted by several species of mosquitoes within the genera 
Culex, Aedes and Anopheles. In West Africa, LF is transmitted by Anopheles 
mosquitoes. Humans are the definitive hosts. The adult worms inhabit the lymphatics 
and subcutaneous tissues causing damage to them resulting in the clinical manifestation 
of the disease as hydrocele, lymphoedema and elephantiasis.   
3.1.2 Objectives  
To examine the epidemiology of LF in humans and the distribution of W. bancrofti 
mosquito populations in Liberia using historical data. This chapter does not contain 
new data collected by the researcher. The data is based on historical review.  
3.1.3 Methods  
A systematic review of the literature in four electronic databases (PubMed, University 
of Liverpool Library, the National Center for Biotechnology Information [NCBI] 
bookshelf, and WHO Library – Thomas Allen) published before the Liberian civil war, 
which occurred in 1990, was undertaken. The search terms used were ‘vector’, 
‘lymphatic filarisis’ and ‘Liberia’. In total, 1,689 titles and abstracts were identified, 
where 17 articles were selected to be included in this paper using thematic analysis. To 
augment the literature on epidemiology of LF and medical entomology, fieldwork was 
undertaken involving collection of vectors by wild-caught and laboratory-reared 
mosquitoes and serology was performed by peripheral blood smear.  
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3.1.4 Results  
A total of 17 articles met the inclusion criteria and their results are as follows:   
• Entomology: Based on the dissections of the mosquitoes for the presence of the 
infective larvae of W. bancrofti incrimination of the main vector for the 
distribution of LF in Liberia was A. gambiae followed by A. melas. From the 
data review, wild-caught mosquitoes produced the greatest number of live 
mosquitoes e.g., in a study by Gelfand (1955a) the most effective method for 
mosquito collection was the wild-catch method.   
• Epidemiology: In humans, LF was reported in all four regions of Liberia with 
varying endemicity. The microfilariae prevalence is highest in the south-eastern 
(1.2% to 37.3%) and northern regions (0.5% to 26.2%), and the lowest 
prevalence was in the rainforest regions.  
• Entomology and Serology data: High prevalence of infections of W. bancrofti 
in both mosquitoes and human serological data were noted in the coastal region. 
In a study conducted by Brinkmann (1972), in the Marshall Territory (coastal 
region), out of the 871 persons tested using night blood smear, a prevalence rate 
of 12.7% was recorded, while out of 306 mosquitoes dissected the infection 
prevalence was 27.1%.  
  
3.1.5 Conclusions  
Historical documentation on entomological and human population distribution of W. 
bancrofti, has clearly established that the vectors and human distribution of filarial in 
Liberia is prevalent and is the highest in the coastal region of the county. However, the 
infection may also be high in other regions of Liberia where no study has been 
undertaken. Therefore, there is a need for investigation in these regions.   
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3.2 Introduction  
LF is one of the oldest and most debilitating of all the NTDs. It is caused by infection 
from one of the three species of the parasitic filarial nematodes (roundworms): W. 
bancrofti, B. malayi or B. timori. The filarial infection is transmitted by either of the 
following vectors the mosquito species: Culex, Aedes and Anopheles. Humans are the 
definitive host. LF affects populations that are the poorest in the world, mostly those 
living in communities that have poor water supply and sanitation (Perera, Whitehead, 
Molyneux, Weerasooriya, & Gunatilleke, 2007).   
According to WHO (2016a), an estimated 67.88 million people are infected with 
the disease, approximately 36 million people are disfigured, and 947 million across the 
world remain at risk of infection with LF. The life cycle of the microfilarial begins with 
introduction of third stage filarial larvae onto human skin by a mosquito during a blood 
meal; subsequently, larvae migrate through the bite wound into the lymphatic vessels. 
Once a person gets infected, the infection inhabits the lymphatic vessels and 
subcutaneous tissues and eventually leads to their damage, resulting in clinical diseases 
manifested as hydrocele, lymphoedema and elephantiasis (CDC, 2014).  
In Liberia, according to a study conducted by Young (1953) there is a 
descending infection percentage prevalence moving from the coast to the rainforest 
exhibited by the three Bioclimatic zones. The coastal zone of the country has a higher 
percentage prevalence of LF followed by the savanna zone. The rainforest zone has the 
lowest infection rate. The common mosquito vectors of LF in Liberia are: A. gambiae 
and A. melas. These vectors are in abundance in many localities of the country. Other 
less common mosquito vectors are: Anopheles funestus; Aedes aegypti; Cynoscion 
nebulosus; and Mansonia africana (Briscoe, 1948).  
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Clinical manifestations of advanced forms of LF can be common and include 
elephantiasis in the lower extremities and scrotum, particularly amongst the adults in 
the Kru and Grebo Tribes in the counties of the south-eastern coastal region, than 
amongst those in the savanna and rainforest zones (Zielke & Chlebowsky, 1979).  
A 14 year civil conflict in Liberia tore apart the social fabric costing at least  
200,000 lives, of which Liberia is gradually recovering. The entire health system in 
Liberia was severely affected during the civil conflict, which led to a total collapse of 
a control on the interventions for all diseases including NTDs.  
In the context of controlling for LF, there is currently a need to update 
information in Liberia and also to reassess the involvement of mosquito transmission 
in Liberia. To this end, I sought to review the historical literature of the epidemiology 
of LF in humans and the distribution of W. bancrofti mosquito populations and also, 
where appropriate, to conduct fieldwork to collect contemporary information.  
  
3.3 Methods  
A systematic review of the published literature before the 1990 Liberian civil war was 
conducted using four electronic databases: (i) PubMed; (ii) University of Liverpool 
Library; (iii) NCBI bookshelf; and (iv) WHO Library – Thomas Allen. A total of 1,689 
titles and abstracts were identified, 83 of these articles were found appropriate for 
review, 51 articles were selected and 17 articles were included for thematic analysis.  
  
  
3.3.1 List of articles selected for thematic analysis. This was done by closely 
examining common themes and topics that was related to epidemiology and distribution 
of W. bancrofti in vector and human population in Liberia.  
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Table 3.1 The 17 articles selected for the historical review  
No  Name of study  Researcher  
Type  of  
Study  
1  
Studies on Bancroftian filariasis in Liberia, West 
Africa  
Zielke  &  
Chlebowsky, 1979  
Human MF  
Sampling  
2  
Epidemiological investigations of Bancroftioan 
filariasis in the coastal zone of Liberia  Brinkmann, 1977  
Human MF  
Sampling  
3  
Distribution and prevalence of W. bancrofti in various 
parts of Liberia  
Kuhlow & Zielke, 
1976  
Human MF  
Sampling  
4  
Microfilariae and trypansomes in a blood survey of 
Liberia  Young, 1953  
Human MF  
Sampling  
5  
Filariasis bancrofti studies in Liberia  
Poindexter, 1950  
Human MF  
Sampling  
6  
Filariasis in Liberia  
Burch  &  
Greenville, 1955  
Human MF  
Sampling  
7  
The Anopheline mosquitoes of Liberia, West Africa  
Gelfand, 1954  
Vector  
Sampling   
8  
Man-biting mosquitoes in coastal Liberia  
Richard Fox, 1958  
Vector  
Sampling   
9  
Dynamics and intensity of W. bancrofti transmission 
in the savannah forest regions of Liberia  
Kuhlow & Zielke, 
1978  
Vector  
Sampling   
10  
Studies on the vectors of W. bancrofti in Liberia  
Gelfand, 1955a  
Vector  
Sampling   
11  
Malaria studies on the firestone rubber plantation in 
Liberia   
Barber,  Rice, 
 & Brown, 
1932  
Observation 
with 
plasmoquine  
12  
A. gambiae in relation to malaria and filariasis in 
coastal Liberia  Richard Fox, 1957  
Vector  
Sampling   
13  
Havard African expedition in Liberia in 1926  
Liberianhistory.org, 
nd  
Human MF  
Sampling  
14  
Mosquitoes of Liberia: a general survey  
W. Peters, 1956  
Vector  
Sampling   
15  
Distribution of Bancroftian filariasis in Africa   
Hawking, 1957  
Vector  
Sampling   
16  
Microfilariae and Trypansomes found in a blood 
survey of Liberia  Young, 1953  
Vector  
Sampling   
17  
Field notes on mosquitoes collected in Liberia, West 
Africa  Briscoe, 1950  
Vector  
Sampling   
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Figure 3. 1: Flow chart of methodology  
 
  
3.3.2 Mosquito collection methods for the entomology survey  
Entomology control plays a major role in eliminating LF; therefore, it is important to 
understand the behaviour of the vectors to develop tools for vector control. Therefore, 
the examination of the vector, their species, distribution, abundance and infectivity need 
to be understood before any initiation of the MDA.  
The human landing catch is one of the most accurate ways of mosquito 
collection in Africa, this is because it mimics the real situation of the mosquitoes 
wanting to bite the individual; however, there are ethical concerns about the collectors 
being bitten by the mosquitoes, the labour intensiveness, and possible collection bias. 
There are alternative mosquito collection methods to overcome these ethical concerns 
such as the Biogents sentinel traps (Govella, Chaki, Mpangile, & Killeen, 2011). In this 
historical review, most of the methods for mosquito collection bridge the ethical 
concerns.  
Four electronic databases:  
Pubmed; University of  
Liverpool Library; NCBI  
bookshelf; WHO Library  –  
Thomas Allen   
Total of 1,689 titles and  
abstracts   
Titles and abstracts assessed  
for relevance to the systematic  
review   
83 articles were dee med  
r elevant for systematic review   
51 articles regarded as eligible   
17 articles selected to be  
included for thematic analysis   
Of the 83 articles 32 were  
discarded, 51 regarded as  
eligible   
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For the entomology survey in this historical review, mosquitoes were gathered by 
two methods: (i) wild-caught mosquitoes; and (ii) laboratory-reared mosquitoes.   
The collection of wild-caught mosquitoes involved:  
  
1. Supervised two-man team bait collectors (human landing catch).  
2. Trap made of strong framework, covered with screen outside household.  
3. Hand collecting on human bait in opened areas.  
4. Hand collecting of the mosquitoes resting in the local houses each morning.  
  
To augment field observations experimental infections of mosquitoes were also undertaken.  
Laboratory-reared mosquitoes of different species were fed on infected participants.  
The mosquitoes were than dissected to check for infection with W. bancrofti.  
  
3.3.3 Laboratory analysis  
All mosquitoes were collected outside the laboratory and were taken to the laboratory. 
Samples were identified by species (A. gambiae and A. melas) if possible by the 
identification of their eggs from the females.   
At the time of dissection, each mosquito was teased apart separately, the 
abdomen was discarded and the head and thorax were dissected in saline using a 
binocular microscope at 30X and then using a compound microscope at 75X to examine 
the mosquitoes.  
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3.3.4 Epidemiological survey (microfilaria)  
The 17 articles reviewed did not mention ethical clearance from the MoH, but only 
stated that permission for the surveys were obtained from the town chief or villages 
before the teams embarked on their research activities.  
The investigators during the period under review identified microfilariae in 
humans in peripheral blood using microscopy to detect the filarial parasite. Blood 
preparations varied from thin to thick blood smears stained by the Giemsa method or 
the Knott method using both the day smear method and the night smear method.  
Thick blood smear was made from a finger prick blood sample. The sample was 
air-dried and stained with Giemsa, washed and dried for 30 minutes, then examined 
under a microscope. This allows the distinction of the W. bancrofti from other filarial 
species (McMahon, Marshall, Vaughan, & Kolstrup, 1979).   
For the Knott’s concentration technique: approximately 1 mL of blood is placed 
in 10 mL of 1.0%–2.0% of formalin or citrate–saponin solution after which the mixture 
is centrifuged at 500 g for a minute. The sediment is examined under the microscope 
for W. bancrofti (Melrose, Turner, Pisters, & Turner, 2000).  
The blood smears in most of the surveys were at times taken from the entire 
population or subset of the villages and towns. The sampled population age varied 
across the various studies ranging from babies to adults (from 9 months to >50 years 
old). Table 10 gives the distribution and prevalence of infection of W. bancrofti in 
human populations in Liberia using both the day and night smears. The blood was 
examined under microscope after staining the slides with Haematoxylin using the thick 
smear technique.  
Table 3.2: Dissection of A. melas and A. gambiae in Marshall Territory, Liberia  
 
  A. melas  A. gambiae  A. melas/gambiae +   
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 No.  
Dissected  
No.  
Positive  
%  No.  
Dissected  
No.  
Positive  
%  No.  
Dissected  
No.  
Positive  
%  
Malaria*  
Filariasis   
Total  
427  
306  
6  
83  
11  
1.4 
27. 
1  
3.6  
369  
262  
21  
51  
4  
5.7  
19.5  
1.5  
1,142  
592  
27  
132  
11  
2.4  
22.3  
1.9  
Source: Gelfand (1955a, 1955b); * Salivary gland infections only.  
  
3.4 Results  
3.4.1 Entomology/mosquitoes survey  
A total of 17 articles were reviewed and the data analysed. Six articles were selected 
based on entomological distribution of LF, while 11 articles were selected based on 
human distribution of LF. Eight of the articles conducted surveys using night blood 
smears and the remaining nine articles conducted surveys using day blood smears.   
Participants were distributed according to regions and counties. Gender 
distribution could not be ascertained in some of the studies making it difficult to conduct 
a total aggregate of all the participants by gender.    
Seasonal variations of the vectors were noted where the highest catches of 
mosquitoes were during the rainy season from April to October, and the lowest catches 
of mosquitoes were in the dry season from December to March.   
The results of the systematic review also showed that the coastal region has the 
highest percentage of prevalence for A. melas and A. gambiae mosquitoes, this was 
demonstrated by Gelfand (1955a, 1955b) in the Marshall Territory (now known as 
Margibi County) in the coastal region of Liberia for both malaria and filariasis. The 
survey also showed that A. melas (27.0%) was a more effective vector in transmission 
than A. gambiae (20.0%) (see Table 3.3).  
  
  
46  
 Figure 3.2: Seasonal prevalence of A. gambiae  
 
Source: Briscoe (1948).   
  
Table 3.3: Summary results of various surveys showing distribution of W.  
bancrofti in mosquitoes in Liberia  
Year    Region  Location  Proportion 
(%)  
Mosquitoes 
species  
Observer  
1947    South 
Central  
Robertsfield   1.6  Anopheles 
gambiae  
Diller (1947)  
1950    
South 
Central  
Robertsfield  0.8  
Anopheles 
gambiae  
Briscoe (1952)  
1952–   
1955  
South 
Central 
   
Marshall 
Territory 
   
19.5  Anopheles 
gambiae  
Gelfand ( 
1955a)  
    27.1  Anopheles 
melas   
 
    22.3  Anopheles 
melas/ 
gambiae  
 
    10.0  Anopheles 
hancocki   
 
    0.0  Anopheles 
hancocki   
 
    0.6  Culex 
thallasius   
 
    0.0  Culex 
nebulosus   
 
    0.0  Culex fatigans   
  
63 13 57 59 61 
3,023 
4,182 
3,279 
1,487 
528 
55 9 
4.22 
0.7 
4.72 3.67 5.73 
29.7 
53.72 
18.58 
29.57 
10.97 
6.59 
2.86 
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Seasonal prevalence of  A. gambiae from huts in Bwa village, Liberia 
No. Mosquitoes Collected from huts in Bwa village Inches of rain 
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   0.0  Culex   
nebulosus   
   0.0  Culex decens   
  4.4  Mansonia 
uniformis   
   4.9  Mansonia  
africanus   
   0.0  Ades africanus  
Theo  
   3.4  Ades aegypti  
  0.0  Ades 
nigricephalus  
   0.0  Ades  
punctothoracis  
1957–   South  Marshall  3.6  Anopheles  Fox  (1957,  
1958  Central  Territory  gambiae  1958  )  
1976    North  Bolil    48.9  Anopheles  
   Central    gambiae  
   47.9  Anopheles  
funestus  
   2.86  Anopheles nili  
  Gbandu  8.7 
 Anopheles 
gambiae  
   3.1  Anopheles  
funestus  
   95.7  Anopheles nili  
  Grahntown  92.9 
 Anopheles 
gambiae  
   Anopheles  
 1.2  funestus  
   Anopheles  
 74.4  gambie  
Kaikatown  
   Anopheles  Kuhlow  &  
 23.3  funestus  Zielke (1978)  
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 Figure 3.3: Proportion of wild catch and infected mosquitoes  
 
  
  
  
  
Figure 3.4: Proportion of W. bancrofti in mosquitoes, by Bioclimatic zones in five Liberian 
villages  
   
3 .7 % 6 .0 % 6 .0 % 
1 6. 1 % 1 5. 8 % 
Rainforest Savannah Savannah Costal Costal 
Grahntown Bolilo Gbandu Bassa point Cowfarm 
W. bancrofti  in mosquitoes in Bioclimatic Zones per villages  
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Source: Gelfand (1955a).  
In 1948, Briscoe conducted a study, which revealed that there are various 
species of mosquitoes found in the coastal and savanna zones of Liberia. A. melas and 
A. gambiae are the most abundant mosquitoes documented. Fairly abundant were also  
A. funestus, Aedes aegypti, Culex nebulosus, C. mucheti and Mansonia Africana.  
  
Figure 3.5 The prevalence of microfilariae in four counties in the coastal region in Liberia  
 
Source: Kuhlow & Zielke (1976).  
  
  
  
  
3.4.2 Human survey of W. bancrofti in human populations in Liberia  
In all the studies where gender was included, men in Liberia had higher prevalence of 
microfilaria 9.5%–24.0% as compared to their female counterparts 7.4%–19.0% 
(Zielke & Chlebowsky, 1979). A study carried out by Brinkmann (1972) also noted that 
men were twice as likely to have the infection compared to women. This increase in 
percentage was attributed to working in outdoor environments and that men tend to 
sleep late at night making them more prone to getting bitten by mosquitoes. The highest 
prevalence of parasites was observed amongst people between the ages of 40 and 49 
years.   
% 37.3 
14.5 % % 13.0 
% 33.1 
0.0 % 
10.0 % 
20.0 % 
30.0 % 
40.0 % 
50.0 % 
60.0 % 
% 70.0 
% 80.0 
% 90.0 
% 100.0 
Maryland Rivercess Grand Bassa Sinoe 
Counties 
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Table 3.4: Comparison of percentage prevalence of microfilariae in Liberia, by gender  
Region   Total 
examined  
Prevalence of 
microfilariae 
in females  
(%)  
Prevalence of 
microfilariae 
in males  
(%)  
Author,  
Year  
Technique 
used  
South-Eastern,  
Coastal  
1,136  7.4%  9.5%  Diller  
(1947)  
Thick 
blood film  
South-Eastern,  
Coastal  
180  19.0%  24%  
Gratama  
(1966)  
Knott 
method  
Coastal  871  4.2%  8.4%  
Brinkmann  
(1972)  
Thick 
blood film  
North  Central  
/non-coastal   
1,968  14%  19.0%  Zielke  &  
Chlebowsky  
(1979)  
Night 
blood 
smear  
  
In the human population, the day blood smear revealed that there was active 
transmission of microfilariae in all four regions of Liberia. The highest percentage of 
prevalence for microfilariae was seen in the south-eastern region, coastal zone in 
Harper, Maryland County with a prevalence of 8.0% (Young, 1953), and the lowest 
percentage of prevalence of 0.3% was seen in the north-western region in the Gola 
Rainforest, Bomi County. These results correlate well with those by Kuhlow and Zielke 
(1976) who surveyed four counties in Liberia and found that Maryland County had the 
highest percentage prevalence of microfilaria (37.3%) compared to the other three 
counties: Bassa County (37.3%); Sinoe County (14.5%); and Rivercess County  
(14.0%).   
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 The historical data correlates with the result of a nationwide mapping survey, which 
was conducted in Liberia by the MoH in collaboration with its partners, to determine 
the prevalence and epidemiology of LF in the country, the overall 
immunochromatographic test (ICT) prevalence was 24.0% with the highest percentage 
prevalence observed in the coastal regions as observed in the historical studies. In 2012, 
in order to conduct MDA after a period of 14 years of civil war, a total of 3,132 persons 
were examined between 22:00 p.m. and 02:00 a.m. This result also correlated with that 
of the historical data that reported the highest prevalence in the coastal regions.  
  
Figure 3.6: Regional distribution of human population of W. bancrofti in Liberia per 
year of study    
 
Source: Diller (1947); Briscoe (1952); Gelfand (1955a); Gratama (1966); Brinkmann (1972).  
  
   
Table 3.5: Natural infection of W. bancrofti in humans in Liberia, by using day smear  
Yea 
r  
Regions   Counties  Prevalence  rate 
microfilariae (%)   
of  Author, 
Year  
1930  North Central  Bong   0.02  
 Strong  &  
Shattuck  
(1930)  
 
 South Central  Montserrado  0.3  
 Roberts  Field  
52  
 /Margibi  0.8  
South-Eastern  
 Grand Bassa  5.0  
 Sinoe – Greenville  Poindexter  
1950  & Maryland – Webo  (1950)  
 Tchien/Grand  5.0  
 Gedeh   3.0  
 North- Gola  
 Western  Forest/Gabrpolu  0.3  
 North Central  Nimba   0.3  
 North Central  Nimba  1.0  
 Bong  1.5  
 Lofa  0.3  Young  
1953 South-Eastern Maryland  8.0  
 Grand Gedeh  0.0  (1953)  
 South Central  Montserrado  2.0  
Margibi  
 Margibi  3.5  
 
  
  
Table 3.6: Natural infection of W. bancrofti in humans in Liberia, by using night smear  
Year   Regions   County  Prevalence  of  
microfilariae (%)   
Author, Year  
1930  North Central  Bong  1.9%  Strong & Shattuck  
(1930)  
1947  South Central  Margibi  8.8%  Diller (1947)  
1950  South Central  Margibi  8.2%  Briscoe (1952)  
1953  
South-Eastern  
North Central   
Grand Gedeh  
Nimba  
Lofa  
2.6%  
1.3%  
1.2%  
Young (1953)  
 Southern-Eastern B  Maryland   16.7%  Hawking (1957)  
1966  
North-Western  Grand  Cape  
Mount  
21.0%  Gratama  (1966)  
Poindexter (1950)  
53  
  Gbarpolu  1.0%   
 
 South-Eastern B   Maryland   8.3%   
 
South Central  Montserrado  5.9%  
 
  Margibi  6.6%   
  Grand Bassa  20.0%   
 South-Eastern A   Grand Gedeh  14.0%   
  Sinoe  15.0%   
 North Central   Nimba  0.8%   
1976  
South-Eastern A  
South-Eastern A  
Rivercess  
Sinoe   
14.5%  
33.1%  
Kuhlow & Zielke  
(1976)  
 South-Eastern B  Maryland  37.3%   
 South Central  Bassa  13.0%   
 
  
  
  
Table 3.7: Continued and concluded natural infection of W. bancrofti in humans in 
Liberia, by using night smear  
 
                                                                                        Prevalence  % of microfilarae   
 
 Wreboken  3.9% (153)  
1977  
South-Eastern B  Grand  
Gedeh  
Jiboken  
Sureke  
Gbalake  
Dwekehn  
0.0% (29)  
3.0% (200)  
2.5% (120)  
1.2 (161)  
Hawking,  
1977  
 
South-Eastern A  Sinoe  
Laryi  
Chebioh  
Tumbanville   
Worteh  
0.0% (58)  
0.0% (80)  
1.8% (112)  
13.3% (75)  
Hawking,  
1977  
  
Maryland  
54  
15.2% (46)  
17.0% (47)  
 
Men 19.0%;  
 North Central  Lofa  Upper Lofa  women 10.4%  
 
3.5 Discussion  
3.5.1 Vector population  
Sir Patrick Manson (1878) was the first who showed evidence that mosquitoes were the 
primary vectors of W. bancrofti. The principal mosquito species that convey the 
lymphatic filariae of humans are found in five genera: Anopheles (W. bancrofti, B. 
malayi and B. timori); Aedes (W. bancrofti and B. malayi); Culex (W. bancrofti); 
Mansonia (W. bancrofti and B. malayi); and Ochlerotatus (Chernin, 1983; Bockarie & 
Molyneux, 2009).   
In sub-Saharan Africa, entomological investigations reported that A. gambiae 
complex are the principal vectors of W. bancrofti (Kiszewski, et al., 2004). In rural areas 
of East Africa bancroftia filariasis is mainly transmitted by A. gambiae and A. funestus 
and Culex pipiens fatigans is the main vector in urban areas. It has also been 
documented that effective vector control for malaria has been linked to the control of 
LF (Bockarie & Molyneux, 2009). In the study, national data from 17 countries on ITN 
ownership was analysed and the results reported there were some regions with >70.0% 
ITN ownership and suggested if this trend continued and is monitored, this may impact 
vector control of vector borne diseases (Kelly-Hope, et al., 2006).   
Quizah  4.8 %  (104)  
Tuoh  (84) %  1.2  
1979  South  Central  Bassa  
Blewen  Zielke  &  
Chlebowsky  
1979  
Kun  
Balle Wreh  5.6 %  (143)  
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This paper gives up-to-date information on the distribution of LF in the vector 
and human populations in Liberia. The main vectors for the transmission of W. 
bancrofti judging by dissections of wild-caught mosquitoes across the various surveys 
in Liberia are A. melas and A. gambaie (Gelfand, 1955a). It has also been reported in  
Mali that A. gambiae and A. funestus species are the predominant vectors of LF 
(Coulibaly, et al., 2006). In Gambia, the vectors responsible for the transmission of LF 
are A. arabiensis, A. gambaie and A. funestus (Knight, 1980); while in Freetown the LF 
vectors were identified as A. costalis and A. funestus (Gbakima & Sahr, 1996). In Ghana 
A. gambiae and A. funestus have been reported as LF vectors (Gyapong, et al., 2002).   
The principal determining factors of the distribution and abundance of the 
mosquitoes are altitude, rainfall and humidity (Lardeux & Cheffort, 2001). Liberia, 
which is mostly flat land, has high humidity and heavy rainfall during the rainy season, 
which has the right environmental factors for mosquitoes to survive. Seasonal variations 
of the vectors were noted in this study. A. gambiae was seen essentially during the rainy 
season, while A. melas was found mainly during the early dry season in Liberia. A. 
melas was also found to be the predominant species in human dwellings (Peters, 1956).  
The highest catch of the mosquitoes was noted during the rainy season from  
April to October, and the lowest catch was in the dry season from December to May 
(Briscoe, 1948). It has been observed that climate determines the spatial, seasonal 
distribution and inter-annual variability of many infectious diseases. Marshall 
Territory, now known as Margibi County, had the highest percentage prevalence of 
mosquitoes A. gambiae (19.5%) and A. melas (27.1%) (Gelfand, 1955a, 1955b). 
Ribbands (1944a, 1944b) reported that A. gambaie was observed to breed in seawater. 
Entomological studies along the coast of Ghana has also shown endemic foci of LF 
along the coast of the country (Dunyo, et al., 1996).  
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The study also observed that the breeding for A. gambiae and A. melas were 
mainly in small shaded streams, ditches and rocky pools that were in connection with 
running water and water containing dead vegetation, wells, swamps, grassy waterholes, 
slow flowing water temporary pools, borrow-pits, ditches, rock pools, small grounded 
pools found near houses, old cars and sandy small pools with muddy water fully 
exposed to sunlight (Peters, 1956). In Ghana, Gyapong (2000) observed that rainfall, 
humidity, temperature and surface area contributed to disease transmission.  
The methodology for vector collection varied across the different studies in 
Liberia. The mosquitoes were caught using three different methods: (i) some of the 
investigators set up nightly collection stations where mosquitoes were trapped; (ii) 
human baited traps; and (iii) early morning catching of mosquitoes from the huts of the 
local population. In Ghana, an entomological study was carried out in the Upper East 
region, to investigate the transmission dynamics and intensity of LF. Mosquitoes were 
collected by indoor spraying of houses in cluster communities. The dissection and 
processing of these mosquitoes were also approached in various ways. Wild mosquitoes 
caught were dissected for the presence of filarial larvae that resemble those of W. 
bancrofti, while laboratory-reared mosquitoes of various indigenous species were fed 
on human volunteers who demonstrated microfilaria of W. bancrofti in the peripheral 
blood film.   
These mosquitoes were then dissected to verify the presence or absence of W.  
bancrofti larvae. Dissection methods used were not uniform but varied. In some studies, 
the head, thorax and abdomen of the mosquitoes were dissected separately, while in 
other studies the dissection of the thorax was not done and other investigators did not 
mention the parts of the mosquitoes dissected or infected with larvae of W. bancrofti. 
Dissection was performed over a period of time and the various species were not all 
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present at any one time. In the Ghana study (Appawu, Dadzie, Baffoe-Wilmot, & 
Wilson, 2001) each mosquitoe was dissected and put on a slide separately, with head 
thorax and abdomen dissected separately for each mosquitoes. The polymerase chain 
reaction (PCR) method can also be used to examine A. gambiae complex members for 
specific species identification; this technique provides accurate information about the 
transmission of W. bancrofti (Goodman, Orelus, Roberts, Lammie, & Streit, 2003).  
  
3.5.2 Human population  
Before the 1980s, the only parasitological method used to confirm diagnosis of infection 
with W. bancrofti was through the identification of microfilariae in peripheral blood 
using the thick smear method or Knott's technique (Knott, 1935). Since then, several 
other tests have been made to confirm the diagnosis of infection with W. bancrofti. 
Examples of such tests are the ICT used to detect the filarial antigen, which are released 
by the adult W. bancrofti worms in humans. ICT has the advantage to be used both 
during the day and at night (Weil, Lammie, & Weiss, 1997). The urine Enzyme-Linked 
Immuno-Sorbent Assay (ELISA test) has been used in countries for the purpsoe of 
verification post-MDA to detect the antifilarial IgG4 antibodies in human urine post-
MDA (Takagi, et al., 2019).  
The method used to identify microfilariae in humans by the authors of the 
various studies under review were by peripheral blood; microscopy was used to detect 
the filarial parasite. Blood preparations vary from thin to thick blood stained by using 
the Giema or the Knott methods. Both the day smear method and the night smear 
methods were observed across studies. They also observed that all mirocfilaria found 
were that of W. bancrofti (Young, 1953).  
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The standard method or gold standard for diagnosing active infection of LF is 
the identification of microfilariae in blood smears by microscopic examination using 
the night blood film examination (blood taken between 21:00 p.m. and 01:00 a.m.) 
(WHO, 2005). In recent times, PCR assay based on the amplification of a highly 
repeated DNA sequence found in W. bancrofti was developed to address some of the 
limitations of the traditional diagnostic methods (Fischer, at al., 2007). Wuchereria 
bancrofti antigen Wb123 is highly specific and sensitive, which aided in the 
development of its lateral-flow strip immunoassay. Enzyme linked immunosorbent 
assay (ELISA) tests carried out on patients infected and uninfected with W. bancrofti 
infections revealed that there was high sensitivity 93% and 97% (ELISA) with 
specificities of 92% and 96% (strips), respectively. Separation of the patients uninfected 
with W. bancrofti to those infected with other helminths or filarial infections including 
strongyloidiasis and onchocerciasis together with those who were free from any parasite 
infection, the assay specificities ranged between 91% and 100%. Additionally, the 
geometrical means obtained by ELISA of W. bancrofti-infected patients was 
established to be elevated as compared to those uninfected with W. bancrofti (P < 
0.0001). This implies that W. bancrofti Wb123 protein is highly sensitive and specific 
to the IgG4 proving that it has the potential as a post-mass drug administration 
monitoring tool.   
The sample population age varied across the different studies ranging from 
babies to adults (9 months to >50 years old). The participants also varied across the 
studies ranging berween 105 to 10,128 persons per study. Brinkmann in 1977 conducted 
a survey that covered the four regions of the country. The results revealed a high 
infection rate of microfalariae in the coastal region. This corroborated with the other 
three investigators’ findings that showed that infection with nocturnal bancrofti occured 
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in the human population in various parts of the country and they were more common in 
the coastal zone compared to the forest zone (Poindexter, 1950; Young, 1953). 
However, Kuhlow and Zielke (1976) reported high prevalence amongst the Gissi Tribe 
in the Lofa County located in the north-western region of Liberia. In Ghana, a baseline 
LF study revealed high prevalence of microfalariae 1.8%–20.0% in the northern 
savanna and the southern coastal areas with low prevalence in the middle forest belt 
(Gyapong, Adjei, Gyapong, & Asamoah, 1996).  
Kuhlow and Zielke (1976) conducted surveys in four counties located in the 
coastal region of Liberia; their results revealed that the prevalence of microfilariae was 
highest in Maryland (37.3%), Sinoe (33.1%), Rivercess (14.0%) and Grand Bassa 
(13.0%). This result compared W. bancrofti transmission in three different Bioclimatic 
zones namely, coastal, savanna and forest zones, and showed that only 5.0% of the 
8,072 persons examined from 82 localities in various parts of these zones in the country 
were positive for W. bancrofti. All these analyses showed an uneven distribution of the 
prevalence of microfilariae in the coastal zone showing the highest prevalence rate of  
9.0% in the forest zone (Kuhlow & Zielke, 1976). Previous authors (Poindexter, 1950; 
Young, 1953) also reported that infections with nocturnal W. bancrofti occurred in 
various parts of Liberia were much common along the coastal region compared to the 
forest and savanna regions with a high prevalence of W. bancrofti 14.2% amongst the 
Gissi Tribe in the upper Lofa County, a forest region. A national survey for filariasis 
was conducted in Ghana to determine the prevalence and distribution of W. bancrofti 
microfilariae, the results showed a high prevalence of the disease and microfalariae in 
the northern Guinea savanna and the southern coastal savanna, the middle forest belt 
was somewhat free (Gyanpong, et al., 1996).  
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Young (1953) examined blood film of 10,128 persons of all ages and found a 
prevalence of microfilariae of 4.3% by using the night blood smear and W. bancrofti 
was the only species identified. The heaviest foci were again found in the coastal area. 
The daytime examination was performed mainly on students. In this study, the 
prevalence of microfilariae in adults at night was 6.0%. This was 15 times higher than 
the daytime rate of 0.4%. Young also showed that the natural infection of W. bancrofti 
in humans in Liberia using the day smear was seen to be the highest in the south-eastern 
region in Harper, Maryland County, having the highest daytime prevalence of 8.0%, 
which indicates active transmission of W. bancrofti (Young, 1953). A similar finding 
was shown in a study conducted in the coastal area of India, West Bengal. Night blood 
samples of 4,016 participants revealed the microfilariae rate of 9.1% (Chandra, 
Chatterjee, Das, & Sarkar, 2007). The intensity of the infection could not be ascertained 
in all of the studies as various methods of identification of W. bancrofti were used 
ranging from the night blood film method to the Knott method.  
Overall, the serological data shows that microfalariae prevalence rate is higher 
in the coastal regions of the country, this correlated with the entomological findings of 
studies that reported that LF vectors were also highest in the coastal regions.  
  
3.6 Limitations  
1. The total mosquitoes collected and dissected in the studies could not be verified.  
2. Lack of standardisation of the methodologies used for blood smear collection.  
3. The intensity of the infection could not be ascertained in all studies carried out.   
4. Total aggregate of the gender and population of both humans and mosquitoes was  
not possible.  
5. Dissection of mosquitoes to determine the location of infective larvae present in the  
mosquitoes was not standardised across the studies.  
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 3.7 Study strength  
 
The main strength of this systematic review is that it provides an up-to-date listing of the 
literature on the distribution of the vector and human populations of W. bancrofti in  
Liberia.   
3.8 Conclusions  
Historical documentation has clearly established the vectors and human distribution of 
W. bancrofti in Liberia. It is probably prevalent in other entomological host and human 
populations in the country, but these have not yet been recorded. Therefore, further 
studies on the vectors and human distribution of filariasis needs to be conducted in 
Liberia to provide recent data of the vectors and human infections caused by W. 
bancrofti species. The serological data showed that the microfilariae prevalence rate is 
higher in the coastal region of Liberia, which correlated with various entomological 
studies in the country that also reported that the LF vectors were also highest in the 
coastal regions.  
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CHAPTER 4: BASELINE MAPPING FOR LF BY ICT CARDS AND 
BASELINE MICROFILARIA PRE-MDA IN LIBERIA  
 
4.1 Abstract  
4.1.1 Background  
A nationwide mapping was undertaken in Liberia in 2010 to determine the prevalence 
and geographical distribution of LF. In 2012, a baseline microfilaria survey was 
conducted to determine the prevalence and intensity of the disease in order to perform 
longitudinal monitoring of the impact of MDA during the intervention phase.  
4.1.2 General objective  
To map the distribution of LF in Liberia prior to implementation of a mass drug distribution.  
4.1.3 Specific objectives:   
• To determine the geographical distribution and prevalence of LF.   
• To identify the implementation units before the start of MDA and implementation.  
• To determine the population at risk for LF in Liberia.  
4.1.4 Methods  
In 2010, a total of 1,560 persons aged >15 years were sampled in all 15 counties of 
Liberia using the ICT cards to determine the presence of the filarial antigen. In 2012, a 
total of 3,132 persons aged >5 years had blood samples taken between 01:00 a.m. and  
02:00 a.m. to determine the intensity of the microfilaria in the 11 endemic counties in  
Liberia.   
4.1.5 Results  
The overall ICT prevalence was 24.0% with the highest prevalence rate observed in the 
coastal region in Maryland and Grand Bassa Counties where antigenaemia exceeded 
45.0%. Impact of gender and age on the distribution and levels of rates were not 
analysed for ICT as both parameters were not properly recorded. A total of 3,132 
63  
persons were examined between 22:00 p.m. and 02:00 a.m. in 2012 for microfilaria. 
The overall prevalence rate of microfilaria was 6.2%, with men having a higher 
prevalence compared to women (8.0% for men and 4.2% for women). A total of 1,498 
men were examined for LF morbidity. The survey found a prevalence of 12.8% for 
hydrocele and 6.3% for lymphoedema, Maryland (7.5%) and Grand Gedeh (3.6%) had 
the highest prevalence rates for hydrocele. Maryland (3.0%) and Rivercess (2.3%) were 
observed to have the highest percentage for lymphoedema cases.  
4.1.6 Conclusions  
The mapping using the ICT cards showed that LF was endemic in 13 out of the 15 
counties in Liberia. The survey provided a nationwide epidemiological data on W. 
bancrofti infections in Liberia and serves as the bedrock for the establishment of the  
NTD programmes in Liberia.  
  
4.2 Introduction  
In 2000, WHO established the GPELF with two main objectives: (i) to interrupt the 
transmission of LF; and (ii) to manage the morbidity associated with it and to prevent 
disability. The World Health Assembly Resolution WHA50.29 called on Member 
States to work towards the elimination of LF as a public health problem by 2020 (WHO, 
1997).   
The swelling due to LF is called lymphoedema and can be found on the breasts, legs 
and genitals of men. The advanced form of lymphoedema is called elephantiasis.  
The clinical manifestation of elephantiasisis is graded as follows. Elephantiasisis of the 
limb is graded from 0 to 3: 0 = Normal; 1 = Loss of contour or lymphoedema; 2 = Thick 
skin and loss of elasticity; and 3 = Evidence of elephantiasis. Hydrocoele is graded from 
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0 to 3: 0 = Normal; 1 = Swelling of spermatic chord; 2 = Swelling up to 10 cms in 
diameter; and 3 = Swelling greater than 10 cms. Scrotal elephantiasis is graded from  
0 to 3: 0 = Normal; 1 = Lymphoedema; 2 = Thick skin and loss of elasticity; and 3 = 
Evidence of elephantiasis, (Gyapong, et al., 1994, cited in Melrose, 2004).  
According to WHO (2017b), around 947 million people worldwide are at risk 
of LF, of which approximately 40 million are incapacitated and disfigured by the 
disease. Although not fatal, WHO has ranked LF as the world’s leading cause of 
permanent and long-term disability. Cutting the transmission of W. bancrofti can be 
achieved through annual MDA to the entire population at risk for a period of 5 to 6 
years with the goal of reaching 65.0%–80.0% coverage yearly and/or vector control, 
which could lead to the elimination of the disease (WHO, 2011b).  
The recommended therapy for cutting the transmission of LF is treatment of the 
population at risk with Ivermectin and Albendazole in areas where Oncho is coendemic 
with LF, such as in Liberia, whereas DEC and Albendazole are administered in areas 
where Oncho is not co-endemic. The regimens for MDA is as follows: annual treatment 
of the entire population at risk with a single dose of Albendazole (400 mg) and 
Ivermectin (150–200 mg/Kg) or DEC (6 mg/Kg) for 4 to 6 years or DEC, Albendazole 
and Ivermectin used for a period of 1 to 2 years as recently recommended by WHO for 
countries or districts not endemic for Oncho. There was a trial of a triple regimen 
therapy for LF in Papua New Guinea, which included the use of Ivermectin 200 μg and 
DEC 6 mg/Kg and Albendazole 400 mg all together given once a year for a period of 3 
years. The result showed that there was a greater clearance of microfilaria compared to 
the two doses of DEC 6 mg/Kg and Albendazole 400 mg (King, et al., 2018).   
There are surveys as far back as the 1930s that determine the presence of LF 
from clinical cases reported in the Marshall Territory (Gelfand, 1955a). However, there 
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has been no national survey to determine the prevalence of the disease before 2010. The 
first nationwide baseline mapping for LF by using the ICT in Liberia was conducted in 
2010 by the MoH in collaboration with WHO before the establishment of the NTD 
programme in the country. A prevalence map was developed, which indicated that LF 
was endemic in 13 of the 15 counties in the country (MoHSW, 2017a). In 2010, all 15 
counties in Liberia were mapped. The survey revealed that 13 out of the 15 counties 
were endemic for LF. Those counties with levels of antigenaemia <1.0% ICT 
considered non-endemic for LF. The 2010 map guided the implementation of MDA by 
the LSTM and NTD Programme at the MoH Liberia. This paper presents an evolution 
of the national programme and looked at potential factors that could influence the 
prevalence of LF in Liberia.  
Liberia has a total population of around 4.5 million when applying the growth 
rate of 3.2% according to the nationwide census in 2008 (Government of the Republic 
of Liberia, 2008). This paper will be the first comprehensive description of the 
geographical distribution of LF throughout Liberia.  
  
Table 4.1: Key events related to elimination of LF implementation in Liberia  
Year  Event  
1947  Microfilariae survey conducted in Margibi County 
using night blood on 297 participants, showed a mean 
microfilaria prevalence of 8.8% (Diller, 1947)  
 
1949 Young and Johnson recorded the finding of A. melas larvae in Monrovia (Young & 
Johnson, 1949)  
1952–1955 Greater than 11,000 A. melas and A. gambiae complex were collected in 
Margibi County of which 733 were dissected and 
27.1% were positive for filariasis (Gelfand, 1955a)  
2010  National mapping of LF survey based on the use of ICT  
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2012 First baseline sentinel site microfilaria survey carried out prior to MDA 
implementation  
2012 First round implementation of MDA  
2013 Second round implementation of MDA  
2015 Third round implementation of MDA  
2016 Mid-term sentinel site survey implementation after  
three rounds of MDA  
2017 Fourth round implementation of MDA  
 
  
4.3 Randomisation method  
Survey design: Cross-sectional survey.  
Inclusion criteria: Random community sampling of 15 years and above that lived in the 
district and consented to participate.  
Exclusion criteria: <15 years and considered to be sick.  
Study period: July to October 2010.  
  
4.3.1 Planning for mapping at national level  
The national level planning meeting was held in Monrovia at the MoH. A 1-day training 
was held for research assistants at the MoH. Pre- and post-test was administered during 
the training to help access the knowledge of the participants before and after the training 
exercise. At the end of the training, participants were divided into three groups of five 
based on their counties of assignment. Each team developed a detailed work plan to 
enable them to systematically complete the survey. The meeting included surveillance 
officers, laboratory technicians and community health volunteers from the 15 counties. 
Included in the training was a WHO representative. After the training, participants were 
knowledgeable about the LF mapping procedures and demonstrated some skills and 
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knowledge in carrying out the survey. Surveillance officers were responsible to work 
with their respective counties and health teams to carry out sensitisation in the targeted 
communities.   
  
4.3.2 Ethical issues  
Ethical approval for the survey was obtained from the research unit of the MoH. 
Participants of the study gave consent before they were enrolled. Two years after the 
baseline study MDA was started in all endemic counties. The investigating teams in 
collaboration with the county health officers in the various counties, obtained verbal as 
well as written consent from the town chiefs and elders as well as the study participants 
before the survey commenced.   
  
4.3.3 Field activities  
Pre-sensitisation was carried out before the survey, community members were asked to 
assemble at a central point, preferably a palaver hut or clinic. The details and objectives 
of the survey were explained. Individuals who consented to be part of the study were 
invited to a designated place within selected communities.   
  
  
  
4.3.4 Data collection  
A total of 1,560 persons aged >15 years old was sampled for daytime antigenaemia, 
using the ICT provided by WHO in Liberia (Weil, et al., 1997). During the survey, 60 
μL of fingerprick blood was collected from each participant and placed on the ICT 
cards. Results were regarded as negative if after 10 minutes the card indicated a 
negative result; positive results were usually seen within 5 minutes of beginning the  
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test.  
Based on WHO guidelines, in each of the sampled communities at least 100 
people aged >15 years old were sampled. The survey was stopped if one of the first 50 
adults were found to be positive since this gives sufficient precision (1/50 = 0.02%) for 
an implementation unit (IU) to be declared positive. If 100 ICTs were negative in a 
county this county was considered negative for LF. Assessing the prevalence of LF 
using ICT cards is easy to use when trained properly because it has been observed that 
in large surveys, crowd control as well as handling the cards by untrained staff members 
may read the cards wrongly, which could contribute to misinterpretation of the results 
and may lead to an inappropriate decision for a district (Ottesen, 2000).  
  
4.3.5 Microfilaria prevalence and density data collection prior to MDA  
implementation  
Survey design: Cross-sectional survey.  
Inclusion criteria: Random sampling of people 15 years and above that lived in the district 
and consented to participate.  
Exclusion criteria: <15 years and considered to be sick.  
Study period: 2–20 August, 2012.  
  
Microfilaria prevalence and density data was conducted to define LF sentinel 
sites in Liberia and to collect baseline data on LF microfilaraemia. Sampling was 
conducted in accordance with WHO guidelines; recommending to have one sentinel 
site by county and one to two spot check sites or IU was selected. In Liberia, a county 
is considered an IU (WHO, 2010a). According to WHO, when counties are not highly 
populated, several IUs could share one sentinel site considering that, at a minimum, 
there has to be at least one sentinel site and one spot check site per 1,000,000 people 
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(WHO, 2010a). In Liberia, the sizes of the IUs are small, therefore, some units were 
merged and one sentinel and spot check site represents the merged units. Sites were 
chosen from areas of known high and low LF transmission, low or high mosquito 
densities, and high or low antigenaemia prevalence.   
Pre-sensitisation was carried out before the survey at each sentinel site. 
Individuals were asked to assemble at a central point, preferably a health centre, clinic 
or town hall. All those consenting were tested using ICT cards and those tested positive 
were further tested for microfilaraemia using night blood collection. However, some 
individuals who were tested positive with ICTs refused to be tested at night. To ensure 
the standardisation of activities and data, prior to the study commencing, all technicians 
were given a 2-day practical training.  
According to a study by Weil et al. in 1997 on the comparison of tests for the 
detection of circulating filarial antigen, prevalence of microfilaraemia before the 1990s 
was assessed by parasitological methods, which used the microscope to determine 
filarial infection. The sensitivity of these methods depends on the time of the day the 
blood was collected, which in Africa, microfilariae circulates in the peripheral blood 
between midnight and 02:00 a.m. (Knott, 1935) This method is widely used in countries 
that are endemic for filariasis.   
The data collected from the sentinel sites were used by the NTD programme to determine 
the impact MDA has had on LF.  
  
4.4 Methodology  
A total of 3,132 samples were collected and examined using the night blood method. 
The gender distribution for the participants were as follows. A total of 60 μL blood 
sample was taken from fingertips of each participant between midnight and 02:00 a.m. 
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Blood collected was smeared on the slide and allowed to air-dry at room temperature. 
The following day, the dried smears were dehaemoglobinised by flooding with distilled 
water for about 5 minutes, air-dried again, fixed with methanol for 30 to 60 seconds, 
and then stained with Giemsa for 10 minutes before being examined for microfilaria 
under a light microscope. Positive findings of microfilaria were recorded.  
  
4.5 Results  
Table 4.2 provides the summarised results of the distribution of LF in Liberia.   
  
Table 4.2: Crude baseline LF prevalence with antigen detection and microfilaria test, 
by county and sex in Liberia  
Mapping   Baseline microfilaria   Morbidity    
No.  of persons  
 tested  %   
 using  prevalence  
ICT of antigen  cards 
positive   
No.  of %  
persons prevalence 
examined of for 
microfilaria  
microfilaria  positives  
%  
Hydrocele 
positive  
% 
Lympho 
edema  
positive   
Total  by        
counties  1,560  24.1%  3,132  6.2%  12.8%  6.3%  
Montserrado  210  16.7%  300  0.3%  0.5%  0.0%  
Bong  110  2.7%  300  3.0%  0.6%  0.0%  
Sinoe  38  39.5%  294  20.0%  0.0%  0.0%  
Rivercess  84  15.5%  300  5.0%  0.0%  2.3%  
Maryland  52  46.1%  299  21.0%  7.5%  3.0%  
Grand Bassa 28  46.4%  300  8.0%  0.0%  0.0%  
Lofa  162  
Grand  
8.0%  300  4.7%  0.0%  0.7%  
Gedeh  128  6.3%  298  0.3%  3.6%  0.0%  
Nimba  147  
Grand Cape  
1.4%  300  0.0%  0.6%  0.0%   
Mount  101  2.0%  290  1.7%  0.0%  0.3%  
River Gee  119  5.0%  151  2.0%  0.0%  0.0%  
Margabi  100  2.0%  –  –  –  –  
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Grand Kru  50  25.4%  –  –  –  –  
Bomi  104  0.0%  –  –  –  –  
Gbarpolu   126  
By sex  
0.0%  –  –  –  –  
Male  –  –  1,496  8.0%  All males  –  
Female  –  –  1,636  4.2%  All males  –  
 
Source: MoHSW (2017a).  
  
  
Figure 4.1: Google map showing ICT survey and the “baseline” survey carried out 
in Voinjama district (2010) and Foya disrtrict (2012) in Lofa County  
  
  
4.5.1 ICT  
All 15 counties in Liberia were surveyed using ICT cards. The results revealed that 13 
of the 15 counties had a prevelance of ICT positive >1.0%. Figure 22 gives a graphic 
description of the communities. The overall ICT prevalence was 24.0% with the highest 
in the south-eastern coastal regions (Maryland and Grand Bassa Counties).  
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Figure 4.2: Map of baseline ICT card, results from survey in 2010 Liberia  
 
  
Source: MoHSW (2017a).  
  
4.5.2 Microfilaraemia prevalence  
A total of 3,132 blood samples were examined between 22:00 p.m. and 02:00 a.m. of 
which 1,496 were males (47.8%) and 1,636 were females (52.2%). The results showed 
an overall prevalence rate of 6.3% with men having a higher prevalence compared to 
women.   
  
  
Table 4.3: Crude data on the distributions of microfilaria prevalence and antigenaemia levels 
in Liberia from 1930–2022, by counties and year Baseline results 2012  before first MDA  
 
Total 
counties  
by  
Historical data  
1930–1990  
(range)  
Mapping  
2010  by 
ICT  
Baseline  
by ICT  
%  
prevalence 
microfilaria  
Montserrado  
7.6–21.0%  
16.7%  0.0%  0.3%  
Bong   1.9–3.6%  2.7%  3.3%  3.0%  
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Sinoe  
 15.0–33.0%  
39.5%  19.3%  20.0%  
Rivercess   –  15.5%  3.3%  5.0%  
Maryland   15.3–37.0%  46.1%  21.3%  21.0%  
Grand Bassa  13.0–20.0%  46.4%  7.3%  8.0%  
Lofa   2.1–15.2%  8.0%  4.7%  4.7%  
Grand Gedeh  33.0%  6.3%  33.6%  0.3%  
Nimba  
0.8–39.0%  
1.4%  0.0%  0.0%  
Grand Cape  
Mount  
2.0–21.2%  
2.0%  1.7%  1.7%  
River Gee  –  5.0%  0.0%  2.0%  
Margabi  3.8–14.0%  2.0%  –  –  
Grand Kru  –  25.4%  –  –  
Bomi  –  0.0%  –  –  
Gbarpolu  –  0.0%  –  –  
Source: MoHSW (2017a).  
  
A total of 1,498 men were examined for LF morbidity the survey found an 
overall prevalence of 12.8% for hydrocele and 6.3% for lymphoedema. Maryland 
(7.5%) and Grand Gedeh (3.6%) Counties had the highest percentage prevalence for 
hydrocele. Maryland (3.0%) and Rivercess (2.3%) Counties had the highest percentage 
for lymphoedema.  
Table 18 shows an uneven geographical distribution of W. bancrofti in Liberia. 
It also shows significant variations between regions and within regions. All the surveys 
were cross-sectional surveys.   
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4.5.4 Comparison of Liberia historical serological and entomological data to LF  
baseline data prior to MDA implementation in Liberia  
The critical analysis of historical data on the distribution of W. bancrofti in vectors and 
human populations in Liberia reported that the south-eastern region in coastal areas had 
the highest prevalence of W. bancrofti vectors and microfilaria (see Chapter 3). This 
correlates with the nationwide survey performed in 2010 by the MoH, which also 
reported that indeed the south-eastern coastal region had the highest prevalence of 
microfilaria (MoHSW, 2017a).  
In Liberia, for the purpose of determining the distribution of these diseases, 
various studies have been conducted. However, the first published report was by Diller 
in 1947, who reported that the disease was endemic in all Bioclimatic regions of the 
country and clinical manifestations was also found in the coastal region. Comparisons 
of results across the various surveys prior to MDA implementation in Liberia have 
demonstrated that LF is highly prevalent in the southern coastal regions of the country 
compared to the savanna and rainforest zones. There has also been evidence of repeated 
infected mosquito bites in the coastal region leading to the development of clinical 
filariasis in Liberia (Poindexter, 1950).   
Various studies across West Africa showed the prevalence of W. bancrofti in 
the coastal regions. In Ghana, a study carried out by Gyapong et al. (2002) showed that 
the disease has a higher prevalence in the northern savanna areas with a microfilaria 
prevalence between 20.0%–40.0% and the coastal savanna areas (10.0%–20.0%). In 
Sierra Leone, a nationwide survey showed that LF was endemic in all 14 districts with 
W. bancrofti antigenaemia prevalence >1.0%, with a higher prevalence in the northeast 
regions (Bombali 52.0%; Koinadugu 46.0%; Tonkolili 37.0%; and Kono 30.0%) and 
lower in the south-west regions of the country (Koroma, et al., 2012). Also in the East 
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African country of Malawi a survey in 2002 showed that W. bancrofti infections were 
widespread in the country. The antigenaemia prevalence using the ICT cards was about 
80.0% in some of the sampled villages (Ngwira, Tambala, Perez, Bowie, & Molyneux, 
2007). In Kenya, similar studies were carried out by Wijers (2016) to get an insight on 
the prevalence of the disease in the coastal province. A cluster sample survey revealed 
28.4% of the total of 5,004 males examined were found to be microfilaria positive.  
  
4.5.5 Recent epidemiological studies in Liberia  
Using the same platform used at the baseline in 2012, the NTD programme in Liberia 
in December 2016 carried out a survey after three rounds of interruption of MDA due 
to the Ebola virus. This survey confirms our baseline study carried out in 2012, which 
showed that microfilaria prevalence was highest in the south-eastern coastal region of 
the country. In order to determine the level of impact made through the MDA 
intervention for the control and elimination of LF, a couple of strategies have been 
instituted by the NTD programme in Liberia, including sentinel and spot check sites to 
evaluate the impact of the drugs. The sentinel sites are also used throughout the 
programme to determine the baseline parasitological indicators and to evaluate the 
changes in the indicators throughout the course of the programme.    
MDA impact is ascertained when microfilaria surveys are performed using 
sentinel and spot checks. Since the implementation of MDA, there have been two 
rounds of sentinel and spot check sites in the country. The first sentinel and spot check 
site was conducted in 2012, while the second was conducted in 2016. According to 
WHO protocol, the first sentinel site survey should be conducted after two to three 
rounds of MDA (WHO, 2010b). The long period between first and second rounds of 
sentinel sites was due to the disruption of MDA activities caused by the Ebola outbreak 
in early 2014 to late 2015.  
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Sentinel sites require a minimum of 500 individuals, located in an area known 
to be highly endemic, where the population is stable and ideally with no previous history 
of Oncho and LF MDA. While spot check sites are used in association with sentinel 
sites and are selected based on the same criteria, they can change during each survey.   
4.5.6 Key objectives of sentinel and spot check sites activities  
• To determine the impact of the national LF elimination programme by detecting 
changes in LF prevalence and intensity using sentinel and spot check sites.  
• To assess when the level of microfilaraemia is less than 1.0% in all sentinel sites 
suggesting that transmission has been interrupted and the country is ready to 
implement a Transmission Assessment Survey (TAS).  
  
A survey to confirm LF transmission in big cities affected by conflict-related 
rural-urban migration in Sierra Leone and Liberia was conducted in 2014. The results 
revealed no evidence of active transmission of LF in cities, where internally-displaced 
persons from rural areas lived for many years during more than 10 years due to conflict  
(de Souza, et al., 2014).  
  
Table 4.4: Microfilaria prevalence at spot check/sentinel sites, by county in 2012  
Counties  Type of site  Participants  No. tested 
Microfilaria per site  positive 
 prevalence   
 
 
Grand Gedeh  Spot check  300  1  0.3%  
Grand Bassa  Spot check  300  1  0.3%  
Sinoe  Spot check  300  13  4.3%  
Rivercess  Spot check  300  0  –  
Maryland  Sentinel  300  33  11.0%  
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Grand Cape Mount  Sentinel  300  1  0.3%  
Nimba  Sentinel  300  0  –  
Bong  Sentinel  300  1  0.3%  
Lofa  Sentinel  300  4  1.3%  
Montserrado  Sentinel  300  0  –  
Rivergee  Sentinel  300  4  1.3%  
Total    3,300  58  0.2%  
 
Source: NTDs unit MoH sentinel site survey  
  
  
  
4.5.7 The role of vector control programmes on LF  
The Roll Back Malaria Partnership programme established in 1998 by WHO and 
funded by its partners the United Nations Children’s Fund (UNICEF), the United 
Nations Development Programme (UNDP) and the World Bank advocates for the use 
of integrated vector management and utilises the use of multi-programme synergies. 
However, global financial crisis affected the sustainability of the programme (Mutero, 
et al., 2015).   
A study conducted by Njenga et al. (2011a) in coastal Kenya found that despite 
some of the villages had missed MDA during 2 years, the microfilariae were maintained 
in the absence of further MDA by the use of ITNs. The anitgenaemia levels declined 
form 34.6% in 2002 to 10.8% in 2009. These results were especially apparent when the 
major vector of W. bancrofti in these areas was Anopheles (Njenga, et al., 2011b).   
  
Table 4.5: Distribution of bednets per county (Roll Back Malaria)  
Counties  Nimba  2006  
27.3%  
2007  
32.1%  
2008  
35.1%  
2009  
36.3%  
2010  
48.8%  
Bong  34.6%  39.0%  41.7%  44.0%  57.2%  
Bomi  27.6%  30.4%  32.5%  35.8%  50.1%  
Rivercess  22.9%  26.4%  28.6%  30.1%  43.0%  
Margibi  22.3%  25.4%  27.6%  29.8%  42.8%  
Grand Gedeh  27.4%  31.6%  34.2%  35.0%  46.9%  
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Grand Kru  21.2%  24.0%  25.3%  25.7%  36.6%  
Sinoe  21.2%  24.8%  27.0%  27.9%  40.2%  
Maryland  23.6%  26.3%  27.5%  27.9%  38.7%  
Montserrado  21.6%  24.3%  26.3%  29.0%  42.2%  
Grand Cape Mount  32.5%  36.2%  38.4%  41.3%  55.9%  
Grand Bassa  23.0%  26.3%  28.5%  30.2%  43.1%  
Lofa  33.8%  40.0%  43.1%  44.2%  57.0%  
Gbarpolu  32.3%  37.2%  40.0%  42.0%  55.8%  
Source: President Malaria Initiave (2018).  
  
In Liberia, according to the National Drug Service, there has been an upscale in 
bednets distribution by the MoH and its partners. The three Demographic and Health 
Surveys carried out in the country in 2007 (30.1%), 2009 (48.6%) and 2013 (59.6%), 
respectively showed an increase in household ownership of bednets in the country (see 
Table 20). ITNs could be a confounding variable in the decrease in both the microfilaria 
and antigenaemia levels in the country. The use of ITNs and improvement in 
environmental sanitation has proven to be effective in eliminating LF in the Solomon 
Islands (Webber, 1977). Preventive measures on the use of ITNs seems to be effective, 
but the cost-effectiveness still needs to be researched.  
  
4.6 Discussion  
Mansonella perstans  
Mansonella perstans is a vector-borne human filarial nematode, which is transmitted through 
tiny insects known as biting midges or sucking flies. Geographically, it is widely spread across 
sub-Saharan Africa as well as parts of America (Central and South). The parasite can cause 
various morbidities and complications if not well managed. However, despite the prevalence 
of the parasite there is still lack of definite therapy for its complete elimination. Specifically, 
in Africa, there is a lack of adequate documented evidence on its transmission, symptoms, 
diagnosis and prevention. This thus poses a gap, which requires further investigation in order 
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to improve the management of the filarial nematode and for recommending appropriate 
strategies on its treatment and control. Understanding this is vital in reducing any risks, 
complications, morbidity or mortality associated with Mansonella perstans. The donations of 
Ivermectin and Albendazole began since the establishment of GPELF and have been tested 
and found to be safe and effective in reducing the number of circulating microfilariae in the 
blood and preventing transmission of the infection (Horton, et al., 2000). Yearly MDA is 
carried out with at least 65.0% coverage of the total population in endemic areas (WHO, 
2013b). The first campaign was in Egypt and Samoa and by the 2009 MDA had covered at 
least 496 million people at risk, and 37 countries were in the process of completing their fifth 
MDA. Since the establishment of GPELF in 2000, a total of 6.2 billion treatments have been 
delivered to greater than 820 million people at risk for at least once. By using the strategy of 
the GPELF the elimination of LF has occurred in some countries, for example, Korea, Japan, 
China, Thailand and the Solomon Islands. These countries followed the elimination strategy 
and have stopped the transmission of the infection permanently (Molyneux, 2003). Timor 
Leste and Senegal and have now achieved 100.0% geographical coverage bringing these 
countries on track to achieving elimination. Community sensitisation on the knowledge and 
perception of the disease must be carried out in order for successful elimination of LF (Cabral, 
2017). Two pharmaceutical companies have given donations for the antifilarial drugs 
Albendazole by GlaxoSmithKline and Ivermectin by Merck and Co.  
  
4.6.1 Baseline prevalence and intensity of infection for ICT  
The baseline study on LF in the country has contributed immensely to the knowledge 
and epidemiology of LF in Liberia it has been the basis for which the NTD programme 
has been built. It provided the epidemiological information of the distribution, 
prevalence and intensity of LF, which could be used to build an elimination strategy of 
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LF in the country. The baseline data collected included demographic information, 
prevalence of the disease and its intensity. The NTD programme in the country used 
this baseline data for the longitudinal monitoring impact of MDA that has been carried 
out annually.  
There have been different studies on Bancroftian filariasis in Africa that have 
showed how highly endemic the disease is. The baseline study of the epidemiology 
assessment of LF was the most comprehensive survey ever documented to have been 
carried out in Liberia prior to starting MDA implementation. The survey showed 
variation in and between regions. Due to the population size of the country and 
implementation of health-related activities 13 out of the 15 counties of Liberia have 
been declared endemic for LF. The transmission was confirmed to be in all regions and 
Bioclimatic zones of the country with the south-eastern coastal region (Grand Bassa 
and Maryland Counties) having the highest prevalence rate of 46.4% and 46.1% 
respectively). The prevalence ranged from 2.0%–46.4% with an overall prevalence of 
24.0%. This confirms the findings of a previous study by Brinkmann (1977) who 
worked in the coastal zone of Liberia and reported W. bancrofti prevalence ranging 
from 2.0%–37.0% and had a median microfilariae density between 250 mf/mL and 
1,200 mf/mL. All studies in Liberia have reported that the south-eastern coastal region 
has high transmission of W. bancrofti. In Sierra Leone, a nationwide LF mapping study 
was carried out to obtain baseline data on the prevalence of W. bancrofti infection using  
ICT for circulating filarial antigen, where the overall LF prevalence was 21.0%  
(Koroma, et al., 2012).   
The baseline results also found high prevalence in the northern savanna regions 
of Lofa and Bong Counties. Lofa County had ICT prevalence of 8.0% and microfilaria 
prevalence of 4.7%, Bong County had ICT prevalence of 2.7% and microfilaria 
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prevalence of 3.0%, but Nimba County had negative results for both the ICT and 
microfilaria prevalences. This shows how disproportionately the disease is distributed 
in the country. Unevenness in the geographic distribution of the disease in the country 
has also been reported by Diller (1947), when he conducted a survey in four counties.   
The Ghana Health Services in 1999 conducted a nationwide prevalence survey 
to determine the prevalence and distribution of LF in which they reported that the 
disease had a higher prevalence in the northern savanna regions of the country and the 
coastal region and a lower prevalence in the forest region (Gyapong, 2000). These 
findings correlate to our results obtained during the baseline study, which showed that 
the coastal and savanna regions have a higher prevalence of LF as compared to the 
rainforest regions. This could be attributed to the presence of the vector in these regions 
as compared to the rainforest. A study on the distribution of LF in West Africa reported 
that the disease foci occurred in the savanna, coastal and some rainforest regions. The 
low altitude and tropical nature of Liberia could be a contributing factor to the 
prevalence of the disease. Cano et al., (2014) showed that LF transmission increased 
with mean maximum temperature and decreased with altitude.  
  
4.6.2 The microfilaraemia  
In Liberia in 1947, a microfilaria survey was done in Margibi County and night blood 
showed that 297 (8.8%) of the participants were positive for the larval worms. A 
breakdown by age and sex indicated that the infection can be acquired during the early 
years of life and continues into adulthood. The prevalence of microfilaraemia and 
antigenaemia increased with age. The circulating filarial antigen is an indicator of adult 
worm loads (Weil, et al., 1997). The age-related increase in the prevalence of 
antigenaemia indicates that the infection is age-related. A study of a cohort of children 
in Haiti established that filarial infections are acquired early in life (Hamlin, 2012).   
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The historical surveys noted that many males with scrotum enlargement, knee 
and ankle swelling and females with elephantiasis of the breasts were seen (Diller, 
1947). The baseline microfilaraemia survey in 2012 in 11 counties showed an overall 
microfilaria prevalence of 6.2% with a range of 0.3%–21.0%. Maryland a coastal 
county had the highest prevalence of 21.0%. This is because Maryland the most 
populated costal county in the southeast of the country, and the communial life style of 
the people. They are more netted together. Males were twice as positive as females; this 
may be due to the fact that males sit outside with friends late at night making them 
exposed to mosquito bites. The prevalence of infection has been stated to be higher in 
males than females in many studies. It has been hypothesised that gender differences, 
sex hormones, immune effectors and females in reproductive age have markedly lower 
levels of infection. The microfilaraemia survey corroborated the results of the mapping 
survey in 2010.   
During the survey in 2012, the presence of the clinical form of the disease was 
assessed and was found to be hydrocele 0.0%–8.0% and for lymphoedema was 0.0%– 
4.6%; this is much higher then that of Ghana were the baseline prevalence of the clinical 
forms were 0.4% for elephantiasis and 0.0%–35.0% for hydroceles (Gyapong, Webber, 
Morris, & Bennett, 1998). In Liberia, the overt forms of the disease have caused a 
significant social stigma. People presenting with the clinical signs tend to go further in 
the forest to live to avoid having contacts with others. Gelfand (1955b) stated in one of 
his communications that an entire community in Marshall Territory (now known as 
Margibi County) was deserted because some of the community members showed  
clinical signs of the disease.   
The baseline study also gives an estimate of the population at risk for LF in 
Liberia. In 2010, the population of the country was 3.9 million, but with a 3.9% annual 
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change, the population has increased to 4.7 million in 2017. Of the 15 counties surveyed 
and mapped using ICT, 13 had >1.0% circulating filarial antigen (CFA) positive. This 
is around 80.0% of the country’s population at risk. The total population at risk of LF 
in Liberia is projected to be 4 million.   
  
4.6.3 Impact of vector control on the reduction of microfilaria  
Low microfilaria prevalence of W. bancrofti was found in Liberia during the baseline 
study despite 2 years of interrupted MDA due to the Ebola crisis in the country. Studies 
conducted between 1930 and 1990 have revealed a decline in the endemicity of LF pior 
to MDA. This could be attributed to vector control through distribution of bednets by 
the Roll Back Malaria programme through the MoH and the indoor residual spraying 
(see Figure 24). However, there is a need for studies to be conducted. WHO gave a 
Position Statement in 2011, which endorsed integrated vector management for the 
control of LF and malaria (WHO, 2011c).   
  
  
4.7 Conclusions  
In Liberia, 13 counties were endemic for LF although at different levels in terms of 
burden. Mapping and sentential sites survey conducted respectively in 2012 and 2016 
clearly illustrated the foci of LF. The mapping results indicate that Maryland County, 
which is a coastal county, despite four rounds of MDA, still had the highest LF 
prevalence. This could be attributed to communites being missed during the MDA due 
to difficult road conditions. The research gives the baseline data for the country’s NTD 
programme to design and implement MDA and serves as the bedrock for the monitoring 
and evaluation of LF in Liberia.  
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4.8 Recommendations  
1. Additional research on LF to be conducted in Bomi and Gbarpolu Counties, 
which had less than 1.0% ICT prevalence and were considered non-endemic for 
LF because the protocol for mapping by WHO may have caused these two 
counties to have been missed.  
2. The NTD programme should collaborate more with the malaria control 
programme to ensure that areas with high transmission rate of LF be given 
priority during distribution of ITN and residual spraying.  
3. Those counties in the south-east are given priority during MDA in order not to 
have them missed, as was the case for Maryland County.  
  
4.9 Study limitations  
Some participants who had a CFA positive by the ICT were not willing to give blood or 
night blood smears owing to fears of undue experimentation.   
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CHAPTER 5: ASSESSMENT OF KNOWLEDGE  
AND COMPLIANCE TOWARDS MDA INTERVENTION FOR  
THE CONTROL OF LF IN BONG COUNTY, LIBERIA: A  
CROSS-SECTIONAL STUDY  
 
5.1 Abstract  
5.1.1 Background  
In Liberia, there have been four MDA campaigns for LF interrupted due to the EVD.  
In the country, annual MDA is carried out using Ivermectin and Albendazole.   
5.1.2 Objective  
To access the efficiency of drug distribution by the community drug distributors 
(CDDs) and to assess associated compliance and knowledge of individuals in Bong 
County after four rounds of MDA.   
5.1.3 Methods  
A descriptive cross-sectional population KAP survey was conducted using structured questionnaires. 
The survey was conducted from January to February 2018 in Bong  
County.   
5.1.4 Results  
More than 60.0% of the participants were aware of the disease and more than 50.0% of 
the participants knew of the common symptoms of the disease. Around 63.0% of the 
participants were compliant to the MDA programme. Those that were non-compliant 
were afraid of the side effects. However, only 43.3% of the participants admitted to 
taking both medications, while 50.0% of the participants knew the mode of 
transmission of the disease.  
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5.1.5 Conclusions  
The findings from this study have shown that there was some awareness regarding LF 
in the communities. Majority of the participants had knowledge of the MDA 
programme. However, there is a great need for pre-MDA campaigns and health 
education to improve compliance by the community.   
  
5.2 Introduction  
The GPELF was established in 2010 by WHO with the goal of eliminating LF by 2020. The 
GPELF launched a two-pronged strategy for the elimination of the disease. First, by  
MDA to people living in endemic communities in order to stop the spread of the 
infection (interrupting transmission). Since the beginning of MDA there are some 
counties that have been declared free of LF. The second strategy of GPELF is morbidity 
control to reduce the suffering of those already affected by the disease (WHO, 1997). 
Five rounds of medications are needed to interrupt transmission. In countries like 
Liberia where Oncho is also endemic it is recommended that annual MDA using 
Ivermectin (150– 200 μg/Kg) combined with Albendazole (400 mg) in communities 
where LF and Oncho are more prevalent be distributed to the entire population at risk, 
but with the exception of pregnant women, children <90 cms in height and very sick 
people. According to the 2017 WHO report on LF, about 28.0% of the countries that 
are endemic for LF are now having post-MDA surveillance to confirm that they have 
achieved elimination (WHO, 2017c).  A randomised controlled study conducted in 
2013 by Awadzi et al. (2013) to determine if the combination of Ivermectin with 
Albendazole was safe, reported that the drug was effective with no serious adverse 
effects observed. Compliance with Ivermectin and Albendazole medication is cardinal 
to achieving the elimination of LF as advocated by GPELF. A study conducted by 
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Yirga, Deribe, Woldemichael, Wondafrash and Kassahun (2010) in south-western 
Ethiopia, showed four positive predictors that can influence compliance to Ivermectin: 
(i) high risk perception; (ii) family support; (iii) perceiving that CDDs are doing their 
work well; and (iv) perceiving that measuring the height is the best way to determine a 
person's treatment dose. Health education before the MDA helps to improve 
compliance to the drugs (Nuwaha, Okware, & Ndyomugyenyi, 2005). Figure 25 gives 
a graphic description of vector control for the control of LF.  
  
5.3 Assessment of coverage  
Coverage is defined as the percentage of individuals in a given population that received 
drug or a drug combination in an intervention area (Albonico, Engels, & Savioli, 2004). 
WHO also defined coverage as the percentage of all residents of an endemic area who 
swallow the drugs should at least be ≥65.0%. If high drug coverage is not attained, 
untreated individuals could potentially act as reservoirs of transmission, hindering 
control and elimination efforts (WHO, 2011b).  For the assessment of coverage, the LF 
coverage report 2016–2017 was obtained from the MoH NTDs unit, Liberia (.Due to 
the EVD outbreak in 2014, the NTD programme was suspended. However, there have 
been four rounds of MDA, which all reported high coverage. To verify the coverage 
reports, a cross-sectional survey was carried out from 23 March 2017 to 20 May 2017 
by the MoH and its partners. This study was conducted in eight counties by the NTDs 
unit (one district each). Using population-proportionate sampling, the survey report 
showed that an overall coverage percentage of 84.0% had taken the medication. This is 
above the required 65.0% coverage recommended by WHO.  
The Community-Directed Treatment with Ivermectin (CDTI) first adopted by the 
African Programme for Onchocerciasis Control (APOC) was found to be effective.  
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Community members selected by the community leaders were trained in the distribution of medication 
(Amazigo, 1999).  
  
Table 5.1: Coverage of LF MDA, by district  
County   District  
Communities  
(individuals) 
surveyed   
Reported 
coverage*   
%  (total  
population)   
Verified 
coverage**   
%  (total  
population)   
Count  of  
communities  
with   
<65% verified 
coverage (total 
population)   
 
 
Source: MoH NTDs unit 2016–2017 coverage report. *Reported coverage = Mass drug 
treatmnent reported by drug distributors during MDA; **Verified coverage = A 
coverage survey done to verify mass drug treatment by a programme.  
  
  
  
  
Bong   
Panta 
Kpaai   
27 (809)  84.0  44.4   17  
Grand  
Bassa   
Grand  
Buchanan   28 (929)  84.0  29.5   24  
Cape 
Mount   
Garwular   30 (943)  82.0  71.4   11  
Grand 
Gedeh   
Konobo   29 (895)  81.0  57.9   12  
Lofa   
Marylan 
d   
Riverces 
Voinjama   
Pleebo  
Sodoken   
Jowen   
30 (913)  
30 (895)  
24 (823)  
88.0  
82.0  
83.0  
94.3  
61.8  
92.5  
 30  
 13  
   0  
s        
Sinoe   Kyanyan   27 (939)  83.0  84.2     3  
Total   
 
225 (7,146)     67.0  110  
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5.4 Objectives  
To access the efficiency of drug distribution by the CDDs and to assess associated compliance and 
knowledge of individuals in Bong County post-Ebola MDA. The researcher used structured 
questionnaires.   
5.5 Methodology  
5.5.1 Study area  
Geographically, Bong County is located in the North Central region of Liberia. It is one 
of 15 counties. According to the 2008 census, Bong County has a population of 328,919 
and measures approximately 3,387 square miles. The 2008 census puts Bong County 
as the third largest county of Liberia (Government of the Republic of Liberia, 2008). 
The Bong County has 12 political districts. However, the MoH has also divided Bong  
County into eight health districts. The Bong County is co-endemic for LF, STH and SCH. 
The survey was conducted in Zota (18,943 population) and Suakoko (28,277  
population) districts.   
  
5.5.2 Design (randomisation)  
This survey was a population-based survey, using the EPI 30 x 7 method (WHO, 2008). 
Participants were selected from 30 clusters in each district where LF is endemic. For 
each cluster, seven houses were randomly selected. Those interviews were with the 
heads of the household, spouse and anyone above the age of 15 years. A standardised 
pre-tested questionnaire was used to collect data on compliance and knowledge of mass 
drug treatment using Ivermectin and Albendazole. The participants were asked on their 
KAP towards LF. The respondents were the head of each household their spouses and 
anyone above the age of 15 years who lived in the house and participated in the 
interview.  
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 Figure 5.1: Interviewing a man with elephantiasis in Suakoko district, Bong County  
  
Note: Written consent was obtained from this participant for his photo to be placed in this 
thesis (see Appendix D).  
  
5.6 Results  
5.6.1 Household survey  
The survey was conducted in two districts, Zota and Suakoko. A total of 1,191 study 
participants were surveyed in 60 different communities within the Zota and Suakoko 
districts and 420 households were visited. There were 210 households visited in each 
district (see Table 22). Majority of the participants were in the age group 25–44 years 
(N =642) (see Table 23).  
There were 617 (51.8%) females and 574 (48.2%) males that took part in the 
study. Liberia is predominantly a Christian nation and 86.6% of the participants were 
Christian. Around 58.3% of the participants were farmers and only 11.7% of the 
participants had a high school diploma (see Table 5).  
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Table 5.2: Surveyed population, by the two districts  
District  No.  of  
surveyed  
clusters  No. 
households 
surveyed  
of  Surveyed 
population  
Suakoko  30   210   632  
 
Zota  30  210  559  
Total  60  420  1,191  
 
  
  
Table 5.3: Surveyed population, by gender and age  
Sex  
Age     
15–24 years  25–44 years  45 years +  Total  
Female  123  329  166  618  
Male  111  313  149  573  
Total  234  642  315  1,191  
  
  
Table 5.4: Sociodemographic characteristics  
Sociodemographic characteristics  N = 1,191  %  
Age  15–24 years  234  19.6  
 25–44 years  642  53.9  
 45 years and above  315  26.4  
Gender  Male  574  48.2  
 Female  617  51.8  
Religion  Christian  1,031  86.6  
 Muslim    158  13.3  
 None        2    0.2  
Educational 
level  
Completed high school 
Elementary  
139  
301  
11.7  
25.3  
 Have never had formal education  449  37.7  
 Junior high  207  17.4  
 Secondary high    95    7.9  
Marital status  Cohabiting  161  13.5  
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 Divorced    47    3.9  
 Married  587  49.3  
 Single  314  26.4  
 Widowed    82    6.9  
Occupation  Business person  197  16.5  
 Farmer  694  58.3  
 Fisherman    44    3.7  
 House wife    50    4.2  
 Hunter    76    6.3  
 Others  130  10.9  
  
  
5.6.2 Assessment of drug compliance in relation to the two districts  
Compliance (sometimes referred to as adherence) is a term used to denote a degree to 
which a client correctly follows advice. In this study it indicates how correctly the 
individuals followed instructions from drug distributors (Albonico, et al., 2004). For 
the community to be compliant to the MDA, the CDDs have to be accepted by the 
community, selected by the community, live within the community and be people of 
integrity (WHO, 1996). They could also be placed on payrolls to enable them to 
adequately carry out their duties.  
Liberia is endemic for LF and a survey to determine the compliance of the 
medication is necessary to determine the impact of the NTD programme. Following the 
fourth round of drug distribution, a post-MDA survey was undertaken in Bong County 
from January to February 2018, this was done to assess possible factors influencing 
compliance/non-compliance and potential adverse effects. A total of 1,190 individuals 
were enrolled in this study.   
93  
In this study, 63.6% of the participants admitted to taking the medication during 
the MDA, 9.3% said they took Albendazole alone, and only 43.3% said they took both 
medications. The reasons for non-compliance varies, but majority (20.0%) said it was 
due to itching of skin after taking the medication, while 12.9% said it was due to 
weakness and dizziness (see Table 5.5). The side effects of MDA are specific to the 
drug that are given and and individual tolerance. This includes, vomiting, neausea, 
rashes, abdominal pains, dizziness  and headheaches.   
  
Table 5.5: Compliance and non-compliance  
Compliance   N  %  
Did you take the medication?  Yes  757  63.6  
 No  434  36.4  
Did you take Ivermectin alone?  Yes  110   9.2  
 No  1,081  90.8  
Did you take Albendazole alone?  Yes  111    9.3  
 No  1,081  90.8  
Took both of the medication together?  Yes  516  43.3  
 No  675  56.7  
Reasons for non-compliance   N  %  
Weakness and dizziness   154  12.9  
Impotency      1    0.1  
Abdominal pain    80    6.7  
Diarrhoea    42    3.5  
Blood in faeces      5    0.4  
Sweating    32    2.7  
Nausea    13    1.1  
Vomiting   100    8.4  
Itching of skin   238  20.0  
Fever and chills     58    4.9  
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 5.6.3 KAP towards intervention of LF  
A total of 1,191 participants participated in the survey. The study found that 69.3% had knowledge 
of the disease and 71.5% had known about MDA (see Table 5.6).  
  
Table 5.6: KAP  
 
   N  %  
Knowledge of LF  Yes  825  69.3  
 No  30.7  
 N  %  
Knowledge of how the  
disease is acquired  
Through drinking dirty water 
Through traditional rituals  
21  
22  
1.8  
1.8  
 Through mosquito bites  18  1.5  
 Through farming    8  0.7  
 Others    1  0.1  
 
    N  %  
 
Knowledge  of  clinical  
manifestation of the disease  
Enlarged legs  
Enlarged scrotum  
623  
108  
52.3  
  9.1  
 Enlarged breast    75    6.3  
 Fever and chills    38    3.2  
Mumps  131  11.0  
    N  %  
 
Knowledge of prevention  By taking medication  138  11.6  
 By drinking clean water    38    3.2  
 By using mosquito nets    11    0.9  
 By spraying your house    14    1.2  
 Others      4    0.3  
MDA programme    N  %  
 
Do you know about MDA?  Yes  851  71.5  
 No  293  24.6  
 Don’t Know    47    3.9  
    N  %  
 
366  
Total    1,191    
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How many times was the 
drug distributed in your 
community?  
One  
Two  
Three  
436  
103  
132  
36.6  
  8.6  
11.1  
 Four  111    9.3  
 Don’t know  409  34.3  
 
  
5.7 Discussion  
There is overwhelming evidence that for chemotherapy-based control strategies such as 
that implemented for LF to be successful, adherence to treatment is cardinal for 
ensuring and sustaining good coverage. In this study, only 63.6% of participants 
admitted to taking the medication during MDA. Whereas 12.9% said that they did not 
take the medication because they experienced weakness or dizziness after taking the 
medication and 20.0% said that they experienced itching of the skin once they 
consumed the medication. Results from a similar study in Haiti showed that 74.0% of 
the respondents said they were given medication during MDA but only 71.0% 
swallowed the tablet (Eberhard, 1996). The results obtained from this study will be 
communicated to the MoH on the importance of pre-MDA educational campaigns in 
Liberia. If the community is aware of the risk factors associated with the disease, there 
will be a higher compliance rate and that in the upcoming MDA the NTD unit should 
have strategies, which will help to improve compliance and sustain the success of the 
programme.  
For MDA to be successful there has to be pre-MDA sensitisation to help to alleviate 
the fears of community members who believe that the drugs cause adverse effects. 
There have been similar studies in India, which reported that reasons for 
noncompliance to the implementation ranges from fear of side effects to lack of 
perceived benefits (Babu & Mishra, 2008). In this study, 71.5% of participants had 
knowledge about the MDA before the distribution of the drugs, which indicates that the 
96  
awareness of the implementation of MDA was adequate. However, a similar study 
carried out in Lofa County in Liberia reported 89.0% of respondents knew the purpose 
of the MDA (Bogus, et al., 2016). A KAP survey carried out in India on the predicators 
of compliance of MDA reported that in one community 97.1% of the respondents knew 
about MDA in advance, while in another community only 69.1% of the respondents 
knew about MDA (Cantey, Rout, Rao, Williamson, & Fox, 2010). For successful 
implementation of MDA it is very important that the community is aware of the purpose 
of the MDA as there are many health-related activities ongoing in the various 
communities, which makes it difficult for them to differentiate. Health education 
should be carried out and the risk and benefits of the drug be properly explained to the 
community (Talbot, et al., 2008). Of the total 1,191 respondents, 617 (51.8%) were 
females and 574 (48.2%) were males. This can be attributed to the fact that in Liberia 
women mostly stay at home or do farming compared to men who go on hunting  
expeditions. The result in this study correlates to a similar study carried out in Port-
auPrince, Haiti, which reported that 70.0% of the respondents in their study were 
women and 88.0% of their respondents said information about MDA was disseminated 
to them before the process had started (Beau de Rochars, et al., 2004).   
In our survey, the majority of participants indicated that LF is obtained from 
drinking dirty water and through traditional rituals and not transmitted by mosquitoes. 
This is in agreement with the findings of a study in West Bengal, India, which reported 
that only 13.9% of the respondents did not know the mode of transmission of LF and 
few had incorrect knowledge that direct contact, water and air are modes of 
transmission (Karmakar, et al., 2011). In this study 52.3% of participants knew that 
enlarged legs was a symptom of LF as well as enlarged scrotum, where some of the 
participants thought that mumps was a clinical manifestation of LF. This result 
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corresponds to a study in Malaysia, which reported that majority of the participants 
responded that the common symptom of LF was leg swelling (Nazeh, et al., 2014).   
  
5.8 Conclusions  
The findings from this study have showed that there was some awareness regarding LF 
in the communities. Majority of the participants had knowledge about the MDA 
programme. However, the study also revealed that those particpants who did not take 
the medication did so because of the perceived side effects. This shows that the 
information of the disease has not been adequately conveyed to the community, making 
some of the people in the community to be non-compliant. Pre-MDA campaigns by the 
health promotion unit in collaboration with the NTD unit at the MoH will improve the 
rate of compliance and hence, programme success.   
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CHAPTER 6: AN EPIDEMIOLOGICAL SURVEY ON 
UROGENITAL AND INTESTINAL SCH AMONGST 
SCHOOL-AGE CHILDREN IN BONG COUNTY,  
LIBERIA, WITH OBSERVATIONS ON STH  
 
6.1 Abstract  
6.1.1 Background  
Urogenital (S. haematobium) and intestinal (S. mansoni) SCH are serious public health 
problems in sub-Saharan Africa and school-age children are often at high risk for 
acquiring STH, i.e., Ascaris, T. trichiura, hookworms and STH. SCH infection is 
typically acquired by playing and bathing in cercarial infested water while STH is 
usually acquired ingesting eggs of Ascaris or T. trichiura or by walking barefoot on soil 
that is contaminated with hookworm larvae infections. Helminth infections are most 
obvious in school-age and pre-school-age children. An epidemiological followup study 
was performed to assess the prevalence and intensity of SCH and STH amongst school-
age children in Liberia after MDA using Bong County as an exemplar.   
6.1.2 Methods  
A cross-sectional parasitological study was conducted from September to October 
2017. A total of 1,003 school-aged children (5–15 years of age) were recruited from 10 
randomly selected schools in Bong County. The school list was a representative of high 
and low infection prevalence in the Bong County. The listing of the schools was 
obtained from the Ministry of Education. Participants were registered on a prestructured 
and tested questionnaire and were given two labelled containers with their name and 
identification number (one for the stool sample and the other for the urine sample). 
Stool samples were collected and processed by the Kato-Katz method for STH and S. 
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mansoni. To determine the prevalence of S. haematobium urine specimens were 
collected and processed using the 10 mL urine filtration method.  
6.1.3 Results  
Of the total 1,003 school-aged children sampled, 504 (50.2%) were female and 499 
(49.8%) were male. The results from the study showed that 123 (12.3%) schoolchildren 
were infected with S. mansoni and 112 (11.2%) schoolchildren were infected with S. 
haematobium. The results of the STH survey revealed a low prevalence for the disease 
with hookworm at 3.3% and Ascaris at 1.2%.  
6.1.4 Conclusions  
This study clearly showed that STH, S. mansoni and S. haematobium are endemic in 
Bong County and are a public health problem in Liberia. There is a need for 
implementation of MDA, continuous health education, and mobilisation and 
sensitisation activities, at both district and community levels. The low prevalence of 
STH in Bong County could be attributed to the annual national deworming programme 
in the country.   
  
6.2 Introduction  
STH, SCH, LF and Oncho are the most common NTDs in sub-Saharan Africa and are 
major public health problems (Molyneux, et al., 2005). SCH, or Bilharziasis, is a 
disease caused by parasitic trematode flatworms of the genus Schistosoma. There are 
more than 200 million people infected globally with the disease, with many more at 
risk of being infected, and 192 million cases of SCH occur in sub-Saharan Africa. The 
highest cases are found in Nigeria, Tanzania, Democratic Republic of Congo and Ghana  
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(Steinmann, et al., 2006). WHO has declared SCH as a public health disease, and an 
NTD targeted for elimination by 2020 (WHO, 2012b). However, there are some 
countries that still have ongoing transmission (Fenwick, 2017).  
Studies on the epidemiology of SCH were carried out at the LIBR from the  
1970s to 1989. Many water bodies (streams, ponds and rice paddies) in Lofa, Bong and  
Nimba Counties examined during the period were found to be harbouring molluscs 
(Biomphalaria and Bulinus species), which are the intermediate hosts of human 
schistosome. As a result of these findings, an SCH Surveillance Unit was established 
in each of the affected counties and was set up jointly by the World Bank and the 
Government of Liberia Development Projects. The SCH Surveillance Unit collected 
baseline data on the prevalence of SCH and other helminthic infections, amongst other 
activities, in these affected counties also known to be agriculture project areas, as it has 
been reported that SCH prevalence increases as a result of irrigation and agriculture 
projects (MoHSW, 2017a). Results from these studies showed that the prevalence of S. 
mansoni was significantly higher than S. haematobium (Mangal, Paterson, & Fenton, 
2008).   
People living close to water bodies, lakes, rivers, reservoirs and ponds that are 
infected with snails, which is the intermediate host, are at high risk of contracting the 
disease. These are some of the challenges, which in the future may cause the elimination 
of this disease to be unattainable by 2020 (Fenwick, 2006). After the civil war and to 
restart interest in disease control the Liberian MoH in collaboration with LSTM and 
APOC in 2010 conducted a study in all 15 counties consisting of a sample size of 3,144 
schoolchildren who provided both stool and urine samples. The mean age of the 
schoolchidren examined was 10.7 years, with an age range between 7 and 14 years. The 
prevalence of S. mansoni and S. haematobium were 9.0% and 6.0% respectively  
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(MoHSW, 2017a).  
There are five species of Schistosoma that can cause disease in humans of which 
there are three major species, which cause morbidity in humans namely, S. 
haematobium found in Africa and the Middle East, S. mansoni found in Africa and 
South America, and S. japonicum found in China and East Asia. The other two species 
are S. mekongi found in Laos and Cambodia and Schistosoma intercalatum found in 
West and Central Africa. Both S. japonicum and S. mekongi are mainly zoonotic 
species. In some countries, mixed infection has been observed with S. mansoni and S. 
haematobium. SCH may cause approximately 200 million deaths annually (Chitsulo, et 
al., 2000). Pre-school and school-age children are at high risk of infection, where 
infection is caused by bathing in freshwater, lakes, ponds and rivers that are 
contaminated with cercarial larvae. It has been observed amongst children living in 
endemic areas that the burden of the worms progressively increase and climax during 
adolescence (Gryseels, at al., 2006).  
SCH can cause a wide range of symptoms and consequences depending on the 
species, the worm burden and the length of time infected. Individuals may have 
moderate to mild parasitic load and limited morbidity, while heavy infection with the 
disease occurs in fewer populations (Tukahebwa, et al., 2013). It has been reported in 
many studies that malaria and SCH are co-endemic in many regions and that developing 
hepatocellular carcinoma may be potentiated in people with co-infection (Yosry, 2006). 
Infection with Schistosoma is not evenly distributed within communities, which may 
be attributed to distribution of infected aquatic snails, acquired resistance, age-related 
and differences in exposure patterns. Each schistosome species requires a specific 
freshwater snail species S. mansoni (Biomphalaria), S. haematobium and S. 
intercalatum (Bulinus), S. japonicum (Oncomelania) and S. mekongi (Tricula) 
(Clements, et al., 2006). The current control strategy recommended by WHO for SCH 
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and STH is by MDA with Praziquantel and Albendazole (Praziquantel 40 mg/Kg body 
weight + Albendazole 400 mg), targeting mainly school-age children and adults at high 
risk of infection. Pre-school-age children and infants are also being considered for 
inclusion in the target population (WHO, 2010d).  
STH, commonly known as intestinal worm infection, is a public health problem 
in the tropics. They are the most common infections affecting the most deprived 
communities in sub-Saharan Africa (Hotez, et al., 2009). STH are transmitted due to 
exposure to contaminated soils containing larvae e.g., hookworm, or by ingestion by 
eating foods that are contaminated with eggs of T. trichiura and Ascaris (WHO, 2012b).  
The warm climate is essential for the STH eggs to thrive. Risk factors for developing STH 
are poor hygiene, poor sanitation and poverty (Vandemark, Jia, & Zhou, 2010).  
Of the 7 billion population of the world it is estimated that between 807–1,121 
million are affected with Ascaris, 604–795 million are infected with T. trichiura and 
567–740 million are infected with hookworms. School-age children in particular are 
mainly affected with STH. It has been reported that approximately 89 million of the 
181 million school-age children in sub-Saharan Africa are affected with one or more of 
the STH infections. About 135,000 deaths of STH occur annually (Brooker, Clements,  
& Bundy, 2006). The three main STH infections are: Ascaris lumbricoides  
(roundworms); T. trichiura (whipworms); and hookworm (Ancylostoma duodenale and 
Necator americanus). Common clinical conditions of STH can be anaemia, poor 
nutrition, stunted growth, diminished cognitive development and decreased physical 
fitness (Bethony, et al., 2006; Stothard, et al., 2009a).  
Morbidity control of STH is primarily achieved through MDA administering a 
single tablet of Albendazole 400 mg or Mebendazole 500 mg. This control strategy has 
been used for decades and is still the forefront intervention for STH control alongside 
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improvements in food, water, sanitation and hygiene. The addition of Mebendazole to 
vitamin A supplementation expanded the treatment to children aged 12–59 months with 
high coverage. The control of STH is also integrated into other programmes such as 
nutrition, school health and often parts of SCH control programmes or LF control 
programmes.  
In Liberia, following the civil war and collapse of health infrastructures, there 
are not many studies conducted to assess STH prevalence and intensity. However 
anecdotal data from MoH clinics and hospitals indicate that Ascaris, T. trichiura and 
hookworm are the widely distributed STHs in Liberia (MoHSW, 2011a). However, in  
2010 a study by the MoH and its partners reported that of the 3,144 schoolchildren from 
59 schools around the county, the main STH species were Ascaris followed by 
hookworm, which also ranged from 0.0% to >50.0% per school. Liberia has now 
established a nationwide co-ordinated deworming programme due to the estimated high 
prevalence of the disease. UNICEF and the MoH in collaboration with the School 
Health Division of the Ministry of Education have targeted children aged 2 to 5 years 
in all 15 counties for deworming. It is believed that 65.0% of children under 5 years 
and pregnant women in rural areas in Liberia are anaemic due to Ascaris, T. trichiura, 
and hookworm (MoHSW, 2011a). Deworming also takes place when the LF drugs are 
distributed. To remedy this weakness, this chapter describes a survey that was 
conducted in Bong County to provide up-to-date information on SCH and STH  
infections.  
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6.3 Objectives  
6.3.1 General objective  
• To provide up-to-date information on the distribution, prevalence and intensity of 
SCH and STH in Bong County using an integrated surveillance approach with stool 
and urine sampling.  
6.3.2 Specific objectives  
• To determine demographic and clinical information from each of the schoolage 
children that was investigated on SCH and STH.  
• To determine the prevalence and infection intensity of SCH (S. haematobium and S. 
mansoni) and STH (Ascaris, T. trichiura and hookworm) in Bong  
County.  
• To create an integrated map for SCH and STH across sampled schools.  
  
6.4 Methodology  
6.4.1 Ethical considerations  
The study protocol received ethical approval from the Univeristy of Liberia – Pacific 
Institute for Research and Evaluation Institutional Review Board at the MoH and the 
Ethics Committee of the LSTM. Approval was also received from the County Health 
Team and Ministry of Education in Liberia. The method and purpose of the study was 
explained to selected school authorities.   
Prior to conducting demography and obtaining informed consent, the research 
team held repeated community meetings in all of the selected schools to communicate 
the purpose of the study and to answer questions at individual and community levels. 
The meetings highlighted: participant selection and participation; procedures and 
protocol; duration of the study side effects; risks and benefits of the study; 
confidentiality and sharing the results; the right to refuse or withdraw from the study; 
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and who to contact in case of any event. School heads were asked to sign written consent 
forms on behalf of schoolchildren targeted to participate in the study. The procedure 
was then explained to each schoolchild, who met the inclusion criteria, and asked to 
consent verbally to participating in the study. Amongst the schoolchildren that met the 
inclusion criteria, only those who provided consent were registered and requested to 
provide samples. Verbal consent was documented by recording the name of each 
schoolchild who provided consent. Paper forms were stored for the duration of the study 
plus 3 years per Institutional Review Board protocol for primary data storage. 
Demographic and morbidity forms included the following details: the participant’s 
name; a unique study identification number (USIN); date of the sample collected; date 
of birth; sex; family relationships; and place of residence.   
  
6.4.2 Team composition and training  
The research team comprised of five members: a principal investigator; one 
microscopist; one datarecorder; one specimen collector; and one smearer. A 1-day 
orientation was held in Bong County for the research team. The principal investigator 
was Dr Louise Kpoto, the datarecorder was a school principal/teacher, and the 
microscopist, specimen collector and smearer were all county laboratory technicians.   
The orientation was aimed at updating the team on the: research protocol; 
administration of informed consents; handling and transportation of samples to The C 
B Dumbar Laboratory for microscopy; parasitological examinations (Kato-Katz and the 
urine filtration methods); completion of data forms; and the manipulation of the GPS 
(Garmin eTrex 20) for collecting geographical co-ordinates. The GPS was truned on to 
determine our locations using satellites signals.   
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Pre-test was carried out after the team training and before the project began. The 
pre-test was aimed at standardising the specimen collection. The day was spent on 
evaluating the consistency of egg counting amongst the laboratory technicians. A 
simple method consists of preparing 10 slides and comparing the reading of each slide 
by each laboratory technician with that of the quality control officer. A discrepancy of 
5.0%–10.0% for egg per slide count was considered normal, but a larger discrepancy 
led to the test not being considered valid, and reasons were identified and corrected. 
Accurate egg per slide count is particularly important for the Kato-Katz method for 
intensity assessment. Each school was investigated for 2 days and then the team moved 
on to the next school.   
  
6.4.3 Selection of study population  
The method used to select primary schools from the sampling frame was by stratified random 
sampling and involved:   
  
• The sampling frame consisted of a list, obtained from the MoH, on all primary 
schools in the Liberian districts classified as high or medium risk for S. 
haematobium and S. mansoni.  
• Ten schools were randomly selected from a sample frame, which included 
schools co-endemic for S. haematobium, S. mansoni and STH.  
• The sampling frame included: the name of each school; the district in which 
each school was located; the identification code of each school; the location of 
each school (geographical co-ordinates); the total number of students in each 
school; and whether the school was a high- or medium-risk area for S. 
haematobium and S. mansoni.  
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6.4.4 Inclusion and exclusion criteria  
The inclusion criteria involved: the willingness of the school to participate and provide 
informed consent; the school being a resident in the Bong County, North Central region 
of Liberia; schoolchildren aged 5–15 years; and the school located in an area at high or 
medium risk of SCH and STH.  
Schools who were unable to provide informed consent or refused to participate were 
excluded from the study (Figure 6.1).   
Figure 6.1:Criteria for exclusion to participate  
  
 
  
6.4.5 Sample size calculation  
Based on the inclusion criteria of schoolchildren aged 5–15 years, the average number 
meeting this criterion was 100 schoolchildren. Using the Creative Research Systems 
sample size calculator for a confidence level of 95.0% with a confidence interval of 5, 
from the population of 134 schoolchildren meeting the criteria per school, the calculated 
sample size was 100 schoolchildren per school and 1,000 schoolchildren for the 10 
schools.   
  
6.4.6 Data collection for SCH and STH  
Upon arrival to the selected schools, the schoolchildren that met the selection criteria were 
registered on the child personal form by the recorder and were each given two labelled 
exclusion  
criteria  
Inability to  
give  
informed  
consent 
Refusal to  
participate  
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containers, which contained their name, their USIN and their class. Each schoolchild was 
explained, which cup was for the stool sample and, which cup was for the urine sample. 
When the schoolchild returned the specimen cups, the recorder for quality control, checked 
that the labels on the cups were correct and the specimens properly collected.  
  
6.5 Survey methods  
To determine the prevalence and intensity of S. mansoni and STH infection, the 
KatoKatz method was used. To determine the presence and intensity of urinary SCH, 
the 10 mL urine filtration method was used. The detection of haematuria was also 
carried out on the schoolchildren by using the hemastix method.  
  
6.5.1 The Kato-Katz method  
In the Kato-Katz method for diagnosing S. mansoni, the general principle is that people 
infected with intestinal schistosomes pass the eggs of the worms with their faeces. By 
examining a stool specimen under a microscope, it is possible to count the number and 
the type of eggs that are present (see Figure 28).  
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Figure 6.2: Using the Kato-Katz method for the diagnosis of S. mansoni  
 
  
6.5.1.1 Safety precautions  
• The stool should be considered potentially infectious.  
• Wear gloves and laboratory coats whenever handling stool samples.  
• Benches, instruments and equipment should be routinely decontaminated with disinfectants 
after use.  
• Materials contaminated with infectious waste should be disinfected before disposal.  
• Drinking or eating during laboratory procedures is prohibited.  
• Appropriate disinfectant(s) should be used for disposal of contaminated materials, wooden 
spatulas and specimen containers, and for cleaning of workbenches.   
• Used specimen containers must be disinfected before washing. 6.5.1.2 Equipment for the Kato-
Katz method  
Kato-Katz equipment involved:   
• Stool sample in container (polythene squares tied with grass or plastic pot).  
• Microscopic glass slides.  
• Cellophane sheets (hydrophilic, 30–50 µm thick).  
• Malachite green (or methylene blue).  
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• Glycerol.  
• Metal sieve (Endecott Sieve) with 200–250 µm mesh size.  
• Slide boxes.  
• Newspapers.  
• Wooden or plastic applicators.  
• Forceps.  
• Kato-Katz plastic template with a hole of 6 mm on a 1.5 mm thick template  
(delivering 41.7 mg of faeces).  
Microscopic examination equipment involved:   
• Microscope.  
• Hand tally counter.  
• Laboratory forms.  
Disinfectants and waste disposal equipment involved:   
• Disinfectant wipes.  
• Medicated soap.  
• Methylated spirit.  
• Waste container (containing disinfectant).  
6.5.1.3 Preparation steps of Kato-Katz reagents  
Below are the five steps involved in the Kato-Katz reagents.  
Step 1: Weigh out 3 g of Malachite green powder (or methylene blue).   
Step 2: Dilute it in 100 mL of distilled water (this is the ‘stock solution’).  
Step 3: Dilute 60 mL of glycerine in 40 mL of distilled water.  
Step 4: Take 1 mL of Malachite green (or methylene blue) stock solution and add it to 100 
mL of the 60.0% glycerol solution (this is the ‘working solution’).  
Step 5: Cut cellophane into 25 mm x 30 mm pieces and soak them overnight in the working 
solution.  
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6.5.1.4 Before preparation  
• Use clean containers for stool collection.  
• Ensure the reusable sieves, templates and spatulas are well cleaned and dry.  
• Clearly and correctly label the stool containers to match the participant USIN.  
6.5.1.5 Kato-Katz steps  
Step 1: Place two glass slides alongside each other and label both slides with the sample number 
and then place a plastic template on top of each.  
Step 2: Place a small amount of the faecal specimen on a newspaper and press through 
the metal sieve. Using a spatula, scrape the sieved faecal material through the sieve so 
that only the debris remains on top.   
Step 3: Scrape up some of the sieved faeces from the underside to fill the hole in the 
templates, avoiding air bubbles and levelling the faeces off to remove any excess.  Step 
4: Carefully lift off the templates and place it in a bucket of water mixed with 
concentrated detergent so that they can be reused.  
Step 5: Place one piece of the cellophane, which has been soaked overnight in the 
Malachite green (or methylene blue) working solution, over the faecal specimen. Step 
6: Place a clean slide over the top and press it evenly downwards to spread the faeces 
in a circle (this can be done by inverting the slide onto clean newspaper and pressing 
firmly). If done well, it should be possible to read the newspaper print through the stool 
smear.  
Step 7: The ideal time for observing S. mansoni eggs is 24 hours after preparation, however, in 
bright sunlight the slides clear rapidly and a 24 hour delay is not necessary.   
6.5.1.6 Microscopic examination for S. mansoni  
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Step 1: After 10 minutes place a little amount of eosin on the slide and place it under microscope 
using x 10 objective.  
Step 2: Count ALL eggs present using a hand tally counter; start in one corner of the sample 
and systematically scan the whole sample in a ‘zig zag’ scheme.  
Step 3: Record the number and the type of each egg on a recording form alongside the sample 
number. If no eggs are seen, record ‘0’.   
Step 4: Each sample should be examined by two technicians, one technician reading slide A 
and the other technician reading slide B.  
Step 5: 10.0% of slides A and B should be randomly selected and re-examined by a more 
experienced technician.   
Discrepancy in egg count should not be greater than 10.0%. If discrepancy between 
readers is greater than 25.0% all slides should be re-read.  
The participants were placed in three categories (light, moderate or heavy) based on 
the intensity of the infection.  
For S. mansoni:  
Light (1–100 eggs per gram).  
Moderate (101–400 eggs per gram).  
Heavy (>400 eggs per gram).  
For S. haematobium, intensity of the egg per 10 mL of urine:  
Light (1–50 eggs per 10 mL).  
Moderate (51–499 eggs per 10 mL).  
Heavy (>400 eggs per 10 mL).  
Step 6: Once examination of the slides is completed, including quality control, remove 
the faeces and cellophane using a tissue into the waste container. Place all slides used 
when conducting the Kato-Katz method into the disinfectant. These slides should be 
cleaned and used again for the survey.  
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6.5.2 Hemastix method  
In diagnosing S. haematobium, all manufactured kits come with instructions on how to 
use them. It is very important to follow the instructions to ensure the quality of the 
results.  
6.5.2.1 Equipment for Hemastix test  
• Case record form.  
• Hemastix test strip and Hemastix pot with scale.  
• Scissors.  
• Gloves.  
• Disinfectants and waste disposal.  
6.4.2.2 Steps for reagent strips  
Step 1: Collect a fresh urine specimen in a clean plastic container. Ensure that the urine 
is tested in the field within 2 hours of collection. If there is a delay, refrigerate the 
specimen if possible.  
Step 2: Remove one strip from its bottle (you can cut the strip in two to save resources) and 
label the strips with the patient identification.  
Step 3: Completely immerse the reagent areas of the strip into the urine specimen for a few 
seconds.  
Step 4: When removing the strip, run its edge against the rim of the container to remove 
any excess urine.  
Step 5: Put the strip horizontally on the table so that the chemicals do not mix together. 
Step 6: Read the strip between 1 minute and 2 minutes after it has been dipped in the 
urine specimen.  
Step 7: Match the colour of the strip with the colour chart on the bottle label and record the 
results on the monitoring form. Record ‘0’ if the result is negative.    
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1 = trace non-haemolysed.  
2 = trace haemolysed.  
3 = +  
4 = ++  
5 = +++  
6.5.3 Urine filtration Standard Operating Procedures  
In diagnosing S. haematobium, all manufactured kits come with instructions on how to 
use them. It is very important to follow the instructions to ensure the quality of the 
results.  
6.5.3.1 Safety precautions  
• The urine should be considered potentially infectious.  
• Wear gloves and laboratory coats whenever handling urine samples.  
• Benches, instruments and equipment should be routinely decontaminated with disinfectants 
after use.  
• Materials contaminated with infectious waste should be disinfected before disposal.  
• Drinking or eating during laboratory procedures is prohibited.  
• Appropriate disinfectant(s) should be used for disposal of contaminated specimen containers 
and for cleaning of workbenches.   
• Used specimen containers must be disinfected before washing.  
  
6.5.3.2 Equipment For 
general use:  
• Gloves.  
• Laboratory forms.  
For urine filtration:  
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• Urine pots (20 mL).  
• Swinnex Filter Holder.  
• Tweezers/Forceps.  
• Syringe, plastic, 10 mL.   
• Nucleopore Membrane Filter, 13 mm diameter and pore size 12 µm.  
• Microscope glass slides.  
• Lugol’s Iodine (5.0% solution).  
For microscopic examination:   
• Microscope.  
• Hand tally counter.  
For disinfectants and waste disposal:   
• Bucket (to discard urine).  
• 1.0% hypochlorite solution (domestic bleach).  
• Methylated spirit.  
• Medicated soap.  
• Rubber washing gloves.  
• Disinfectant wipes.  
• Waste container (containing disinfectant).  
6.5.3.3 Sample collection  
The number of eggs in the urine varies throughout the day, with the highest between 
10:00 a.m. and 14:00 p.m. The specimen should be taken between these times and 
consist of a single urine sample. Since eggs are more often found at the end of a urine 
flow, at least 10 mL should be collected at the end of urination (the terminal urine). The 
easiest way to ensure a terminal urine sample is to ask individuals to ‘try to fill’ a large 
pot, e.g., 250 mL. Note that some children, particularly those who are heavily infected 
with SCH, may not be able to provide 10 mL of urine. Do not discard these smaller 
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samples, but note the volume (mL) of urine provided. Specimens should be examined 
as soon as possible after collection as the eggs may hatch and then become invisible, or 
crystals may form, making a correct diagnosis more difficult.  
6.5.3.4 Steps for urine filtration  
Before preparation:  
• Use clean containers for urine collection.  
• Ensure the filter holders and syringes are well cleaned and dry.  
• Clearly and correctly label the stool containers to match the participant USIN. Step 1: 
Unscrew the filter holder and insert a nucleopore filter between the two parts of the filter holder. 
Make sure it is correctly held in place before screwing the unit together again.   
Step 2: Thoroughly shake and mix the urine specimen before drawing a 10 mL  
specimen into the syringe. Then attach the filter unit.   
Step 3: Keeping the syringe and the unit in a vertical position, press the plunger down to 
push all the urine through the filter and out into a bucket.   
Step 4: Carefully detach the syringe from the filter unit. Draw air into the syringe, 
reattach the syringe to the filter unit holder and expel the air again. This is important as 
it removes any excess urine and ensures that the eggs are firmly attached to the filter.  
Step 5: Unscrew the filter holder and use a pair of tweezers to remove the filter and 
place it inverted onto the glass microscope slide labelled with a USIN. The top side of 
the filter, where the eggs were captured, should be face-up on the slide.    
Step 6: Add one drop of Lugol’s iodine and wait 15 seconds for the stain to penetrate the 
eggs. This makes the eggs more easily visible.   
Step 7: Immediately examine the whole filter under a microscope at a low power (x 
40). Schistosome eggs can be seen clearly because they stain orange. Record the total 
number of eggs on the filter.  
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Step 8: At the end of the day, wash all reusable equipment (forceps, filter holders, 
syringes, urine containers and glass slides) in 1.0% hypocholorite solution (domestic 
bleach) for use next day, discard used filters and clean the workbench.   
Step 9: Around 10.0% of slides should be randomly selected and re-examined by a 
more experienced technician. Discrepancy in egg count should not be greater than 
10.0%.  If discrepancy between readers is greater than 25.0% all slides should be 
reread.   
6.5.3.5 Quality control measure  
Quality control was implemented to verify the consistency of the microscopic readings 
and to ensure compliance with the following: wearing protective gloves and clothing at 
all times when handling the specimen. Make sure all specimens are properly labelled.  
A quality control officer, highly trained personnel on microscopy of SCH and  
STH, cross-examined 10.0% of all positive and negative specimens to ensure the quality of the data. 
School and student personal data forms were properly filled and  
USIN on the form matched with the specimen.   
  
6.5.3.6 Survey data and processing  
Standardised pre-tested, paper base form was used for data collection. Participant information 
included: name of schoolchild; assigning a USIN; date sample was  
collected; date of birth; and sex.  
Data was entered using SPSS (IBM SPSS Statistics for Windows, Version 25.0. 
Armonk, NY: IBM Corp.) directly from labelled forms that were collected during the 
field survey, using chi square to determine the  cross tabulation.   
  
  
  
  
118  
6.6 Results  
6.6.1 Schools and districts  
A total of 10 schools were randomly selected to participate in the study. The schools 
were selected from each of the eight health districts. Two districts had two schools 
selected from it due to the size of the districts (see Figure 6.3).  
  
Figure 6.3: Bong County showing the location of schools surveyed  
 
  
Table 6.1: Name of schools and number of participants per school  
School Name  Frequency   
Barsee Kpangbai  100    
Community House Elementary School  100    
David Fejue High School  101    
E. J. Yancy Public School  100    
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Faith Community AG Elementary and Junior High 
School  
100    
Jorkpemue Public School  100    
Mawah Public School  101    
Mbelequah Public School  100    
Nyaquoi Bee Public School  100    
 
Sanoyea  101    
 
Total  1,003    
  
Table 6.2: Sociodemographic characteristics of participants  
Level of education by gender  
Level  of  
education  
Female  Male  Total   
Grade 3 to Grade 
6  
160 (31.7%)  125 (25.1%)  285 (28.4%)  
Grade  7  and  
above  
17 (3.4%)  16 (3.2%)  33 (3.3%)  
K1–Grade 2  327 (64.9%)  358 (71.7%)  685 (68.3%)  
 
  
Of the total 1,003 school-age children that participated in the study 504 (50.2%) 
were males and 499 (49.8%) were females. The majority of schoolchildren at 685 
(68.3%) were in K1–Grade 2 (see Table 28). The mean age was 10.9 years and medium 
was 11 years (see Table 6.3).  
  
Table 6.3: Mean and median age of participants, by sex  
Age  Female   Male   Overall  
Mean (SD)  10.9 (2.1)  10.9 (2.0)  10.9 (2.0)  
Median (IQR)  11 (9–12)  11 (9–13)  11 (9–12)  
IQR = interquartile range; SD = standard deviation.   
  
T otal  504  499  1 , 003  
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6.6.3 Prevalence of S. mansoni, S. haematobium, and STH  
Of the total 1,003 school-age children that had their stools examined using the single 
Kato-Katz method, 123 (12.3%) schoolchildren were infected with S. mansoni. For 
STH, hookworm infection was found in 2 (0.2%) schoolchildren and T. trichiura and 
Ascaris infections were found in 12 (1.2%) schoolchildren. Amongst STH, hookworm 
had the highest prevalence at 3.3% followed by Ascaris at 1.2%. The results showed 
that females had the highest prevalence of S. haematobium (58.0%) whereas males had 
the highest percentage of Ascaris (66.7%).  
The urine filtration on S. haematobium showed a prevalence of 112 (11.2%) 
schoolchildren infected with single infections, for S. mansoni a prevalence of 123 
(12.3%) schoolchildren infected with single infections, and a prevalence of 27 (2.7%) 
schoolchildren infected with double infections. There was no statistical significance 
between single infections, double infections and age (See Table 6.4). 
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Table 6.4: Prevalence of S. mansoni, S. haematobium and STH  
Age  Frequency  S. mansoni   
N (%)  
Hookworm   
N (%)  
T. trichiura   
N (%)  
Ascaris  
N (%)  
S. haematobium  
N (%)  
double  
parasite  
7–11 years  607 (60.5%)  59 (48.0%)  15 (45.5%)  2 (100%)  9 (75.0%)  61 (54.5%)  14 (51.9%)  
12–14 years  352 (35.1%)  59 (48.0%)  15 (45.5%)  0 (0.0%)  3 (25.0%)  42 (37.5%)  12 (44.4%)  
15 years  44 (4.4%)  5 (4.0%)  3 (9.1%)  0 (0.0%)  0 (0.0%)  9 (8.0%)  1 (3.7%)  
Total  1,003 (100%)  
  
123 (12.3%)  33 (3.3%)  2 (0.2%)  12 (1.2%)  112 (11.2%)  27 (2.7%)  
Sex  
Female  504 (50.2%)  57 (46.3%)  13 (39.4%)  1 (50.0%)  4 (33.4)  65 (58.0%)  11 (40.7%)  
Male  499 (49.8%)  66 (53.7%)  20 (60.6%)  1 (50.0%)  8 (66.7)  47 (42.0%)  16 (59.3%)  
Total  1,003 (100%)  123 (12.3%)  33 (3.3%)  2 (0.2%)  12(1.2%)  112 (11.2%)  27 (2.7%)  
     
Table 6.5: Bivariate and multivariate logistical regression analysis of STH in relation to selected variables amongst school-age children 
in Bong County, 2017  
Variables  Presence of Helminths, n (%)  COR (95% CI)  AOR(95% CI)  AOR(95% CI)**  
Positive (N=47)  Negative (N=956)        
Female  18 (38%)  486(51%)  1.00  1.00  1.00  
Male  29 (62%)  470(49%)  1.85 (1.02–3.41)  1.85 (1.03–3.42)  1.84 (0.97–3.50)  
Age (year)            
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7 – 11  26 (55%)  581(61%)  1.00  1.00  1.00  
12 – 14  18(39%)  334(35%)  1.22 (0.71–3.07)*  1.28 (0.69 – 3.46)*  1.09 (0.78–3.52)*  
15  3(6%)  41(4%)  1.61 (0.79–3.25)*  1.78 (0.38–5.75)*  1.79 (0.56 – 5.84)*  
COR crude odds ratio, AOR adjusted odds ratio, CI confidence interval, *statistically significant at P < 0.05 in multivariate logistic 
regression analysis**Adjusting for clustering within schools – schools included as a fixed effect  
  
As shown by Table 2, the prevalence of STH infection was 4.68% whereby a total of 47 school age tested positive for the soil-transmitted 
helminthiasis. This prevalence is relatively low compared to a study done by Novianty, et al., (2018) who investigated the risk factors for 
soiltransmitted helminthiasis in preschool children in North Sumatera and found a prevalence of 40.5%. Whereas Wang et al., (2012) reported that 
there was STH infection prevalence of 21.2% in school children.   
  
The prevalence of soil-transmitted helminthiasis was high among male pupils 62% (29) compared with females 38% (18) showing a difference 
between sex and the infection of schistosomiasis. Male pupils were established to have a significant correlation with the prevalence of 
soiltransmitted helminthiasis (OR=1.85, 95% CI: 1.02–3.41). This shows male pupils were 1.85 times more likely to have soil-transmitted 
helminthiasis as compared to the female pupils. Similarly, studies conducted have also confirmed the prevalence of STH to be higher among male 
children as compared to the female children (Novianty, et al, 2018; Pullan, & Brooker, 2012; Speybroeck, 2017).  
With regards to age, children aged between 7 and 11 years were the most infected with an infection rate of 55%, followed by those between 12 
and 14 years (39%) and those aged 15 years the least at 6%. Children between 12 and 14 years, and those at 15 years were further found a 
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significant positive relationship with the number of soil-transmitted helminthiasis in relation infections (OR=1.22, 95% CI: 0.71–3.07 and 
OR=1.61, 95% CI: 0.79–3.25 respectively). This shows children between 12 and 14 years, and those at 15 years were 1.22 and 1.61 times 
respectively more likely to have soil-transmitted helminths as compared to the  other age groups. In a similar manner, Alemu, et al, (2016) who 
investigated Schistosoma mansoni and soil-transmitted helminths among children in Chuahit, Dembia district, Ethiopia also established that 
prevalence intestinal helminthic infections showed significant association with age (p. value < 0.05).  
   
Table 6.6: Bivariate and multivariate logistical regression analysis of S. haematobium and S. mansoni in relation to selected variables 
amongst school-age children in Bong County, 2017  
Variables  Presence of Schistosomiasis   COR (95% CI)  AOR (95% CI)  AOR (95% CI)**  
Yes (N=235)  No (N=768)        
Female  122(52%)  382(49%)  1.00  1.00  1.00  
Male  113(48%)  386(51%)  0.62 (0.22–1.84)  0.60 (0.20–1.82)  0.55 (0.19–1.78)  
Age (years)            
7 – 11  120(51%)  487(63%)  1.00  1.00  1.00  
12 – 14  101(43%)  251(33%)  1.59 (1.20–2.75)*  1.60 (1.21–2.78)*  1.81 (1.40–2.98)*  
15  14(6%)  30(4%)  2.43(1.32–4.47)  1.89(0.99–3.64)  1.91(1.01–3.64)  
COR crude odds ratio, AOR adjusted odds ratio, CI confidence interval, *statistically significant at P < 0.05 in multivariate logistic 
regression analysis**Adjusting for clustering within schools – schools included as a fixed effect  
  
As shown by Table 1, the prevalence of Schistosomiasis infection was 23.43% whereby a total of 235 school age tested positive for  
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Schistosomiasis.  This shows a relatively high prevalence as compared to a study done by Hajissa, et al., (2018) among school children in UmAsher 
Area, Sudan and found that the prevalence of S. haematobium was 12.9%, whereas that of S. mansoni was 2.95%.  
  
The prevalence of schistosomiasis was high among female pupils 122(52%) compared with males 113(48%) showing a significance between sex 
and the infection of schistosomiasis. However, the male pupils were established by bivariate and multivariate logistic regression analysis to have 
a significant correlation with the prevalence of S. haematobium and S. mansoni infections (OR=0.62, 95% CI: 0.22–1.84). This shows male pupils 
were 0.62 times more likely to have schistosomiasis as compared to the female pupils. This is confirmed by Omer, et al., (2016) who investigated 
schistosomiasis prevalence among School Age Children at Shendi Locality and also established a statistical significance between sex and the 
infection of schistosomiasis (P value = 0.006).  With regards to age, children aged between 7 and 11 years were the most infected with an infection 
rate of 51%, followed by those between 12 and 14 years (43%) and those aged 15 years the least at 6%. Empirical studies conducted also found 
out that infections of schistosomiasis was high among children aged 8 to 13 years (Bah, et al., 2019; Sokolow, et al., 2016). Accordingly, logistic 
regression analysis confirmed that schistosomiasis infections was statistically related to the age of the children between 12 and 14 years (OR=1.59, 
95% CI: 1.20–2.75). This shows children between 12 and 14 years were 1.59 times more likely to have schistosomiasis as compared to the other 
age groups.  
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 6.6.4 Prevalence of S. mansoni, S. haematobium and STH by school and district 
Table 33 shows the intensity of infection with SCH and STH. Out of the 123 schoolaged 
children positive for S. mansoni based on the Kato-Katz method, results showed that 
75 (61.0%) had a light infection intensity, 25 (20.3%) had moderate infection intensity, 
and 23 (18.7%) had a heavy infection intensity. Out of the 112 school-aged children 
positive for S. haematobium based on the urine filtration method, results showed that 
69 (61.6%) had a light infection intensity and 43 (38.4%) had a heavy infection 
intensity. For STH, out of the 12 school-aged children positive for Ascaris 7 (58.3%) 
had a light infection intensity, 4 (33.3%) had a moderate infection intensity, and 1 
(8.3%) had a heavy infection intensity. Out of 33 school-aged children positive for 
hookworm, 17 (51.5%) had a light infection intensity, 13 (39.4%) had a moderate 
infection intensity, and 3 (9.1%) had a heavy infection intensity. Out of the two 
schoolaged children positive for T. trichiura both showed a light infection intensity 
(100.0%)  
(see Table 33).   
  
Table 6.7: Intensity of infection with SCH and STH  
 Intensity of infection by class   Parasite 
 Light  Moderate  Heavy  Total  
S. haematobium  
S. mansoni  
Ascaris  
T. trichiura  
Hookworm  
  
  
69 (61.6%)   0 (0.0%)  
75 (61.0%)  25 (20.3%)  
7 (58.3%)  4 (33.3%)  
2 (100.0%)  0 (0.0%)  
17 (51.5%)  13 (39.4%)  
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43 (38.4%)  
23 (18.7%)  
1 (8.3%)  
0 (0.0%)  
3 (9.1%)  
112 (100%)  
123 (100%)  
  12 (100%)  
    2 (100%)  
  33 (100%)  
 Table 6.8: Intensity of infection, by gender  
Ascaris  
  Male  Female  Male  Female  Male  Female  Male  Female  Male  Female  
Light  13 (27.7%)  28 (43.1%)  42 (63.6%)  33 (57.9%)  5 (62.5%)  2 (50.0%)  1 (100%)  1 (100%)  11 (55.0%)  6 (46.2%)  
Moderate  13 (27.7%)  15 (23.1%)  14 (21.2%)  11 (19.3%)  2 (25.0%)  2 (50.0%)  0 (0.0%)  0 (0.0%)  7 (35.0%)  6 (46.2%)  
Heavy  21 (44.7%)  22 (33.8%)  10 (15.2%)  13 (22.8%)  1 (12.5%)  0 (0.0%)  0(0.0%)  0(0.0%)  2 (10.0%)  1 (7.6%)  
Total  
47  
(100%)  
65  
(100%)  
66  
(100%)  
57  
(100%)  
8   
(100%)  
4   
(100%)  
1   
(100%)  
1   
(100%)  
20  
(100%)  
13 
(100%)  
 
Intestinal  
parasite  S. haemato bium  S. mansoni  T. trich i ura  Hookworm  
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Table 6.9: Prevalence of S. mansoni, S. haematobium and STH, by schools and districts  
Schools  Districts  
S. mansoni 
N (%)  
Hookworm  
N (%)  
Ascaris N 
(%)  
T. trichiura  
N (%)  
S. haematobium 
N (%)  
Mawah Public School  Fumah  0 (0.0%)  2 (6.1%)  3 (25.0%)  0 (0.0%)  8 (7.1%)  
Community House Elementary School  Jorquelleh  19 (15.4%)  1 (3.0%)  1 (8.3%)  0 (0.0%)  10 (8.9%)  
Jorkpemue Public School  Jorquelleh  18 (14.6%)  0 (0.0%)  5 (41.7%)  1 (50.0%)  4 (3.6%)  
Barsee Kpangbai  Kokoyah  3 (2.4%)  0 (0.0%)  0 (0.0%)  0 (0.0%)  18 (16.1%)  
Nyaquoi Bee Public School  Panta  11 (8.9%)  4 (12.1%)  3 (25.0%)  1 (50.0%)  6 (5.4%)  
E. J. Yancy Public School  Salala  1 (0.8%)  0 (0.0%)  0 (0.0%)  0 (0.0%)  5 (4.5%)  
Sanoyea  Sanoyea  2 (1.6%)  0 (0.0%)  0 (0.0%)  0 (0.0%)  1 (0.9%)  
David Fejue High School  Suakoko  0 (0.0%)  1 (3.0%)  0 (0.0%)  0 (0.0%)  27 (24.1%)  
Faith Community AG Elementary and Junior High  Suakoko  25 (20.3%)  3 (9.1%)  0 (0.0%)  0 (0.0%)  18 (16.1%)  
Mbelequah Public School  Zota  44 (35.8%)  22 (66.7%)  0 (0.0%)  0 (0.0%)  15 (13.4%)  
Overall   123 (12.3%)  33 (3.3%)  12 (1.2%)  2 (0.2%)  112 (11.2%)  
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The intensity of SCH amongst the different age groups and gender showed 
that females had a higher prevalence of S. haematobium compared to males, but males 
had a higher prevalance of S. mansoni, Ascaris and hookworms. However, T. 
trichiura was prevalent in both males and females (see Table 34).  
 Of the total 10 schools surveyed from the eight health districts during the study, for S. 
mansoni, Mbelequah Public School in Zota district had highest positive cases with 44 
(35.8%) followed by Faith Community AG Elementary and Junior High in Suakoko 
district with 25 (20.3%) cases. For S. haematobium, David Fejue High School in 
Suakoko district had the highest positive cases 27 (24.1%) followed by Barsee  
Kpangbai in Kokoya district and Faith Community AG Elementary and Junior High in 
Suakoko district with 18 (16.1%) each. For the STH, Mbelequah Public School had the 
highest positive cases of hookworm with 22 (66.7%) followed by Jorkpemue Public  
School with 5 (41.7%) positive cases of Ascaris.   
  
6.6.5 Prevalence of haematuria using the urine strips  
There was no visible haematuria, however, reagent strips was dipped in the urine 
sample of each of the students for about 1 minute the strips were compared to the 
colorimetric scale on the cup of the strip. Of the 1,003 participants (111) 11.1% had 
positive haematuria. Amongst which 64 (57.7%) were female and 47 (42.3%) were 
male. The age range with the highest positivity was 7–11 years (see Table 36).  
  
Table 6.10: Percentage of participants with haematuria, by age and sex using the 
dipstick  
Age  Haematuria  
7–11 years  60 (54.1%)  
12–14 years  42 (37.8%)  
15 years    9 (8.1%)  
Total (N = 1,003)   111 (11.1%)  
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Sex  
Female  
  
64 (57.7%)  
 
  
  
  
6.7 Discussion  
Studies on the epidemiology of SCH in Liberia indicates high prevalence of SCH in 
northern Liberia, Bong, Lofa and Nimba Counties, with no snail hosts of Schistosoma 
found in the coastal regions although records on earlier scientific research reports and 
other relevant unpublished documents were lost during the war (Strickland, 2006). STH 
is the most prevalent parasitic disease in the world. These infections are most prevalent 
in tropical and subtropical regions of the developing world where adequate water and 
sanitation are lacking. These contribute to malnutrition and impaired physical and 
cognitive development in early childhood, poor school performance, reduced working 
capacity, and complication of pregnancy and birth outcome. According to a recent 
study, it has been noticed that even low infection intensities of multiple helminth 
infections enhance the risk of anaemia (Hotez, 2011).  
The prevalence of S. mansoni infection amongst the 1,003 school-age children 
in Bong County, northern Liberia that participated in this study was 123 (12.3%). This 
is similar to a study on pre-schoolchildren in Sierra Leone that showed a prevalence 
rate of 11.2% (Hodges, et al., 2012) and another study on STH and SCH amongst 
preschool-age children in Ethopia also showed a prevalence of 11.2% (Alemu, 
Tegegne, Damte, & Melku, 2016). These results were higher than the nationwide study 
carried out in Liberia by the MoH and its partners in 2010, where the prevalence of S. 
mansoni  
was 9.0% and S. haematobium was 6.0% (MoHSW, 2011b). A study on the  
Male  47 (42. 3 % )  
T otal  111  (100. 0 %)  
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epidemiology of SCH in Bong County by Dennis et al. (1983) showed that there was a 
higher prevelance of S. mansoni (24.8%) compared to S. haematobium (22.0%). Their 
study also showed that the snail population in Bong County were Bulinus globosus and 
Biomphalaria pfeifferi, but the most prevalent snail population of the two was Bulinus 
globosus (Dennis, et al., 1983). The 1983 study by Dennis et al., collaborated with this 
study and showed that there is a higher prevalence of S. mansoni (12.3%) compared to 
S. haematobium (11.2%) in Bong County, Liberia. A further study conducted in Malawi 
on SCH in pre-school-age children observed that S. mansoni was 17.0% and S. 
haematobium was 45.1% (Poole, et al., 2014). These results are higher than that of this 
study. The prevalence of S. mansoni and S. haematobium observed in this study was 
lower than that of the overall prevalence of STH, where Ascaris had a prevalence at 
1.2%, hookworm at 3.3% and T. trichiura at 0.2%. These results were similar to that of 
a study in Sierra Leone where there was a low prevalence of Ascaris (0.2%–17.2%), 
hookworm (8.4%–22.8%) and T. trichiura (0.9%–2.6%) infections (Hodges, et al., 
2012). The low prevalence of STH can be attributed to the nationwide annual 
deworming programme by the Ministry of Education, MoH and their partners targeting 
all school-age children in the country.  
 Of the 10 schools that enrolled in the study, the Mbelequah Public School located in 
Zota district, had the highest positive cases of S. mansoni with 44 (35.8%) followed by 
Faith Community AG Elementary and Junior High in Suakoko district with 25 (20.3%). 
For S. haematobium, David Fejue High School in Suakoko district had the highest 
positive cases with 27 (24.1%) followed by Barsee Kpangbai in Kokoya district and 
Faith Community AG Elementary and Junior High in Suakoko district with 18 (16.1%) 
each. For STH, Mbelequah Public School had the highest positive cases of hookworm 
with 22 (66.7%) followed by Jorkpemue Public School with 5 (41.7%)  
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positive cases of Ascaris (see Table 35). Of the eight health districts, 10 schools located 
in 10 different communities were surveyed. This study revealed that the highest STH 
prevalence was in Zota district (35.8%) followed by Suakoko district (20.3%) and 
Jorquelleh (15.4%). A similar study by the MoH in Bong County, Liberia reported 
Ascaris at 21.0%, hookworm at 14.0%, and T. trichiura at 1.0% (MoHSW, 2011b). 
This study showed a decrease in the prevalence of STH, which could be attributed to 
the nationwide deworming programme that has been ongoing in schools around the 
country.  
  
6.7.1 Intensity of SCH and STH  
The intensity for S. mansoni based on the Kato-Katz method, results showed that 61.0% 
had a light infection intensity, 20.3% had moderate infection intensity, and 18.7% had 
a heavy infection intensity. The intensity for S. haematobium based on the urine 
filtration method showed a 61.6% had a light infection intensity and 38.4% had a heavy 
infection intensity. For STH, Ascaris had a light infection intensity of 58.3%, a 
moderate infection intensity of 33.3%, and a heavy infection intensity of 8.3%. 
Hookworm had a light infection intensity of 51.5%, a moderate infection intensity of 
39.4%, and a heavy infection intensity of 9.1%. T. trichiura had 100.0% light infection 
intensity.   
The intensity of SCH amongst the different age groups and gender showed 
that females had a higher prevalence of S. haematobium compared to males, but males 
had a higher prevalance of S. mansoni, Ascaris and hookworms. However, both males 
and females showed equal prevalence to T. trichiura.  
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6.8 Limitations  
The study was limited to only one county as opposed to the entire country. However, 
the results obtained were valid and accurate, but is not a representation of the entire 
country. Also the intensity and prevalence of STH and SCH were obtained from a single 
stool specimen, which may have an influence on the accuracy of the egg count.  
  
6.9 Conclusions  
The study confirms urogenital and intestinal SCH are endemic in Bong County and that 
S. haematobium and S. mansoni were the two species of Schistosoma identified in the 
study. The study has shown that the prevalence of the parasitic disease varies across 
schools in the same county. The study also revealed that there is a low prevalence of 
STH across all participating schools and confirms that T. trichiura infection is generally 
low in the country. The decrease in the burden of STH could be attributed to the annual 
deworming programme in the country.   
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CHAPTER 7: KNOWLEDGE, ATTITUDES AND 
PRACTICES TOWARDS SCH, LF AND STH AMONGST 
SCHOOL-AGE  CHILDREN  IN  BONG COUNTY,  
LIBERIA  
 
7.1 Abstract  
7.1.1 Background  
There is considerable overlap in the geographical distribution and endemicity of LF, 
Oncho, SCH and STH in Liberia. Co-endemicity of the four NTDs occurs in 13 
counties: Bong; Grand Gedeh; Grand Cape Mount; Grand Bassa; Grand Kru; 
Montserrado; Maryland; Margibi; Nimba; Lofa; Sinoe; Rivercess; and River Gee. 
Coendemicity of three NTDs excluding Oncho occurs in 14 counties (excluding 
Rivercess  
County); while co-endemicity of three NTDs excluding LF occurs in 13 counties 
(excluding Gbarpolu and Bomi Counties); co-endemicity of two NTDs excluding LF 
and Oncho occurs in three counties: Bong; Nimba; and Lofa. However, there has never 
been a survey to determine the KAP in the population at risk to NTDs in the country.  
7.1.2 Objective  
To assess KAP of SCH, LF and STH amongst school-age children in Bong County, 
northern Liberia in order to prepare a health promotional material on the prevention 
and control of NTDs.  
7.1.3 Methods  
A cross-sectional survey was conducted in 10 primary schools from September to 
December 2018, using a structured and pre-tested questionnaire, to evaluate KAP 
amongst 1,003 school-aged children who met the inclusion criteria age of 5–14 years.  
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The survey was carried out on the second day following collection of samples from the 
schoolchildren to determine the prevalence of STH and SCH. Descriptive analysis was 
used for the data analysis.  
7.1.4 Results  
Of the 1,003 school-aged children, 90.0% had not heard about SCH, 86.0% had not 
heard of STH, and 92.0% had not heard of LF. For the water contact pattern only 9.0% 
had access to pipe water. Around 28.0% of schoolchildren had received medication 
during the MDA by the MoH, 21.4% slept under mosquito nets, and 72.0% used the  
bushes as latrines.    
7.1.5 Conclusions  
The study highlights the need for health education amongst schoolchildren in Bong 
County in order to raise awareness on the prevention and control of SCH, LF and STH 
and its related health risks. The study also highlights the need for improving sanitation 
and the use of mosquito nets.  
  
7.2 Introduction  
KAP in relation to NTDs are crucial in establishing effective disease control measures. 
In Liberia, data on the KAP of populations in endemic areas in Liberia with regards to 
NTDs are not available. Awareness of the community and their involvement are 
considered as one of the fundamental tools for the success and sustainability of any 
disease control programme (Kihara, et al., 2007). To remedy this weakness, this study 
assessed the KAP of school-age children on SCH, LF and STH in Bong County. It is 
anticipated that the findings may add new understandings about the prevention and 
control of NTDs in Liberia. There is considerable overlap in the geographical 
distribution and endemicity of LF, SCH and STH in Liberia. Co-endemicity of the four  
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NTDs occurs in 13 out of 15 counties: Bong; Grand Gedeh; Grand Cape Mount; Grand 
Bassa; Grand Kru; Montserrado; Maryland; Margibi; Nimba; Lofa; Sinoe; Rivercess; 
and River Gee. Co-endemicity of three NTDs excluding Oncho occurs in 14 counties 
(excluding Rivercess County); while co-endemicity of three NTDs excluding LF occurs 
in 13 counties (excluding Gbarpolu and Bomi Counties); co-endemicity of two NTDs 
excluding LF and Oncho occurs in three counties: Bong; Nimba; and Lofa (MoHSW,  
2017a). Bong County was selected for this survey due to the co-endemicity of the three 
NTDs under review; it has a high prevalence for SCH as compared to other counties 
and to be used as an exemplar to update the data on SCH for the NTD programme at 
the MoH after two rounds of MDA.  
Universally, approximately 2 billion people are affected by schistosomes and  
STH, of which over 300 million suffer severe morbidity or permanent impairment. 
These worm infections affect the underprivileged, particularly children (Hotez, et al.,  
2006). At the fifty-fourth Word Health Assembly in 2001 a resolution was adopted for 
Member States to annually administer anthelmintic drugs to at-risk populations and to  
75.0%–100.0% of school-age children that are at risk of morbidity due to STH and SCH 
(WHO, 2001). There is a need for integrating the control of STH with that of other 
NTDs (Stothard, et al., 2009b). In 2002, SCH control was launched with a grant from 
Bill and Melinda Gates. Since then millions of children in sub-Saharan Africa have 
received medication for the control for SCH and STH (Givewell, 2014).  
Liberia has a population of 4.7 million. The NTDs MDA coverage index has 
reached 62/100. In 2016, data showed that there was 74.0% treatment coverage for LF, 
31.0% treatment coverage for SCH, and 90.0% treatment coverage for STH (Uniting 
to Combat Neglected Tropical Diseases, 2016).   
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7.3 Objectives  
• To assess the KAP on SCH, LF and STH amongst school-age children in Bong  
County, northern Liberia.  
• To prepare a health promotional material on the prevention and control of  
NTDs.  
  
7.4 Methodology  
7.4.1 Ethical considerations  
Before being interviewed, information about the questionnaire and objectives of the 
study were explained to the schoolchildren. They were also informed about their rights 
to withdraw from the study at anytime without any penalty. Written informed consent 
was obtained for each participant. During the entire period in each school, the principal 
and a teacher were present. Ethics was obtained from the MoH ethical committee, and 
the LSTM research and ethics committee. Recommendation for health education on the 
prevention and control of NTDs was made to the NTDs unit at the MoH.  
  
  
7.4.2 Study design and study area  
Liberia is located on the West Coast of Africa along the Atlantic Ocean. The country is 
divided into 15 political sub-divisions called counties. According to the World Bank 
development index 50.0% of the population of 4 million people are said to be under the 
national poverty line (World Bank, 2010). A cross-sectional survey was conducted in 
10 primary schools from September to December 2018, using a structured, pre-tested 
and validated questionnaire, to evaluate KAP amongst 1,003 school-aged children who 
met the inclusion criteria (5–14 years old). The survey was carried out on the second 
day following collection of samples from the schoolchildren to determine the 
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prevalence of STH and SCH. The researcher under the supervision of a teacher and the 
school principle interviewed the students.  
  
7.4.3 Study population  
A total of 1,003 schoolchildren were recruited from 10 schools in Bong County. These 
schoolchildren had also participated in the studies on SCH and STH.  
  
7.4.4 Questionnaire survey  
A structured questionnaire for data collection was used to collect data. The 
questionnaire was pre-tested in a school, which was not part of those enrolled in the 
study. The questions were designed based on the research objectives of the larger study.  
  
  
7.5 Results  
7.5.1 Sociodemographic characteristics of participants  
Using an integrated approach, the participants were also enrolled in the follow-up 
survey carried out to determine the intensity and prevalence of STH and SCH. A total 
of 1,003 school-aged children participated in the study where 504 (50.2%) were 
females and 499 (49.8%) were males. The mean age was 10.9 years and the medium 
age was 11 years. The majority of the schoolchildren 685 (68.3%) were in K1–Grade 
2. The demographics are the same as in previous chapters as the participants were from 
the same study (see chapter 6).  
  
Association of knowledge of SCH, STH and LF as it relates to gender and age 
are shown in Table 7.1.  
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Table 7.1: Association of knowledge of STH, SCH and LF, by age and gender  
AGE      
Do you know what LF is?  7–11 years  12–14 years  15 years  Total  
Yes  40 (6.77%)  24 (6.79%)  10 (16.7%)  74 (7.4%)  
No  550 (93.2%)  329 (93.2%)  50 (83.3%)  929 (92.6%)  
Total  590  353  60  1,003  
Do you know what SCH is?  7–11 years  12–14 years  15 years  Total  
Yes  55 (9.3%)  37 (10.5%)  8 (13.3%)  100 (10.0%)  
No  535 (90.7%)  316 (89.5%)  52 (86.7%)  903 (90.0%)  
Total  590  353  60  1,003  
Do you know what STH is?  7–11 years  12–14 years  15 years  Total  
Yes  71 (12.0%)  53 (15.0%)  11 (18.3%)  135 (13.5%)  
No  519 (88.0%)  300 (85.0%)  49 (81.7%)  868 (86.5%)  
Total  590  353  60  1,003  
GENDER      
Do you know what STH is?  Female  Male  Total   
Yes  68 (13.5%)  67 (13.4%)  135 (13.5%)  
No  436 (86.5%)  432 (86.6%)  868 (86.5%)  
Total  504  499  1,003  
Do you know what LF is?  Female  Male  Total  
Yes  37 (7.3%)  37 (7.4%)  74 (7.4%)  
No  467 92.7%)  462 (92.6%)  929 (92.6%)  
Total  504  499  1,003  
Do you know what SCH is?  Female  Male  Total  
Yes  54 (10.7%)  46 (9.2%)  100 (10.0%)  
No  450 (89.3%)  453 (90.8%)  903 (90.0%)  
Total  504  499  1,003  
This study showed that majority of participants had not heard about SCH 
(90.0%), STH (86.5%) and LF (92.6%). However, 13.5% of participants had heard of  
STH compared to SCH (10.0%) and LF (7.4%).  
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The results on the knowledge of school-age children on the signs and symptoms 
of SCH, LF and STH are shown in Tables 40, 41 and 42. The results showed a low 
level of knowledge (>90.0%) on the signs and symptoms of LF, STH and SCH.   
  
Table 7.2: Knowledge on the signs and symptoms of STH (N = 1,003)  
Variables  Yes  No  
Swollen abdomen  27 (2.7%)  976 (97.4%)  
Passing worms  47 (4.5%)  956 (95.3%)  
Passing blood in stool  54 (5.4%)  949 (94.6%)  
Lose of appetite  48 (4.8%)  955 (95.2%)  
Loosing weight  42 (4.2%)  961 (95.8%)  
  
  
  
  
Table 7.3: Knowledge on the signs and symptoms of LF (N = 1,003)  
Variables  Yes  No  
Enlarged legs  44 (4.4%)  959 (95.6%)  
Enlarged breasts  3 (0.3%)  1,000(99.7%)  
Enlarged scrotum  3 (0.3%)  1,000 (99.7%)  
Fever and chills  35 (3.5%)  968 (96.5%)  
  
  
Table 7.4: Knowledge on the signs and symptoms of SCH (N = 1,003)  
 Variables  Yes   No  
 
Abdominal pain  43 (4.3%)  960 (95.7%)  
Vomitting  44 (4.4%)  959 (95.6%)  
Blood in stool  49 (4.9%)  954 (95.1%)  
Blood in urination   14 (1.4%)  989 (98.6%)  
Painful urination   29 (2.9%)  974 (97.1%)  
More frequent urination/urgency   18 (1.8%)  985 (98.2%)   
Fever/headaches/chills  44 (4.4%)  992 (98.9%)  
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Table 7.5: Water contact and sand mining behaviour  
 
 
Collect water from piped water   9 (0.9%)  994 (99.1%)  
Collect water from wells  412 (41.1%)  591 (58.9%)  
Collect water from creeks   207 (20.6%)  796 (79.4%)  
Rivers   29 (2.9 %)  974 (97.1%)  
Collect water from hand pumps   491 (49.0%)  512 (51.0%)  
Others  1 (0.1%)  1,002 (99.9%)  
Play in creeks  492 (49.1%)  511 (51.0%)  
Pick up snails  38 (3.8%)  965 (96.2%)  
Sand mining using pans (to be sold)  86 (8.6%)  917 (91.4%)  
Wash hands before eating   466 (46.5%)  537 (53.5%)  
Fishing  264 (26.3%)  739 (73.7%)  
 
  
Table 7.8, shows the results on the attitude and practices of the participants. Of 
which, 3.8% collect snails, 8.6% were involved in sand mining, 49.1% play in creeks, 
and 46.5% wash their hands before eating.  
On receiving drugs during MDA, of the 1,003 participants only 28.8% said they 
received medication for SCH, 96.9% said they received medication for deworming, but 
surprisingly none of the participants had received medication for LF.  
  
  
Table 7.8: Knowledge on MDA  
SCH    
Knowledge of drug distribution   Yes  No  
Have your received medication for SCH?  289   
(28.8%)  
714  
(71.2%)  
Variable s  Y es  N o  
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  1 time  2 times  3 times  None  
If yes how many 264  45  times? 
 (24.5%)  (4.5%)  
13  (1.3%)  699  
(69.7%)  
STH    
  
Have you taken worm tablets in the last 
12 months?  
Yes  No   
972   
(96.9%)  
31  (3.1%)   
Where did you get the deworming 
treatment?  
School  Health facility  Home  
16 (51.6%)  6 (19.4%)  9 (29.0%)  
Have you taken tablets for LF?  0 (0%)  1,003 (100.0%)    
  
In this study only 1.7% of participants had access to indoor toilets (see Table 
45).  
Table 7.9: Participants knowledge on sanitation  
Where do you go to Latrine   Yes  No  % Yes  
Bush   725  278  72.3  
Pit latrine   157  846  15.7  
Behind the house   104  899  10.4  
Indoor toilet   17  986  1.7  
  
  
Table 7.10: Results from questions on malaria medication and test and 
sleeping under mosquito nets  
 
Have you taken malaria medication in the past 12 months?  
Yes  418  41.7%  
No  585  58.3%  
Have you had malaria test done in the last month?   
No  751  74.9%  
Yes  252  25.1%  
Did you sleep under a bednet last night?   
Yes  217  21.6%  
No  786  78.4%  
Variable s  N  Perc ent age  
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Malaria is endemic in Liberia. Curative consultations across Liberia in 2014 
were 2,347,631 visits and malaria accounts for 41.0% of all curative consultations.  
Inpatient admissions were 81,938, where malaria accounts for 32.0% of the total 
admissions. Therefore, participants were also surveyed for malaria. Of the 1,003 
participants, 41.7% reported that they were treated for malaria in the past 12 months, 
while 74.9% reported that they were tested for malaria in the last month, and 21.6% 
slept under mosquito nets (see Table 46).  
  
7.6 Discussion  
This study carried out information on KAP of school-age children on SCH, LF and 
STH in Liberia. A parasitology follow-up survey was performed on the same 1,003 
participants the day before.  
The study was carried out in Bong County, which according to data from the 
MoH is co-endemic for STH, LF and SCH and is currently undergoing prevention and 
control measures by the NTD unit at the MoH. NTDs are a serious public health 
problem in Liberia that led the MoH to move from vertical programming to form a unit 
called the NTD unit. The NTD unit at the MoH has the following programmes: Oncho, 
which is prevalent in all 15 counties in Liberia; LF, which is prevalent in 13 counties 
in Liberia excluding (Gbarpolu and Bomi Counties); and STH has been recorded in all 
15 counties in Liberia; Buruli ulcer and leprosy has also been recorded in all 15 counties 
in Liberia.  
The NTD programme in the country has conducted three rounds of MDA for 
SCH and LF with a therapeutic coverage of 81.0%. However, results showed that more 
than 90.0% of the schoolchildren interviewed did not have any knowledge of LF and 
SCH, while 89.0% of the schoolchildren did not have knowledge of STH. In a KAP 
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study conducted in rural Yemen it was found that 82.4% of the participants had heard 
of SCH, but their knowledge about the transmission and prevention of the disease was 
low (Sady, et al., 2015). In this present study, 90.0% of the participants had no 
knowledge of how the disease was transmitted and prevented, which shows that there 
is a great need for health education in Liberia. This is a surprise as there is active 
surveillance and treatment that is ongoing for LF, STH and SCH in Bong County. It 
was observed that many of the participants could not distinguish the name STH and  
SCH; therefore, this had to be explained in the local language by the research assistants. 
A study in Zambia reported that 53.0% of school-age children did not know how one 
was infected with the disease (Nyati-Jokomo & Chimbari, 2017). In this study, 90.0% 
of the participants did not know how one could be infected with SCH and LF. A study 
in sub-Saharan Africa also reported that the knowledge amongst community members 
about SCH was low (Sacolo, Chimbari, & Kalinda, 2018).  
Majority of females did not know or had not heard about the disease, while only 
a few females confirmed to have knowledge of the disease. Similar findings were 
obtained in Tanzania where it was reported that male participants had more knowledge 
than female participants (Knopp, at al., 2013). For sourcing water at home only 9.0% 
of the schoolchildren had access to piped water, those who fetched water from wells 
were 41.0% and from creeks 20.6%. Up to 49.0% of the schoolchildren collected water 
from handpumps. This study found that the pattern of water contact in the 
schoolchildren could be a contributing factor for the transmission of SCH and the 
pattern in sand mining could be a contributing factor for being infected with STH. 
During this study, most of the schools were close to water bodies or sand mining, and 
picking up and selling snails could have attributed to the high burden of SCH in Bong 
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County. A study in Mali in West Africa reported that schoolchildren who were close to 
breeding sites of snails were at risk of contracting SCH (Dabo, et al., 2015). Around  
49.0% of the schoolchildren in this study admitted that they played in the creek (i.e., 
swimming). A study in three schools in Sudan reported that frequency of swimming 
was related to urogenital SCH (Ismail, et al., 2014).  
When the schoolchildren were asked about MDA, 71.2% of them had no 
knowledge about MDA, 69.7% did not receive medication for SCH, and of those who 
admitted to receiving medication only 13.0% had received the three rounds of 
Praziquantel from the MoH during the MDA implementation. Of the 1,003 participants 
only 3.1% had received medication for Ivermectin and 97.0% had received 
anthelminthic drugs. Around 51.1% of participants admitted to taking the medication 
at school; this information correlated with the report from the MoH and the Ministry of  
Education that there is an annual deworming programme in all schools in the country. 
A similar study undertaken in Kenya reported that out of the 239 participants, 89.1% 
had heard of SCH and 87.4% had heard of STH (Gitaka, et al., 2019).  
Malaria is endemic in Liberia and there have been various preventive measures 
put into place by the MoH, the Roll Back Malaria initiative and other partners ranging 
from indoor residual spraying and distribution of mosquitoes nets. In this study, 21.6% 
of the schoolchildren said that they slept under mosquito nets, about 99.0% heard of 
malaria and 25.0% had been tested for malaria within a month’s time and 41.0% had 
taking antimalarial medication within the past 12 months. A study in northern Nigeria 
reported that majority of their respondents had good knowledge about malaria (Singh, 
Musa, Singh, & Ebere, 2014). A KAP study in Swaziland reported that a high number 
of the research participants had knowledge of malaria and 90.0% said they would seek 
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treatment within 24 hours of the onset of malaria symptoms (HIongwana, Mabaso, 
Kunene, Govender, & Maharaj, 2006).  
LF is endemic in Bong County, but 92.6% of the participants had not heard 
about LF, a substantial amount of them did not have knowledge of the signs and 
symptoms of LF, and only 3.1% of participants had taken treatment for LF. In a similar 
KAP study carried out in Indonesia, 89.0% of the respondents had heard of LF and 
while 21.0% had taken LF medication before MDA, 88.0% reported to have taken the 
medication after MDA (Krentel, et al., 2006).   
  
7.7 Conclusions  
This study reveals that the knowledge, symptoms and prevention of SCH, LF and STH 
was very low and this could be a major challenge to the achievement of the goals of the 
NTD programme in Liberia of: eliminating LF by 2020; achieving 100.0% treatment 
coverage of STH; and 75.0% therapeutic coverage for schoolchildren for SCH. This 
study revealed a great need for well-co-ordinated health education on NTDs amongst 
schoolchildren and community involvement, as well as prevention and control of these 
diseases. If a community is well informed about a disease the prevention measures will 
be practised by communities, which will lead to a decrease in prevalence of the disease.  
  
7.8 Limitations  
The parents of the schoolchildren in this study were not interviewed. It is possible that 
the parents may have knowledge of the diseases, but these may not be discussed with 
their children due to cultural practices. Also, the accuracy in recall by the participants 
could be low as children are unable to give accurate dates of events.  
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7.9 Recommendations  
The MoH should strengthen the NTD programme. Health education is urgently needed 
in order to accelerate the elimination of NTDs. Annual social mobilisation and 
community sensitisation on the prevention and control of NTDs in Liberia is essential.  
The NTD programme in Liberia should work in collaboration with the health promotion 
unit and the community health unit in order to achieve their objectives.  
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CHAPTER 8: ASSESSMENT OF SCH-RELATED 
MORBIDITY AMONGST SCHOOL-AGE CHILDREN IN  
   BONG  COUNTY,  LIBERIA  BY  THE  USE  OF  
ULTRASOUND: A CROSS-SECTIONAL STUDY  
 
8.1 Abstract  
8.1.1 Background  
S. mansoni and S. haematobium are endemic in three counties in Liberia, despite the 
intermittent MDA by the MoH and its partners the disease is still prevalent. Ultrasound 
is a very important tool for assessing morbidty related to SCH, we can observe 
hepatomegaly, splenomegaly and urinary tract abnormalities. Ultrasound is accessible, 
mobile, cheap, and can be used on the field.   
8.1.2 Objectives  
To assess pathological changes of the bladder caused by S. haematobium.  
To assess pathological changes of the liver caused by S. mansoni.  
To access pathology changes of the spleen caused by S. mansoni.  
8.1.3 Methods  
A Mindray diagnostic system ultrasound Model MS MR–17003578, which has a 3.5 
megahertz convex transducer was used to access the abdomen and urinary tract of 272 
school-aged children from 10 different communities for SCH-related morbidity. A 
single sonographer scanned the participants to avoid intra-observer variability. The  
Niamey protocol was used as the guide for this study.  
8.1.4 Results  
Of the 272 school-aged children examined, only one (0.4%) had periportal fibrosis, one 
(0.4%) had hepatomegaly, three (1.1%) had splenomegaly, and 37 (13.6%) had starry 
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sky liver pattern. The urinary bladder pathology examination revealed that 53 (19.5%) 
had distorted bladder shape, 49 (18.0%) had focal bladder thickening where the 
multifocal was 19 (7.0%). Irregular bladder was found in 69 (25.4%) schoolchildren, 
the multifocal was found in 7 (2.6%) schoolchildren, and 2 (0.7%) of the schoolchildren 
had single pseudopolyp. There was no bladder mass noted.   
8.1.5 Conclusions  
The study revealed that S. mansoni- and S. haematobium-related morbidities such as 
hepatomegaly, splenomegaly and urinary tract abnormalities are prevalent amongst 
school-age children in Bong County, Liberia. The use of ultrasound should be 
encouraged in endemic areas as it helps to detect Schistosoma-related morbidities.  
  
8.2 Introduction  
Although SCH is controlled in some countries, it still remains a major public health 
problem in Liberia, especially in the Central region; this maybe due to farminig in 
swamps practised in this region. In Liberia, the intermediate hosts for a snail are Bulinus 
globosus and Biomphalaria pfeifferi (Dennis, et al., 1983).   
There are more than 230 million people worldwide that are infected with SCH. 
Of which, 120 million are symptomatic, 20 million have severe disease and around 600 
million are at risk of infection. It has been estimated that approximately 192 million 
(93.0% of the world total) are from sub-Saharan Africa (Kramer, Zhang, Sinclair, & 
Olliaro, 2014). The three species of schistosome that affect humans are S. 
haematobium, S. mansoni and S. japonicum (McKerrow & Salter, 2002).   
The female and male adult worms live in the mesenteric veins of their host at different 
locations, where they mate and produce eggs. The female is about 7 mm to 20 mm long 
and the male is slightly smaller about 6 mm to 11 mm long. The eggs produced as a result 
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of mating are released either through the urine or faeces in fresh waters. The eggs then 
are hatched under ideal conditions and release larvae, and then environmental 
transmission can ensue. However, eggs die after a period of 1 to 2 weeks after they leave 
the worm. Upon successful hatching, the miracidium enters the compatibile snail, which 
is the intermediate host. Thousands of cercariae are later produced when the mother and 
daughter sporocytes undergo replications and their produce are released into the fresh 
water. The infected cercariae may penetrate the skin of any person who enters the water 
especially those who do swamp rice farming, swimming, snail picking or sand mining 
(Lawson & Wilson, 1980).  
After entering the human host, the parasite lives for about 3–20 years in its host 
and in rare cases about 40 years (van Oordt, van den Heuvel, Tielens, & van den Bergh, 
1985). In regions where SCH is endemic, research has showed that approximately  
20.0%–40.0% of school-age children remain actively infected (Stothard, et al., 2011).  
  
8.2.1 Pathogenesis and morbidity  
The intensity of the infection depends on continuing exposure, the age of first exposure, 
and whether or not the person develops immunity against the infection (Gryseels, et al., 
2006). It has been noted that the intensity of the infection is mostly seen in the first two 
decades of life, but declines in adults. This could be attributed to acquisition of 
antibodies or antigen from the disease due to continuous exposure (Buttterworth, 1998).  
Not all infected individuals develop signs and symptoms of SCH. If symptoms 
do appear, it usually takes 4 to 6 weeks from the time of infection. The first symptom 
of the disease may be a general ill feeling. Within 12 hours of infection, an individual 
may complain of a tingling sensation or light rash, commonly referred to as 
‘swimmer’s itch’, where this is due to irritation at the point of entrance (Charnock, 
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1980). The rash that may develop can mimic scabies and other types of rashes. Other 
symptoms can occur 2 to 10 weeks later and can include fever, aching, cough, 
diarrhoea or gland enlargement. These symptoms can also be related to avian SCH, 
which does not cause any further symptoms in humans. The manifestations of 
schistosomal infection vary over time as the cercariae, and later adult worms and their 
eggs migrate through the body (Cheng, 2014).   
Signs and symptoms may include abdominal pain, diarrhoea, bloody stool or 
blood in the urine. Those who have been infected for a long time may experience liver 
damage, kidney failure, infertility or bladder cancer (squamous cell carcinoma). In 
children, it may cause poor growth and learning difficulties (Cheng, 2014).  
The first potential reaction is an itchy, popular rash that results from cercariae 
penetrating the skin, often when a person is first infected. The round bumps are usually 
1 cm to 3 cms in size. As people living in affected areas have often been repeatedly 
exposed, acute reactions are more common in tourists and migrants. The rash can occur 
between the first few hours and a week after exposure and lasts for several days. A 
similar, more severe reaction called ‘swimmer’s itch’ can also be caused by cercariae 
from animal trematodes that often infect birds (Rutherford, 2000).   
  
8.2.2 Intestinal SCH  
In intestinal SCH, eggs become lodged in the intestinal wall and cause an immune 
system reaction called a granulomatous reaction. This immune response can lead to 
obstruction of the colon and blood loss. The infected individual may have what appears 
to be a swollen or pot-belly (Charnock, 1980). Eggs can also become lodged in the 
liver, leading to high blood pressure through the liver, enlarged spleen, the buildup of 
fluid in the abdomen, and potentially life-threatening dilations or swollen areas in the 
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oesophagus or gastrointestinal tract can rupture and bleed profusely (oesophageal 
varices). In rare instances, the central nervous system is affected (Grimes, et al., 2014).   
  
8.2.3 Genitourinary disease  
The worms of S. haematobium migrate to the veins around the bladder and ureters. This 
can lead to blood in the urine 10 to 12 weeks after infection. Over time, fibrosis can 
lead to obstruction of the urinary tract, hydronephrosis and kidney failure. Bladder 
cancer diagnosis and mortality are generally elevated in affected areas. In Egypt efforts 
to control SCH have led to decreases in the bladder cancer rate. The risk of bladder 
cancer appears to be especially high in male smokers, perhaps due to chronic irritation 
of the bladder lining allowing it to be exposed to carcinogens from smoking. In women, 
genitourinary disease can also include genital lesions that may lead to increased rates 
of HIV transmission (Cheng, 2014).  
  
8.2.4 Central nervous system disease  
Central nervous system lesions occur occasionally. Cerebral granulomatous disease 
may be caused by Schistosoma eggs in the brain. Communities in China affected by S. 
japonicum have been found to have rates of seizures eight times higher than the 
baseline. Similarly, granulomatous lesions from S. mansoni and S. haematobium eggs 
in the spinal cord can lead to transverse myelitis with flaccid paraplegia. Eggs are 
thought to travel to the central nervous system via embolisation (Oliveira, Rodrigues,  
Romanha, & Bahia, 2004).  
  
8.3 Objectives  
• To assess pathological changes of the kidney due to S. haematobium.  
• To assess pathological changes of the liver due to S. mansoni.  
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• To access pathology changes of the spleen due to S. mansoni.  
  
8.4 Justification of the study  
Liberia is a post-conflict country, which following a number of studies have produced 
evidence of the presence of multiple NTDs where three NTDs are widespread, 
amenable to MDA and could be controlled on the same platform. However, there is no 
study in the country for the assessment of SCH-related morbidity amongst children.  
  
  
8.5 Methodology  
8.5.1 Ethical considerations  
Ethics clearance was obtained from the MoH ethical committee, and the ethics 
committee of LSTM. The objectives of the ultrasound study was explained to the 
students and their parents with verbal and written consent obtained from them. They 
were also informed about their rights to withdraw from the study at anytime without 
any penalties. Informed consent was obtained for each participant. During the 
ultrasound examination most of the parents were present.  
  
8.5.2 Study design and study area  
Liberia is situated on the West Coast of Africa between Sierra Leone on the West, Côte 
d’Ivoire on the East, and Guinea on the North. The study was conducted in Bong 
County, one of the 15 counties in Liberia and located in the northern region. Bong 
County was selected due its co-endemicity with STH, SCH and LF. According to the 
World Bank development index 50.0% of the population of 4 million people are said 
to be under the national poverty line (World Bank, 2010).  
155  
  
8.5.3 Study design and population  
The study assessed the mobidity of S. haematobium and S. mansoni by using a portable 
ultrasound. The bladder, liver and spleen were examined. Physical examination of the 
schoolchildren was performed in addition to the examination of the abdomen and 
urinary tract by the use of ultrasound. About 28.8% of the children admitted to having 
taken Praziquantel treatment. The baseline study to determine the prevalence of S. 
haematobium and S. mansoni was conducted 2 days before the scanning of the 
abdominal and urinary bladder.  
The schoolchildren were aged from 5–15 years. A total of 123 schoolchildren 
examined by the Kato-Katz method, were found to be positive for S. mansoni, while 
112 schoolchildren examined by urine filtration were found to be infect. 37 students 
not positive for S. haematobium and S. mansoni were recruited for the study.  
  
8.5.4 Study procedures  
The schoolchildren that were positive for S. mansoni and S. haematobium, their parents 
were informed that an ultrasound was going to be performed to determine SCH 
morbidity. Upon arrival at the school on the morning of the survey a room was given 
to the research team to be used for the ultrasound procedure.   
A list was given to the school principal of those schoolchildren who were 
positive for SCH and who needed to be scanned. The schoolchildren were called to a 
room where approximately 500 mL of water was given to each schoolchild to drink 30 
minutes to 1 hour before the examination. They were then scanned only if they felt the 
urge to urinate. Once the student entered the ultrasound room accompanied by their 
parents the procedure was explained to them. The schoolchild was than placed on the 
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bed and gel placed on the abdomen to enable better resolution. A convex ultrasound 
probe was used to check the liver and kidney, looking for morbidities related to S. 
haematobium and S. mansoni. A makeshift bed was placed in the room and a portable 
ultrasound placed on a table. A portable generator was used to provide electricity to the 
machine. The ultrasound used was a Mindray diagnostic system ultrasound Model MS  
MR–17003578, which has a 3.5 megahertz convex transducer for the abdominal scan.  
  
8.5.5 Kidney ultrasound  
The ultrasound was performed using the Niamey protocol (Richter, Campagne, 
Berquist, & Jenkins, 2000). Each schoolchild was placed in a supine position, and an 
ultrasound gel and a linear ultrasound probe was placed on the abdomen to assess the 
kidneys and bladder. This procedure was carried out in each school. Bladder wall 
irregularity is considered when thickeness of the wall is about 5 mm. Two or more 
lesions are recorded as multiple lesions. Bladder wall thickness was recorded and 
measured in the proximity of the trigone. Normal thickness of the bladder wall is <5 
mm. When there is a localised thickening of the bladder wall protruding in the lumen a 
score of 2 is given for the mass. The intermediate score for urinary bladder is indicated 
if the participant has SCH or not (Richter, et al., 2000). Scores are as follows: 0–1 =  
SCH unlikely; 2 = SCH likely; and >3 = SCH very likely.  
  
  
8.5.6 Hepatic ultrasound  
The ultrasound was performed using the Niamey protocol (Richter, et al., 2000). Each 
schoolchild was placed in a supine position and an ultrasound gel was placed on the 
abdomen. A linear convex ultrasound probe was placed on the abdomen showing the 
liver to check for any abnormalities as a result of SCH. This procedure was carried out 
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in each school. The procedure was performed early in the morning. The standard view 
as described in the protocol was used, but at times different views were also used. The 
image pattern of liver parenchyma + IP score. If the liver appears normal (pattern A) 
score = 0 then no further investigation is needed. If there is any echogenic periportal 
thickening then the score ranges from 1–8 depending on severity.   
  
8.5.7 Spleen  
The spleen was measured in the left oblique view. Each schoolchild was placed in a 
supine position, tilting a little towards the sonographer and ultrasound gel was placed 
at the anatomical level of the spleen. A linear convex ultrasound probe was used to 
check for abnormality (splenomegaly) as a result of SCH. This procedure was carried 
out in each school.   
The maximium length of the spleen was measured through the splenic hilus: 0 
= splenomegaly absent (mean + 2 SD) ; 1 = moderate splenomegaly (size >2 to 4 SD 
above mean); and 2 = marked splenomegaly (>4 SD above mean).  
The following are the normal lengths of the spleen, taking into consideration 
that in malaria endemic areas like Liberia, the spleen may also be enlarged in the 
absence of SCH: 9.0 cms at 4 years; 9.5 cms at 6 years; 10.0 cms at 8 years; 11.0 cms 
at 10 years; 11.5 cms at 12 years; 12.0 cms at 15 years or older for girls; and 13.0 cms 
at 15 years or older for boys (Rosenberg, et al., 1991).  
8.6 Results  
Of the 272 school-age children examined by ultrasound for periportal fibrosis, only one 
female had periportal fibrosis (see Table 47).   
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Age  
No .  examined  
 
Table 8.1: Prevalence of organomegaly and periportal fibrosis of participants, 
by age and sex (N = 272)  
Total % with   
 Male  Female  periportal fibrosis  
7–11 years  85 (59.9%)  79 (60.8%)  0 (0.0%)  
12–14 years  52 (36.6%)  43 (33.1%)  1 (0.4%)  
15 years  5 (3.5%)  8 (6.2%)  0 (0.0%)  
Total  142  130  1 (0.4%)  
  
    
 Of the 272 school-age children examined by ultrasound and clinical examination for 
hepatomegaly and splenomegaly, only one male (0.4%) was found to have 
hepatomegaly and three schoolchildren (1.1%) were found to have splenomegaly, one 
male (33.3%) and two females (66.7%) (see Table 48).  
  
  
Table 8.2: Prevalence of organomegaly and periportal fibrosis of participants, 
by age and sex (N = 272)  
Male  142  0 (0.0%)  20 (54.1%)  1 (33.3%)  
Female  130  0 (0.0%)  0 (0.0%)  17 (46.0%)  2 (66.7%)  
Total  272  0 (0.0%)  1 (0.4%)  37 (13.6%)  3 (1.1%)  
 
  
  
  
  
  
Sex  No .   
examined  
Liver en largement  Starry  s ky  l iver  Splenomegaly   
Right  l obe  Left lobe   
1 (0. 4 %)  
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Figure 8.1: Participant being scanned during examination  
  
  
Of the total 272 school-age children examined by ultrasound and clinical 
examination for urinary bladder pathology, 53 (19.5%) had distorted bladder shape, 49 
(18.01%) had bladder thickening that was focal, and multifocal was 19 (7.0%). Those 
with irregular bladder, 69 (25.4%) were focal and 7 (2.6%) were multifocal. There was 
no mass noted during the process, but two schoolchildren (0.73%) were noted to have 
single pseudopolyp (see Table 49 and Figures 31 and 32).  
  
Table 8.3: Classification of urinary track diseases of participants  
Urinary bladder pathology  Classification  N (272)  Frequency  
Bladder shape    Normal (rectangular)   0  219  80.5%  
 distorted (round)  1  53  19.5%  
Thickening    Normal  0  204  75.0%  
  Focal  1  49  18.0%  
 Multifocal  2  19  7.0%  
Irregularity    Normal  0  196  72.1%  
  Focal  1  69  25.4%  
 Multifocal  2  7  2.6%  
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Mass    None  0  272  100.0%  
  Single  2  0  0.0%  
 Multiple  n+2  0  0.0%  
Pseudopolyp  None  0  270  99.3%  
  Single  2  2  0.7%  
  Multiple  n+2  0  0.0%  
 
  
Figure 8.2: A scan showing an irregular shaped bladder in a participant  
 
  
  
8.7 Discussion  
The patology due to Schistosoma may heal after the PQZ treatment, provided treatment 
is started early before organic complications such as, bladder cancer and hepatic 
scaring. There are many methods for the examination of Schistosoma induced 
pathology of the liver, kidney and spleen. The changes are usually due to the result of 
the Schistosoma eggs lodging in different tissues causing inflammation, which leads to 
fibrosis as a result of the host response. One of such methods is ultrasound, which is 
now widely used to follow-up patients. Ultrasonography of the liver, spleen and kidney 
for the diagnosis of pathology due to SCH usually correlate with the clinical status of 
the person with the disease (Abdel-Wahab & Strickland, 1993).  
Ultrasound is non-invasive, has low radiation, is portable and can be used in the  
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field. Ultrasound has been used for over 50 years as a key method for monitoring SCH 
morbidity and has been reported to be accepted in communities (Hatz, 1992). The main 
limitations have been reported as operator skill and inter-observer differences (King, et 
al., 2003). In the 10 communities, there were objections by the community for the use 
of ultrasound on their children; this was due to the recent end of the Ebola crisis that 
terrified the nation making them lose confidence in health workers. They asked if adults 
could be scanned instead of the children. After series of meetings with the communities 
and the built confidence of the team, the research was agreed to continue.  
Other imaging methods that can be used to detect Schistosoma pathology in 
humans and experimental animals are intravital microscopy, fluorescence molecular 
tomography and positron emission tomography (Skelly, 2013).  
Globally, ultrasound is now frequently used to assess the morbidity of S.  
haematobium and S. mansoni. In some endemic areas morbidity has been observed in 
children from 7–14 years of age, and pathological changes identified by the use of 
ultrasound usually directly correlates with the intensity of the Schistosoma infection  
(Mostafa, Sheweita, & O’Connor, 1999). It has been reported that there is a relationship 
between S. mansoni and carcinoma of the colorectal and between S. haematobium and 
squamous cell carcinoma of the urinary bladder (Khurana, et al., 1992). In contrast, 
another study reported that there was no cause effect relation with the parasite in 
relation to tumour of the urinary bladder (Dimmette, Sproat, & Sayegh, 1956).  
In this study, no histopathology was performed to determine if there was 
carcinoma due to SCH. Histopathology can detect if there is inflammatory granulomata 
due to eggs and in such cases would require barium enema or colposcopy.  
The measurement of periportal fibrosis can be conducted in two ways: (i) by 
using the qualitative method by using image classification; and (ii) the quantitative 
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method by measuring the diameter of the secondary portal branches 
(DoehringSchwerdtfeger, et al., 1989). In this study, both qualative and quantitative 
methods were used to assess periportal fibrosis.  
In this study, both abdominal and urinary track ultrasounds were performed on 
the 272 school-age children from 10 schools in Bong County.  
The results from this study showed that of the 272 participants only one 
schoolchild (0.4%) was noted to have periportal fibrosis, which may have been due to 
infection with S. mansoni. Periportal fibrosis lesion is usually seen after years of 
infection with the disease, but this was present in a schoolchild in this study. The eggs 
that are produced by the female worms go into the bowel, bladder and the environment. 
In the human body some of the Schistosoma eggs go into the portal veins from the 
mesenteric venules where some get entrapped and cause inflammation, granulomas of 
the liver and then fibrosis. The fibrosis of the liver could lead to obstruction of the portal 
veins, portal hypertension and futher leads to oesophageal varices (Cheever & Andrade, 
1967).  
A study in Tanzania amongst 1,840 children and adults reported that only 458 
participants were invited to have extended examination. The study used the Mangagil 
protocol for classification of their results and reported that 65.0% of the participants 
were classified with periportal fibrosis. The study concluded that the ultrasound scan 
usually does not correlate very well with the staging of SCH and was not found to be 
of significance in classifying periportal fibrosis and therefore, not useful in follow-up 
studies on S. mansoni as it relates to periportal fibrosis (Asztely, Ericksson, Gabone, & 
Nilsson, 2016). In this study, as mentioned earlier, there was only one (0.4%) male 
schoolchild with periportal fibrosis compared to 36.0% in the Tanzanian study.  
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Furthermore, of the 458 participants invited for extended examination, 1.0% of 
participants had right lobe of the liver enlargement compared to 17.0% with left lobe 
enlargement in the Tanzanian study.   
Hepatomegaly and splenomegaly in this study were defined using the Niamey 
protocol. For normal size left liver lobe less than or equal to 2 SD, and the right liver 
lobe greater than or equal to 2 SD, but less than or equal to 4 SD were classified as 
hepatomegaly, and splenomegaly was defined as the length of the spleen greater then 2 
SD above the normal reference.  
In a similar cross-sectional study, in north-western Tanzania amongst 412 
participants aged 18–89 years, 29.6% had left hepatomegaly and 58.5% had right 
hepatomegaly (Mazigo, et al., 2017). A similar study in China, by Wiest, et al. (1992), 
to assess morbidity induced by S. japonicum in 825 participants, found hepatomegaly 
(75.0%) using ultrasound and physical examination. In these participants 20.0% were 
found to have Symmer’s clay fibrosis as compared to this study where 37  
schoolchildren (13.6%) were noted to have starry sky liver (Wiest, et al., 1992).  
The use of ultrasound to assess pathology of the kidney associated with 
infection due to S. haematobium, has also become widely used. Studies have shown 
that there is a strong association between S. haematobium and squamous cell carcinoma 
of the urinary bladder. Therefore, it is important to use ultrasound to record bladder 
wall thickening in endemic areas for the purpose of follow-up. If a person was found to 
have bladder lesions and treated, this should lead to regression. If there is no change 
after taking medications for STH, then malignancy of the bladder should be ruled out 
(Abdoulaye, et al., 2015).  
In this study, we found that of the 272 school-age children 53 (19.5%) had 
distorted bladder shape, 49 (18.0%) had focal bladder thickening, 69 (25.4%) had 
164  
bladder wall irregularity, and 2 (0.7%) had pseudopolyp. This compares favourably 
with a similar study in Mali using the WHO protocol to assess S. haematobium 
pathology from 29 randomly selected schools (Abdoulaye, et al., 2015). This result was 
higher compared to another study in Nigeria where a total of 2,822 schoolchildren were 
examined by ultrasound. The results revealed that 6.0% of the schoolchildren had 
bladder wall thickening and irregularities, masses and pseudopolyps with an estimated 
upper urinary tract pathology of 3.7% (Koukounari, et al., 2006). A similar study also 
carried out in Nigeria amongst 138 participants (both adult and children) showed that 
on ultrasound 55.8% had bladder wall thickness, 69.8% was abnormal and 4.7% had 
pseudopolyps (Nmorsi, Ukwandu, Ogoinja, & Blackie, 2007). A cross-sectional study 
in Kenya amongst 1,014 participants of all ages living in S. mansoni endemic areas, on 
urine cytology examination found that amongst those without therapy for S. 
haematobium the prevalence of cellular inflammation, hyperkeratosis and squamous 
cell metaplasia was greater than 30.0% as compared to those treated for S. haematobium 
(Hodder, et al., 2000).   
A randomised controlled trial was conducted amongst 162 pre-school-age 
children and 141 school-age children in Côte d’Ivoire, West Africa, to assess morbidity 
due to S. haematobium, using ultrasound examination. The participants were positive 
with S. haematobium who were compared with a placebo group. The result revealed 
that 67.0% of the school-age children had bladder morbidities that were mainly 
moderate, 4.0% had pseudopolyps, and 6.0% were found to have dilatation of the renal 
pelvis. Of the pre-school-age children examined, 43.0% were found to have urinary 
tract pathology, of which 7.0% were found to have hydronephrosis. The study reported 
that those in the placebo group had worse pathology compared with those treated with  
Praziquantel (Barda, Coulibaly, Hatz, & Keiser, 2017).  
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Some reasons  communities reject to the study will include if there were no pror 
senstitition , if they think the study may have harmful effect on them and if they think 
there is no financial benfit.  
  
8.8 Conclusions  
This study revealed that S. mansoni and S. haematobium and their associated 
morbidities such as hepatomegaly, splenomegaly and urinary tract abnormalities are 
endemic amongst school-age children in Bong County, but not common. According to 
the MoH report there have been two rounds of MDA of Praziquental in Liberia, in 2013 
and 2015 (MoHSW, 2017b). However, results from our study indicate that, despite the 
intermittent treatment, morbidity due to S. mansoni and S. haematobium are still a 
public health problem in Liberia. Ultrasound is very much important in assessing 
morbidities due to SCH as it is accessible, mobile, cheap and can be used on the field 
with reliable results. Its use should therefore be encouraged to access SCH-related 
morbidities.   
  
8.9 Recommendations  
1. Follow-up ultrasound study to be performed after MDA to assess progression 
of pathology of the disease in the participating school-age children.   
2. Ultrasonography study to be undertaken by the MoH in all endemic counties.  
3. MDA for SCH should be distributed to both adults and children in endemic 
counties.  
4. Continuous and vigilant health education to enhance compliance and to note 
any challenges from participants.  
5. Revison of pathology after Praziquantel treatment.  
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8.10 Limitations  
This study did not take into consideration adult participants as the focus was on 
schoolage children.   
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CHAPTER 9: GENERAL DISCUSSIONS, 
RECOMMENDATIONS AND CONCLUSIONS  
 
9.1. General discussions  
Neglected Tropical Diseases (NTDs) continue to form a huge health burden in majority 
of low income countries. According to Mitjà, et al. 2017 every low income country is 
affected by at least one NTD while others by up to five. Due to the increasing morbidity 
and mortality associated with unmanaged NTDs, there is a need for urgent and effective 
control of NTDs, to prevent hindering of the attainment of the sustainable development 
goals for eliminating NTDs by 2030. As many of the NTDs have the same aetiology, 
epidemiology and treatments, integrated efforts in the management have the potential 
to control NTDs in an accountable, efficient and economical manner (Standley et 
al.2018). Efforts should be geared towards enhancing the detection and surveillance as 
recommended by the World Health Organization (WHO, 2013).   
An integrated approach therefore provides an avenue for tracking the progress, 
promoting accountability and easy verification of the success of the management of the 
disease by improving the efficacy and quality of service delivery in managing NTDs.  
It also reduces disparities in the control programmes (WHO, 2017). Therefore, the 
World Health Assembly emphasises the need to intensify and integrate the programs 
aimed at controlling NTDs and improving the health of those affected by these diseases. 
Efforts have been made by several countries that have high burden of NTDs, including 
Liberia, to integrate the management programs of several of the diseases into a single 
program.  
In Africa, NTDs integration has been embraced and implemented in several 
countries. For example, in West Africa, Sierra Leone a post conflict and post Ebola 
country like its neighbouring country Liberia, has an integrated some of its NTDs 
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program vertical programs examples, LF, SCH, Oncho, and STH since 2007,but have 
is still having challenges like ,budget constraints to fully implement the integration and 
relay on health partners for support.(NTDs Masterplan Sierra Leone (2016-2020) has 
and Nigeria has an integrated plan for the management of tuberculosis and leprosy 
(Walsh et al.2015). Togo and Benin have integrated programmes for the control of 
yaws, leprosy and Buruli ulcers. Cameroon has integrated strategic plans for the 
management of yaws, Buruli ulcers and leishmaniasis (WHO, 2010). Sudan has 
integrated strategies for controlling vector-borne diseases that are arthropod associated  
(Ministry of Health report Sudan, 2015). In post-conflict Côte d’Ivoire integration was 
focused on the elimination of dracunculiasis instead of all of the NTDs.(Standley, et 
al., 2018). In Liberia, strategic plans have been designed and put into place to transfer  
most of NTDs programmes from vertical to integrated for the control of  
Schistosomiasis (SCH), Soil transmitted Helminths (STH), Onchocerchiasis 
(ONCHO), Buruli ulcer and Lymphatic Filariasis (LF).   
In Liberia, NTDs related prolong morbidities and in extension concomitant 
socioeconomic burden posed on the population with an already poor health  
infrastructures, and lack of logistics and funding have necessitated the embracing of the 
integrated program for the control of these diseases. Recent data obtained through a 
survey by the Ministry of Health from the mapping of NTDs in the regions in this study 
revealed high prevalence and overlapping of the following NTDs: onchocerciasis; 
lymphatic filariasis; schistosomiasis; soil-transmitted helminthiasis; Buruli ulcer; and 
leprosy (Ministry of Health, Liberia, 2016). Notably, more than a million people are at 
risk of contracting these specific NTDs. Among these at-risk group is a great proportion 
of school-age children that are affected by soil-transmitted helminths namely, Ascaris 
lumbricoides, Trichuris trichiura and hookworms, This class of NTDs are prevalent in 
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all of the 15 counties. Therefore, WHO in collaboration with the Ministry of Health has 
set up the integrated program for the management of these NTDs in the through 
preventive chemotherapy by Mass Drug Administration (MDA) and management of 
attendant morbidities.  
Accordingly, a 5-year master plan was introduced in 2011 through the NTDs 
programme. This formed the basis for the implementation of the integrated form of 
management of these diseases. The goal of the programme is to reduce the burden of 
targeted NTDs, to a level that it no longer poses a public health problem, whilst 
simultaneously contributing to the socioeconomic development of the country.   
In Liberia, the advantage of the program lies in its efficiency, time saving, cost 
effectiveness through its optimisation and greater control of limited resources, and 
labour saving. Its socioeconomic benefits are through decrease morbidity, improve 
health and increase productivity and therefore the alleviation poverty. However, the 
program implementation started regionally and is yet to cover the entire country. Even 
at that there are challenges experienced in these selected regions that hinder the full 
realization of the potential benefits of the Integrated program.  Some of these challenges 
are either institutional, technical, resource limitation and lack of roads and trained 
manpower capacity. Others include Natural disasters, civil unrest, interregional 
migration mismanagement and lack of political will. These have to be addressed in 
order for the country to realize the full benefits of integration.  
These challenges prevent sustained regular MDA and monitoring and 
evaluation and therefore leads to resurgence of the diseases, depletion of megar 
resources and donor fatigue. In order to succeed the integrated approach to the control 
of NTDs must be multidepartment, to include example, the department of education, 
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and agriculture. Multi-partnership with Tropical medical institutions example, 
Liverpool School of Tropical Medicine, and NGOs like Sight-Savers.   
The challenges enumerated including the Ebola crisis were very interruptive to 
the health sector of the country as well as to the integrated control of NTDs. This study 
however has shown for the first recorded time in Liberia the use of ultrasound to 
diagnose bladder and liver pathologies due to Schistosomiasis.   
The study also showed demographic distribution of the respective NTDs under study 
in Liberia based on the vector habitat and geographic landscape, social practices as well 
as age groups. The absence of substantive resource local records, literatures and data 
base to compare were specific challenges.   
  
The present study was conducted looking at the integrated approach to the control of 
three NTDs: LF; SCH; and STH. Liberia a post-conflict country is endemic for these  
NTDs.   
  
The objectives of the NTD programme in the country are as follows:  
1. To strengthen the government’s ownership, advocacy, co-ordination and  
partnership.  
2. To establish and sustain partnerships for the control, elimination and eradication 
of targeted NTDs at central, county, district and community levels.  
3. To enhance high level reviews of NTD programme performance and the use of 
lessons learned to enhance advocacy, awareness and effective implementation.  
4. To strengthen advocacy, visibility and profile of NTD control, elimination and 
eradication interventions at all levels.  
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5. To strengthen service delivery systems for the prevention, control and 
management of NTDs.  
6. To build the capacity of service providers on NTD prevention, control and 
management.  
  
To get a clearer understanding of the epidemiology and distribution of W.  
bancrofti in human and vector populations in Liberia, a literature review of historical 
documents was undertaken and results from the study showed that A. gambiae and A. 
melas were the prevalent vectors in the country and were found mainly in the coastal 
regions. This result also collaborates with the only nationwide mapping survey for LF 
conducted in 2010 by the MoH and its partners, the results which have been referenced 
in WHO publications, indicates that 13 out of the 15 counties in Liberia are endemic 
for LF. The MoH and its partners conducted a pre-MDA baseline survey for 
microfilaria in 2012. The result showed an overall 6.3% prevalence rate with males 
having higher prevalence compared to females.   
After the establishment of the NTD programme, a nationwide survey was 
conducted amongst 1,489 males, they were examined to determine the morbidity of the 
LF. Results from the survey indicated that 12.8% of those examined had hydrocele and 
6.3% had lymphoedema. Not much has been done on the morbidity control of the 
disease. To date, only 10 cases of hydrocelectomy has been recorded by the national 
health management information system unit of the MoH. The programme has since 
conducted three rounds of MDA for LF in 2013, 2015 and 2017 in all affected counties 
with therapeutic coverage of 83.0%.  
There is currently an MDA plan and budget for the implementation activities in 
the counties including coverage and a sentinel or spot check sites survey.  
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Based on the NTDs master plan 2016–2020, an annual implementation plan for 
the programme has been developed. The programme has also developed a 1-year 
operational plan, which is a subset of the master plan. It describes short-term ways of 
achieving milestones and explains how, or what portion of the master plan will be put 
into operation during a given operational period (MoHSW, 2016).  
  
9.1.1 SCH  
SCH is endemic in Liberia. Unfortunately, in all 15 counties in the country that have 
not been mapped for the disease, records on earlier scientific research, reports and other 
relevant documents were lost during the civil war. In 2010, there was an estimated 
nationwide prevalence of 24.0% for SCH (Jones, 2015). In some unpublished studies 
it was reported that SCH was found in mainly Bong, Nimba and Lofa Counties.  
However, a study by Dennis and colleagues (1983) on the epidemiology of SCH in  
Liberia indicated high prevalence of the disease in Central Liberia (Bong, Lofa and 
Nimba Counties) where the snail host responsible for the transmission was Bulinus 
globosus (for urinary SCH) and Biompjalaria pfeifferi (for intestinal SCH). There were 
no snail hosts of the disease in coastal regions (Dennis, et al., 1983).  
In 2012, the MoH in collaboration with its partners conducted an integrated 
mapping survey for STH and SCH using the Kato-Katz method. The results indicated 
that in Bong County the prevalence rate for S. mansoni was 63.0% and for S. 
haematobium was 56.0%, in Nimba County the prevalence rate was 38.0% for S. 
mansoni and 20.0% for S. haematobium, and in Lofa County, the prevalence rate was 
32.0% for S. mansoni and 10.0% for S. haematobium. Analysis of these results indicates 
that Margibi County showed a prevalence of 9.0% and 7.0% for S. mansoni and S. 
haematobium, respectively. The remaining counties had SCH prevalence rates ranging 
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from 0.0% to 3.0%. The distribution of SCH was 11.6% and 11.2% for S. haematobium 
and S. mansoni respectively in schoolchildren aged 5–8 years. The age group of 9–12 
years had the highest prevalence rate of 58.0% for S. haematobium and 57.0% for S. 
mansoni; age group 13–15 years followed with prevalence of 28.2% and 30.6% for S. 
haematobium and S. mansoni respectively; while age group >15 years had a low 
prevalence rate of 2.2% for S. haematobium and 1.2% for S. mansoni. These results 
showed that Bong County has the highest prevalence rate of SCH in Liberia, 
schoolchildren aged 9–12 years are the most vulnerable, and schoolchildren above 15 
years are the least affected (MoHSW, 2013).  
The MoH in 2013 conducted the study again at 38 sentinel schools in the three 
endemic counties. Results from the 2013 study showed a marked reduction in SCH 
prevalence compared to the 2011 study. Since the establishment of the NTD 
programme in the country, the MoH has conducted two rounds of MDA for STH in the 
three endemic counties and had a therapeutic coverage of 81.0% (MoHSW, 2017b).  
This integrated study on SCH and STH was conducted in Bong County amongst 
school-age children in 10 schools representing the eight health districts of Bong 
County. The study selected Bong County as an exemplar to provide up-to-date 
information for the national control programme after two rounds of MDA because of 
its high prevalence of STH. The study was a cross-sectional parasitological study 
conducted amongst 1,003 schoolchildren aged 5–15 years. The results indicated that 
12.3% of the schoolchildren were infected with S. mansoni while 11.2% were infected 
with S. haematobium. The result in this follow-up study conducted after two rounds has 
shown that there is approximately a 50.0% decrease in the prevalence of the disease in 
Bong County as compared to the 1980s and 2011 survey results. This is attributed to: 
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(i) the two MDA rounds conducted in that county; and (ii) vast migration of citizens 
from rural areas to urban areas – evident by the overpopulation in the capital in  
Monrovia and the scarcity of the population in rural areas.  
  
9.1.2 STH  
STH are widely distributed in Liberia and are prevalent in all 15 counties. A nationwide 
mapping survey was conducted for STH conducted in 2011 by the MoH and its partners 
on 59 sampled schools totalling 3,144 schoolchildren. The results indicated the 
prevalence rates of the disease as: Ascaris at 20.0%; hookworm at 9.0%; and T. 
trichiura at 3.0%. This study found generally a low prevalence of STH in Bong County 
and observed that hookworm had the highest prevalence at 3.3%. The current decrease 
in the prevalence of STH can be attributed to the annual deworming programme by the 
combined efforts of the Ministries of Education and Health as well as the inclusion of 
the deworming programme in the MoH polio campaigns.  
  
9.1.3 KAP towards SCH, LF and STH  
The present study observed the KAP towards SCH, LF and STH amongst school-age 
children in Bong County, northern Liberia. The results highlighted the need for health 
education and improved sanitation for the control of NTDs. Additional significant 
information gathered from this study on 1,003 school-age children was that 92.0% had 
not heard of LF, 86.0% had never heard of STH, and 90.0% had never heard of SCH. 
Furthermore, this study observed that only 9.0% of participants that came from the 
communities had access to pipe water; this is a major reason why these school-age 
children go to vector snails infested streams for their domestic water needs in addition 
to swamp farming.  
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9.1.4 SCH-related morbidity using ultrasound  
This study assessed SCH-related morbidity amongst school-age children in Liberia by 
use of ultrasound. This study was necessary to access the pathological changes of the 
kidney, liver and spleen after MDA. Results from this study showed that of the 272 
school-age children examined, the following pathologies were observed: hepatomegaly 
at 0.4%, splenomegaly at 1.1% and periportal fibrosis at 0.4%. There was no urinary 
bladder mass noted.  
  
9.2 A brief analysis of the county health system and the Ebola outbreak  
  
9.2.1 Health system situational analysis  
Liberia is a low-income country with an estimated GDP per capita of US$454 in 
2013. Although the real GDP growth in 2014 had been projected at 5.8%, it was 
estimated to have declined to 2.5% or less by the end of 2014 due to the EVD crisis.   
During the 14-year period (1989 to 2003), the health system was dysfunctional 
as a result of the destruction of the infrastructure and the mass exodus of the workforce. 
Since 2005, the country has made great strides in rebuilding the health system through 
reform, an introduction of the ‘Basic Package of Health Services (BPHS)’ under the 
‘National Health Policy, National Health Plan 2007–2011’ (MoHSW, 2007); and later 
the ‘Essential Package of Health Services (EPHS)’ under the ‘National Health Policy 
and Plan 2011–2012’, all of which defined the type of services to be delivered at every 
level of care, in the face of the minimum levels of resources required to provide the 
package namely, infrastructure, equipment, essential medicines and human resources  
(MoHSW, 2016).  
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The main health policy document, which is the ‘National Health and Social 
Welfare Policy’ (MoHSW, 2011c), is the blue print of the strategy that identifies the 
priority areas including decentralisation, access to basic services, increasing health 
workforce and expanding the package of health services. The strategy enables 
transformation from a highly centralised to a decentralised client-centred health care 
delivery system, focusing on the essential package of health. The service delivery 
system is pluralistic with a variety of direct service providers (government, faith-based 
organisations, local and international non-governmental organisations and the private 
sector). The government abolished user fees in 2006 towards more equitable access to 
health care. However, communities frequently reported informal payments as a 
common practice.    
There are challenges relating to facility functionality. From the 2014–2015 
health facility assessment, 13.0% of all facilities did not have access to safe drinking 
water, 43.0% had no functional incinerators, while 45.0% did not have a primary power 
source for emergency lighting. This significantly limits the readiness of facilities to 
provide the health services required in the EPHS (MoHSW, 2016).  
  
9.2.2 The Ebola outbreak (NTD)  
The outbreak of the EVD is a zoonotic tropical disease, of which should be classified 
as an NTD. Ebola is usually found in countries with low economic status and in a poorly 
prepared health sector as that of the NTDs.   
In Liberia, the outbreak was first detected in a person from Lofa County 
bordering on 22 March 2014, confirmed on 30 March 2014, and officially declared an 
EVD case by WHO on 31 March 2014. By April 2014, documented cases of EVD had 
spread from Lofa County to Margibi and Montserrado Counties. Because of the the risk 
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involved both to the study participants and the researcher during the Ebola outbreak my 
research was suspended.  
Liberia was declared EVD transmission free for the second time and certificated 
by WHO on 3 September 2015  
  
9.3 Conclusions  
The multiple burdens of different NTDs in Liberia are impediments to socioeconomic 
development of an already resource limited impoverished society with a poor health 
sector. This study showed the nationwide mapping of LF and has therefore, provided 
accurate knowledge on the distribution and epidemiology of LF and the associated 
morbidities in Liberia. This study has further quantifiably, for the first time, revealed 
the socioeconomic benefits derived from integrated MDA by significantly reducing the 
financial, logistics, manpower and time consuming burdens previously involved in the 
individual control methods used for  these NTDs. This is graphically demonstrated in 
the pre- and post-MDA surveys by a significant decrease in SCH and STH after MDA.   
  
9.4 Recommendations  
• The integrated NTD programme at the MoH should endeavour to collaborate 
with other health service-related programmes at the MoH, the Ministry of 
Education, the Liberia water and sewer company, the National Drug Service 
and other relevant stakeholders in order to maximise programme impact.   
• The establishment of a Centre of Excellence for Case Management and 
Disability Prevention of NTDs.  
• Mapping for NTD-related morbidities, such as hydrocele and lymphoedema.  
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• Annual community-based health education programmes on NTDs to be carried 
out amongst all counties in the country.  
  
9.5 Future study  
If further funding was available, in the future I would wish to carry out future studies 
related to NTDs in Liberia. The study of priority would be: ‘Using colposcopy to 
diagnose Female Genital Schistosomiasis (FGS) in Liberia: a cross-sectional study’.  
In Liberia, doctors as well as health workers are unaware of FGS, which has 
gone undiagnosed or misdiagnosed for decades. This may also be due to the similarity 
of FGS to sexually transmitted diseases (STDs). FGS is caused by S. haematobium, 
where the patient will present with vague signs, which are similar to that of any of the 
STDs such as: vaginal discharge; bloody discharge; bleeding after intercourse; spotting, 
itching or burning sensations; pelvic pain; and pain during or after intercourse.  
In my future study, I will enrol females aged 15 years and older who live in the 
three endemic counties (Bong, Lofa and Nimba) for SCH. Using the 28 images that are 
in the pocket atlas for clinical health care workers, I will use the colposcopy and carry 
out visual inspections of the cervix of the participants to help diagnose FGS.  
The results from this study will be used to sensitise the medical community in 
Liberia on FGS, to raise awareness that it is a public health concern, and to highlight 
that FGS is one of the causes of infertility amongst women who live in endemic areas, 
especially in a country where infertility is a rising problem. According to observations 
by doctors in the gynaecological outpatient clinic, a great percentage of the clinic 
attendees come with complaints of primary or secondary infertility.  
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Appendix A: Questionnaire for the Knowledge, Attitudes and  
Practices towards SCH amongst school-age children in Bong County,  
Liberia  
 
  
Name of School     ----------------------------------------------------------------------------  
  
Community -----------------------------------------------------------------------  
  
District -----------------------------------------------------------------------------  
  
Initials of person doing the survey ……………………………………………….         
  
GPS co-ordinate: Longitude …………………Latitude …………………………  
  
Demographic characteristics   
  
Date---------------------------------------------  
  
ID number -------------------------------------  
  
Name of the respondent   
  
Gender   Male {  }  Female {   }   
  
Age----------  
Level of education:  
a) K1–Grade 2  
b) Grade 3 to Grade 6  
c) Grade 7 and above  
1. Knowledge of Schistosomiasis  
Yes -------------if yes, what is your source of information?  
School  
Health workers  
Clinic/hospital  
Relatives  
Parents  
Town chiefs  
I don’t have knowledge of schistosomiasis   
Others specify   
2. Knowledge of sign and symptoms of Schistosomiasis   
Bloody urine (blood in your pee pee)  
Bloody stool (blood in your pop poo)  
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Abdominal pain  
Diarrhoea  
Headache   
Fever  
Chills  
Itching skin/rash  
3. What germ causes schistosomiasis?  
Worm  
Fresh water  
Snail   
Other specify -------------------------  
Don’t know  
4. Water contact pattern  
Where do you get your water from a well/creek/river/hand pump?  
Do you play in fresh water ponds or streams?  
Where do you wash your cloths in the river/creek?  
Do you pick up snails from the swamp?  
Have you helped your parents with their rice farm?  
Do you wash your cloths in the fresh water?  
Where do you get your drinking water from? 
5. Presence of latrine Toilet in the house?  
Go to the nearby toilet house?  
Go to the bush to toilet?  
Go to the waterside to toilet?  
6. Do you know how to prevent Schistosomiasis?  
Avoiding unsafe drinking water  
Washing hands before having a meal  
Washing hands when leaving the bathroom Not 
playing and swimming in unsafe water  
Don’t eat uncooked snail  
Wash fruits and vegetables before eating   
Taking the medications for schistosomiasis during MDA  
7. Mass Drug Administration   
Do you know of any drug distribution in this community where people’s height were 
taken?  
How many drugs did you receive?  
Have you received the medication for schistosomiasis?  
How many times have you received the schistosomiasis medication? Who 
gave you the medication?  
    
Appendix B: Assessment of Knowledge Awareness and Attitude to 
MDA intervention for the control of LF, northern Liberia (Bong, Lofa,  
and Nimba Counties): A post-Ebola survey  
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Name: Dr Louise Mapleh Kpoto, Tel: 0777702609, Health worker       Name:     Tel: 
ID number:  
  
GIS co-ordinates:  
Latitude:  
Longitude:  
A) Sociodemographic characteristics    
1. Age      
2. Sex                                      Male              Female   
3. Marital status    
a) Married  
b) Single   
c) Divorced   
d) Widowed   
e) Cohabiting   
4. Occupation   
a) Farmer   
b) Fisherman   
c) Hunter   
d) House wife   
e) Business person  
f) Others   
5. Religion   
a) Christian   
b) Muslim   
6. Level of education  
a) Have never had formal education    
b) Elementary   
c) Junior high  
205  
d) High school   
e) Completed high school   
B) Knowledge of the disease (you can tick more than one)  
1. Have you heard of the disease LF  a) Yes   b) No  
2. If yes, how does it present?  
a) Enlarged leg   
b) Enlarged scrotum   
c) Enlarged breast   
d) Fever and chills   
e) Mumps  
3. How does one get the disease?  
a) Through traditional rituals  
b) Through drinking dirty water  
c) Through farming   
d) Through mosquito bites  
e) Don’t know  
d) Others   
C) Prevention  
1. Do you know how the disease is prevented?   Yes    NO   
a) By taking medication  
b) By drinking clean water   
c) By using mosquito nets  
d) By spraying your house  
e) Others  
D) Drug distribution/compliance   
a) Has there been drug distribution in your community for LF? Yes or NO  
b) Did you take some of the medications? Yes or No  
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c) How many times was the drug distributed? a)  one b) two   c) three   d) four   
d) Did everyone in your house take the medications? Yes or No  
e) If no, why did they refuse the medication?  
f) How many tablets were given per person?  a) one b) two c) three   
  
1. What are the side effects of the drug?  
a) Nausea  
b) Vomiting  
c) Fever and chills  
d) Itching of skin  
e) Impotency   
f) Weakness/dizziness   
g) Abdominal pains  
h) Diarrhoea  
i) Sweating  
j) Blood in faeces   
2. If these drugs were distributed would you take it again? Yes or No  
Question on the Ebola  
1. Were you or your family affected by the Ebola? Yes or No  
2. If yes, were you in the Ebola Treatment Unit? Yes or No  
3. Did you have a family member in the Ebola Treatment Unit? Yes or No   
4. Did you have a friend in the Eboal Treatment Unit? Yes or No   
5. Did you lose a friend to the Ebola? Yes or No  
6. Did you lose a family member to the Ebola? Yes or No  
7. During the Ebola did you have assess to health care? Yes or No  
8. Do you know how Ebola is prevented? Yes or No  
9. Select any answer  
a) By washing hand  
b) By avoiding others  
c) By praying  
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d) Don’t know  
e) Others   
10 Do you know how Ebola is acquired?  
a) Through food  
b) Through witchcraft  
c) Through hand shake  
d) By bodily fluids  
e) Don’t know  
f) By touching others      
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Appendix C: A practical guide to the standardised use of  
ultrasonography for the assessment of SCH-related morbidity  
 
  
See: www.who.int/schistosomiasis/resources/tdr_str_sch_00.1/en/  
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Appendix D: Informed Consent Form for lymphatic filariasis,  
schistosomiasis prevalence study  
 
  
Study participants ID#   
  
  
Informed Consent  
This Informed Consent Form is for men and women living in the targeted study villages 
who we are inviting to participate in research on the effectiveness of integrated mass 
drug administration in an environment that has not previously received treatment 
through community health workers. The title of our research project is: ‘Integrated 
Approach to the Control of Lymphatic Filariasis, Schistosomiasis and Soil-Transmitted 
Helminthiasis in Liberia, West Africa’.  
  
Principal investigators:   Louise Kpoto  
  
Liverpool School of Tropical Medicine, Liverpool, UK  
  
This Informed Consent Form has two parts:  
• Information Sheet (to share information about the research with you)  
• Certificate of Consent (for signatures if you agree to take part)  
  
You will be given a copy of the full Informed Consent Form  
  
  
PART I: Information Sheet Introduction  
Hello, my name is ____________________and I am in from the Ministry of Health and 
Social Welfare. We are conducting a study about a disease called lymphatic filariasis 
(Guah), which are very common in this county. I am going to give you some 
information about the study and invite you to be part of this research. We would very 
much appreciate your participation; however, your participation is completely 
voluntary. Before you decide, you can talk to anyone you feel comfortable with about 
the research.   
  
There may be some words that you do not understand. Please ask me to stop as we go 
through the information and I will take time to explain. If you have questions later, you 
can ask them of me or any of the other members of the research team.  
  
Purpose of the research  
Lymphatic filariasis is a common disease in this region, spread by mosquitoes. The 
infection is usually acquired in childhood; however, the painful and disfiguring visible 
manifestations are normally visible later on in life. Men suffering from the disease are 
commonly found with hydrocoeles, while both men and women will suffer with 
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enlarged and inflamed limbs. The treatments for this disease are two tablets that will be 
provided by your community health volunteer once a year for everyone in the village, 
including children. For effective treatment it is important to take the tablets every year.  
  
We want to determine if you are affected with this disease. Results from the research 
will then be used by the Ministry of Health in providing treatment for children in this 
district.  
  
Participant selection  
We are inviting healthy adults living in your village to participate in this study.  
  
Voluntary participation  
Your participation in this research is entirely voluntary. It is your choice whether to 
participate or not. You may change your mind later and stop participating even if you 
agreed earlier.  
  
Procedures and protocol  
If you agree to participate, we will first ask you some basic questions about yourself 
and the people living in your household, such as your age, the location of your home, 
how long you have lived in this community, and the type of methods you use in your 
household to control mosquitoes.   
  
Lymphatic filariaisis  
We will take blood from your finger using a lancet. The blood will be tested to 
determine if you have been exposed to lymphatic filariasis and if you have active 
disease.  
  
We will first clean the finger to be pricked with an alcohol swab and allow the finger to 
dry. We will then prick the finger with a sterile lancet and a small amount of your blood 
will be placed on a test card (show a test card). We will share the results with you.  
  
We will also be conducting an additional test for detecting lymphatic filariasis; where 
a very small volume of blood will be collected from another finger approximately 2 mL 
taken at night between 22:00 hours and 02:00 hours will be mixed with approximately 
10 times its volume of distilled water in a simple slide counting chamber and examine 
the slide immediately. We will also share these results with you.  
  
The blood obtained during this research procedure will be used only for this research. 
At the end of the research, in 2 years, any leftover blood sample will be destroyed.   
  
Duration   
Our research study will take about 2 years to complete. During this time, we will return 
to your community to repeat the blood testing on a random sample of the community 
about once per year. When we return, you may or may not be included again in the 
study. Your participation at this time will take place over the next 2 days. During this 
time, we will ask you some simple questions about your household using a 
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questionnaire. This should take approximately 10 minutes. We will then conduct the 
blood test.   
  
Side effects  
Potential side effects are limited. You may experience some mild discomfort at the site 
of the blood drawn from your finger.    
Benefits   
There will not be any monetary benefit for you but your participation is likely to help 
us find the answer to the research question and if people in this county are found with 
the disease they will receive treatment through Mass Drug Administration.    
  
Confidentiality  
With this research, something out of the ordinary is being done in your community. It 
is possible that if others in the community are aware that you are participating, they 
may ask you questions. We will not be sharing the identity of those participating in the 
research.    
  
The information that we collect from this research project will be kept confidential. 
Information about you that will be collected during the research will be put away and 
no-one but the researchers will be able to see it. Any information about you will have a 
number on it instead of your name. Only the researchers will know what your number 
is and we will lock that information up with a lock and key. It will not be shared with 
or given to anyone except the senior members of our research team.  
  
Sharing the results  
The knowledge that we get from doing this research will be shared with you through 
community meetings before it is made widely available to the public. Confidential 
information will not be shared. There will be small meetings in the community and 
these will be announced. After these meetings, we will publish the results in order that 
other interested people may learn from our research.  
  
Right to refuse or withdraw  
You do not have to take part in this research if you do not wish to do so. You may also 
stop participating in the research at any time you choose. It is your choice and all of 
your rights will be respected.  
  
Who to contact  
If you have any questions you may ask them now or later, even after the study has 
started. If you wish to ask questions later, you may contact any of the following: Dr 
Louise Kpoto MoH&SW, Tel: 06514469; Mr Jerry Diaboi Tel: 06543567.  
  
This proposal has been reviewed and approved by the University of Liberia, which is a 
committee whose task it is to make sure that research participants are protected from 
harm. If you wish to find about more about the University of Liberia Institutional 
Review Board, contact: Mr Jamee, University of Liberia Tel: 06583774.   
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PART II: Certificate of consent  
I have read the foregoing information, or it has been read to me. I have had the 
opportunity to ask questions about it and any questions that I have asked have been 
answered to my satisfaction. I consent voluntarily to participate as a participant in this 
research.  
  
Print Name of Participant__________________            
Signature of Participant ___________________  
Date ___________________________  
  Day/Month/Year       
If illiterate  
I have witnessed the accurate reading of the consent form to the potential participant, 
and the individual has had the opportunity to ask questions. I confirm that the individual 
has given consent freely.   
  
Print name of witness_____________________             AND         Thumb print of 
participant  
Signature of witness ______________________  
Date ________________________  
                Day/Month/Year  
Statement by the researcher/person taking consent  
I have accurately read out the information sheet to the potential participant, and to the 
best of my ability made sure that the participant understands the study procedures.  
  
I confirm that the participant was given an opportunity to ask questions about the study, 
and all the questions asked by the participant have been answered correctly and to the 
best of my ability. I confirm that the individual has not been coerced into giving consent, 
and the consent has been given freely and voluntarily.   
  
A copy of this Informed Consent Form has been provided to the participant.  
  
Print Name of researcher/person taking the consent________________________   
Signature of researcher /person taking the consent__________________________  
Date ___________________________        
                 Day/Month/Year  
  
